Section 55

EurekaMag PDF full texts Chapter 54,103


De Araújo, C.F.; Silva, V.ín.M.G.; Cronemberger-Andrade, A.; Aragão-França, L.S.; Rocha, V.C.J.; Santos, P.S.L.; Pontes-de-Carvalho, L. 2014: Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally. Bmc Research Notes 7: 70
Pereira-Carvalho, R.; Mendes-Aguiar, C.O.; Oliveira-Neto, M.P.; Covas, C.áu.J.F.; Bertho, A.L.; Da-Cruz, A.M.; Gomes-Silva, A. 2013: Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous Leishmaniasis, but the renewal capacity of T effector memory compartments is preserved. Plos one 8(11): E81529
Campos-Muñoz, L.; Quesada-Cortés, A.; Martín-Díaz, M.A.; Rubio-Flores, C.; de Lucas-Laguna, R. 2007: Leishmania braziliensis: report of a pediatric imported case with response to liposomal amphotericin B. Actas Dermo-Sifiliograficas 98(1): 42-44
Humberg, R.M.P.; Oshiro, E.T.; Cruz, M.d.S.P.E.; Ribolla, P.E.M.; Alonso, D.P.; Ferreira, A.M.T.; Bonamigo, R.A.; Tasso, N.; de Oliveira, A.G. 2012: Leishmania chagasi in opossums (Didelphis albiventris) in an urban area endemic for visceral leishmaniasis, Campo Grande, Mato Grosso do Sul, Brazil. American Journal of Tropical Medicine and Hygiene 87(3): 470-472
Vides, J.P.; Schwardt, T.F.; Sobrinho, L.S.V.; Marinho, M.ár.; Laurenti, M.ár.D.; Biondo, A.W.; Leutenegger, C.; Marcondes, M. 2011: Leishmania chagasi infection in cats with dermatologic lesions from an endemic area of visceral leishmaniosis in Brazil. Veterinary Parasitology 178(1-2): 22-28
Santos, P.L.; Costa, R.V.; Braz, J.M.; Santos, L.F.V.C.; Batista, A.C.; Vasconcelos, C.R.O.; Rangel, M.R.; Ribeiro de Jesus, A.; de Moura, T.R.; Leopoldo, P.T.G.; Almeida, R.P. 2012: Leishmania chagasi naturally resistant to nitric oxide isolated from humans and dogs with visceral leishmaniasis in Brazil. Nitric Oxide: Biology and Chemistry 27(1): 67-71
Malafaia, G.; Marcon, L.íc.d.N.; Pereira, L.d.F.át.; Pedrosa, M.L.úc.; Rezende, S.A. 2011: Leishmania chagasi: effect of the iron deficiency on the infection in BALB/c mice. Experimental Parasitology 127(3): 719-723
McAvin, J.C.; Swanson, K.I.; Chan, A.S.T.; Quintana, M.; Coleman, R.E. 2012: Leishmania detection in sand flies using a field-deployable real-time analytic system. Military Medicine 177(4): 460-466
Descoteaux, A.; Moradin, N.; Arango Duque, G. 2013: Leishmania dices away cholesterol for survival. Cell Host and Microbe 13(3): 245-247
Chrobak, M.; Förster, S.; Meisel, S.; Pfefferkorn, R.; Förster, F.; Clos, J. 2012: Leishmania donovani HslV does not interact stably with HslU proteins. International Journal for Parasitology 42(4): 329-339
Nico, D.; Gomes, D.C.; Palatnik-de-Sousa, I.; Morrot, A.; Palatnik, M.; Palatnik-de-Sousa, C.B. 2014: Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection. Frontiers in Immunology 5: 273
Smirlis, D.; Boleti, H.; Gaitanou, M.; Soto, M.; Soteriadou, K. 2009: Leishmania donovani Ran-GTPase interacts at the nuclear rim with linker histone H1. Biochemical Journal 424(3): 367-374
Mukherjee, M.; Basu Ball, W.; Das, P.K. 2014: Leishmania donovani activates SREBP2 to modulate macrophage membrane cholesterol and mitochondrial oxidants for establishment of infection. International Journal of Biochemistry and Cell Biology 55: 196-208
Ball, W.B.; Mukherjee, M.; Srivastav, S.; Das, P.K. 2014: Leishmania donovani activates uncoupling protein 2 transcription to suppress mitochondrial oxidative burst through differential modulation of SREBP2, Sp1 and USF1 transcription factors. International Journal of Biochemistry and Cell Biology 48: 66-76
Matte, C.; Descoteaux, A. 2010: Leishmania donovani amastigotes impair gamma interferon-induced STAT1alpha nuclear translocation by blocking the interaction between STAT1alpha and importin-alpha5. Infection and Immunity 78(9): 3736-3743
Lakhal-Naouar, I.; Jardim, A.; Strasser, R.; Luo, S.; Kozakai, Y.; Nakhasi, H.L.; Duncan, R.C. 2012: Leishmania donovani argininosuccinate synthase is an active enzyme associated with parasite pathogenesis. Plos Neglected Tropical Diseases 6(10): E1849
Karunaweera, N.D. 2009: Leishmania donovani causing cutaneous leishmaniasis in Sri Lanka: a wolf in sheep's clothing?. Trends in Parasitology 25(10): 458-463
Gadisa, E.; Kuru, T.; Genet, A.; Engers, H.; Aseffa, A.; Gedamu, L. 2010: Leishmania donovani complex (Kinetoplastida, Trypanosomatidae): comparison of deoxyribonucleic acid based techniques for typing of isolates from Ethiopia. Experimental Parasitology 126(2): 203-208
Vinet, A.F.; Descoteaux, A. 2010: Leishmania donovani delays phagolysosomal acidification. Medecine Sciences: M/S 26(3): 227-228
García-Hernández, R.; Manzano, J.é I.; Castanys, S.; Gamarro, F. 2012: Leishmania donovani develops resistance to drug combinations. Plos Neglected Tropical Diseases 6(12): E1974
Biyani, N.; Madhubala, R. 2011: Leishmania donovani encodes a functional enzyme involved in vitamin C biosynthesis: arabino-1,4-lactone oxidase. Molecular and Biochemical Parasitology 180(2): 76-85
Singh, S.; Raju, K.; Jatekar, D.; Dinesh, N.; Paul, M.S.; Sobhia, M.E. 2014: Leishmania donovani eukaryotic initiation factor 5A: molecular characterization, localization and homology modelling studies. Microbial Pathogenesis 73: 37-46
Srivastav, S.; Kar, S.; Chande, A.G.; Mukhopadhyaya, R.; Das, P.K. 2012: Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response. Journal of Immunology 189(2): 924-934
Karmakar, S.; Paul, J.; De, T. 2011: Leishmania donovani glycosphingolipid facilitates antigen presentation by inducing relocation of CD1d into lipid rafts in infected macrophages. European Journal of Immunology 41(5): 1376-1387
Marr, A.K.; MacIsaac, J.L.; Jiang, R.; Airo, A.M.; Kobor, M.S.; McMaster, W.R. 2014: Leishmania donovani infection causes distinct epigenetic DNA methylation changes in host macrophages. Plos Pathogens 10(10): E1004419
Chandra, D.; Naik, S. 2008: Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clinical and Experimental Immunology 154(2): 224-234
Lafuse, W.P.; Story, R.; Mahylis, J.; Gupta, G.; Varikuti, S.; Steinkamp, H.; Oghumu, S.; Satoskar, A.R. 2013: Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleen. Plos one 8(3): E59509
Haldar, A.K.; Yadav, V.; Singhal, E.; Bisht, K.K.; Singh, A.; Bhaumik, S.; Basu, R.; Sen, P.; Roy, S. 2010: Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation. Plos Pathogens 6(5): E1000907
Léger, N.; Depaquit, Jérôme. 2008: Leishmania donovani leishmaniasis in Cyprus. Lancet. Infectious Diseases 8(7): 402
Antoniou, M.; Haralambous, C.; Mazeris, A.; Pratlong, F.; Dedet, J.-P.; Soteriadou, K. 2009: Leishmania donovani leishmaniasis in Cyprus. LANCET. Infectious Diseases 9(2): 76-77
Getachew, F.; Gedamu, L. 2012: Leishmania donovani mitochondrial iron superoxide dismutase A is released into the cytosol during miltefosine induced programmed cell death. Molecular and Biochemical Parasitology 183(1): 42-51
Boitz, J.M.; Yates, P.A.; Kline, C.; Gaur, U.; Wilson, M.E.; Ullman, B.; Roberts, S.C. 2009: Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host. Infection and Immunity 77(2): 756-763
Das, P.; Amit, A.; Singh, S.Kumar.; Chaudhary, R.; Dikhit, M.Ranjan.; Yadav, A.; Pandey, K.; Das, V.Nand.Rabi.; Sundram, S.; Das, P.; Bimal, S. 2015: Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis. Parasitology international 64(1): 18-25
Baleela, R.; Llewellyn, M.S.; Fitzpatrick, S.; Kuhls, K.; Schönian, G.; Miles, M.A.; Mauricio, I.L. 2014: Leishmania donovani populations in Eastern Sudan: temporal structuring and a link between human and canine transmission. Parasites and Vectors 7: 496
Srivastav, S.; Basu Ball, W.; Gupta, P.; Giri, J.; Ukil, A.; Das, P.K. 2014: Leishmania donovani prevents oxidative burst-mediated apoptosis of host macrophages through selective induction of suppressors of cytokine signaling (SOCS) proteins. Journal of Biological Chemistry 289(2): 1092-1105
Gabriel, C.; McMaster, W.R.; Girard, D.; Descoteaux, A. 2010: Leishmania donovani promastigotes evade the antimicrobial activity of neutrophil extracellular traps. Journal of Immunology 185(7): 4319-4327
Daifalla, N.S.; Bayih, A.G.; Gedamu, L. 2012: Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection. Experimental Parasitology 131(3): 317-324
Messaritakis, I.; Mazeris, A.; Koutala, E.; Antoniou, M. 2010: Leishmania donovani s.l.: evaluation of the proliferation potential of promastigotes using CFSE staining and flow cytometry. Experimental Parasitology 125(4): 384-388
Gupta, P.; Giri, J.; Srivastav, S.; Chande, A.G.; Mukhopadhyaya, R.; Das, P.K.; Ukil, A. 2014: Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 28(4): 1756-1768
Kushawaha, P.K.; Gupta, R.; Tripathi, C.D.P.; Khare, P.; Jaiswal, A.K.; Sundar, S.; Dube, A. 2012: Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis. Plos one 7(9): E45766
Rai, S.; Dwivedi, U.N.; Goyal, N. 2009: Leishmania donovani trypanothione reductase: role of urea and guanidine hydrochloride in modulation of functional and structural properties. Biochimica et Biophysica Acta 1794(10): 1474-1484
Narayan, S.; Bimal, S.; Singh, S.K.; Gupta, A.K.; Singh, V.P.; Sinha, P.K.; Das, P. 2009: Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis. Experimental Parasitology 121(1): 69-75
Mutiso, J.M.; Macharia, J.C.; Taracha, E.; Gicheru, M.M. 2012: Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops). Journal of Biomedical Research 26(1): 8-16
Ranasinghe, S.; Zhang, W.-W.; Wickremasinghe, R.; Abeygunasekera, P.; Chandrasekharan, V.; Athauda, S.; Mendis, S.; Hulangamuwa, S.; Matlashewski, G.; Pratlong, F. 2012: Leishmania donovani zymodeme MON-37 isolated from an autochthonous visceral leishmaniasis patient in Sri Lanka. Pathogens and Global Health 106(7): 421-424
Bimal, S.; Sinha, S.; Singh, S.K.; Narayan, S.; Kumar, V.; Verma, N.; Ranjan, A.; Sinha, P.K.; Das, V.N.R.; Pandey, K.; Kar, S.K.; Das, P. 2012: Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection. Experimental Parasitology 131(3): 274-282
Kaur, J.; Singh, B.K.; Tripathi, R.P.; Singh, P.; Singh, N. 2009: Leishmania donovani: a glycosyl dihydropyridine analogue induces apoptosis like cell death via targeting pteridine reductase 1 in promastigotes. Experimental Parasitology 123(3): 258-264
Singh, S.K.; Bimal, S.; Narayan, S.; Jee, C.; Bimal, D.; Das, P.; Bimal, R. 2011: Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India. Experimental Parasitology 127(2): 552-558
Kumar, V.; Bimal, S.; Singh, S.K.; Chaudhary, R.; Das, S.; Lal, C.; Pandey, K.; Das, V.R.; Das, P. 2014: Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis. Nutrition 30(4): 449-458
Hamad, S.H.; Khalil, E.A.G.; Musa, A.M.; Ibrahim, M.E.; Younis, B.M.; Elfaki, M.E.E.; El-Hassan, A.M. 2010: Leishmania donovani: genetic diversity of isolates from Sudan characterized by PCR-based RAPD. Experimental Parasitology 125(4): 389-393
Kumari, S.; Misra, P.; Tandon, R.; Samant, M.; Sundar, S.; Dube, A. 2012: Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters. Plos one 7(1): E30746
Shivam, P.; Jamal, F.; Kumari, S.; Bimal, S.; Narayan, S.; Das, V.N.R.; Pandey, K.; Gupta, A.K.; Singh, D.; Verma, N.; Das, P.; Singh, S.K. 2013: Leishmania donovani: influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis. Human Immunology 74(12): 1575-1578
Kaur, J.; Singh, N.; Singh, B.K.; Dube, A.; Tripathi, R.P.; Singh, P.; Singh, N. 2010: Leishmania donovani: oral therapy with glycosyl 1,4-dihydropyridine analogue showing apoptosis like phenotypes targeting pteridine reductase 1 in intracellular amastigotes. Experimental Parasitology 125(3): 310-314
Pérez-Pertejo, Y.; Alvarez-Velilla, R.; Estrada, C.G.ía.; Balaña-Fouce, R.; Reguera, R.M. 2011: Leishmania donovani: proteasome-mediated down-regulation of methionine adenosyltransferase. Parasitology 138(9): 1082-1092
Berrocal-Lobo, M.; Molina, A.; Rodríguez-Palenzuela, P.; García-Olmedo, F.; Rivas, L. 2009: Leishmania donovani: thionins, plant antimicrobial peptides with leishmanicidal activity. Experimental Parasitology 122(3): 247-249
Louzir, H.; Aoun, K.; Späth, G.F.; Laouini, D.; Prina, E.; Victoir, K.; Bouratbine, Aïda. 2013: Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of Pasteur Institutes. Medecine Sciences: M/S 29(12): 1151-1160
Koutsoni, O.; Barhoumi, M.; Guizani, I.; Dotsika, E. 2014: Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages. Plos one 9(5): E97319
Silverman, J.M.; Reiner, N.E. 2011: Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection. Frontiers in Cellular and Infection Microbiology 1: 26
Silverman, J.M.; Clos, J.; Horakova, E.; Wang, A.Y.; Wiesgigl, M.; Kelly, I.; Lynn, M.A.; McMaster, W.R.; Foster, L.J.; Levings, M.K.; Reiner, N.E. 2010: Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. Journal of Immunology 185(9): 5011-5022
Listovsky, T.; Brandeis, M.; Zilberstein, D. 2011: Leishmania express a functional Cdc20 homologue. Biochemical and Biophysical Research Communications 408(1): 71-77
Srivastava, S.; Pandey, S.P.; Jha, M.K.; Chandel, H.S.; Saha, B. 2013: Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses. Clinical and Experimental Immunology 172(3): 403-409
Lakshmi, B.S.; Wang, R.; Madhubala, R. 2014: Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis. Vaccine 32(30): 3816-3822
Singh, G.; Shabani-Rad, M.-T.; Vanderkooi, O.G.; Vayalumkal, J.V.; Kuhn, S.M.; Guilcher, G.M.T.; Steele, M. 2013: Leishmania in HLH: a rare finding with significant treatment implications. Journal of Pediatric Hematology/Oncology 35(3): E127-E129
Mock, D.J.; Hollenbaugh, J.A.; Daddacha, W.; Overstreet, M.G.; Lazarski, C.A.; Fowell, D.J.; Kim, B. 2012: Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection. Plos Pathogens 8(4): E1002635
Durán-Martínez, M.; Ferroglio, E.; Acevedo, P.; Trisciuoglio, A.; Zanet, S.; Gortázar, C.; Ruiz-Fons, F. 2013: Leishmania infantum (Trypanosomatida: Trypanosomatidae) phlebotomine sand fly vectors in continental Mediterranean Spain. Environmental Entomology 42(6): 1157-1165
Rico, E.; Oliva, C.; Gutierrez, K.J.ús.; Alzate, J.F.; Genes, C.M.; Moreno, D.; Casanova, E.; Gigante, A.; Pérez-Pérez, M.ía.-J.ús.; Camarasa, M.ía.-J.é; Clos, J.; Gago, F.; Jiménez-Ruiz, A. 2014: Leishmania infantum EndoG is an endo/exo-nuclease essential for parasite survival. Plos one 9(2): E89526
Carrión, J.; Folgueira, C.; Soto, M.; Fresno, M.; Requena, J.M. 2011: Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation. Parasites and Vectors 4: 150
Barhoumi, M.; Garnaoui, A.; Kaabi, B.; Tanner, N.K.; Guizani, I. 2011: Leishmania infantum LeIF and its recombinant polypeptides modulate interleukin IL-12p70, IL-10 and tumour necrosis factor-α production by human monocytes. Parasite Immunology 33(10): 583-588
Bessad, A.; Mouloua, K.; Kherrachi, I.; Benbetka, S.; Benikhlef, R.; Mezai, G.; Harrat, Z. 2012: Leishmania infantum MON-1 isolated from a golden jackal (Canis aureus) in Grande Kabylie (Algeria). Bulletin de la Societe de Pathologie Exotique 105(1): 5-7
Garg, R.; Barat, C.; Ouellet, M.; Lodge, R.; Tremblay, M.J. 2009: Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-alpha. Plos Neglected Tropical Diseases 3(5): E441
Christodoulou, V.; Messaritakis, I.; Svirinaki, E.; Tsatsanis, C.; Antoniou, M. 2011: Leishmania infantum and Toxoplasma gondii: Mixed infection of macrophages in vitro and in vivo. Experimental Parasitology 128(3): 279-284
Barrio, A.; Parodi, C.M.; Locatelli, F.; Mora, M.ía.C.; Basombrío, M.A.; Korenaga, M.; Hashiguchi, Y.; García Bustos, M.ía.F.; Gentile, A.; Marco, J.D. 2012: Leishmania infantum and human visceral leishmaniasis, Argentina. Emerging Infectious Diseases 18(2): 354-355
Lima, I.D.; Queiroz, J.W.; Lacerda, H.G.; Queiroz, P.V.S.; Pontes, N.N.; Barbosa, J.D.A.; Martins, D.R.; Weirather, J.L.; Pearson, R.D.; Wilson, M.E.; Jeronimo, S.M.B. 2012: Leishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeter. American Journal of Tropical Medicine and Hygiene 86(1): 99-107
DebRoy, S.; Keenan, A.B.; Ueno, N.; Jeronimo, S.M.B.; Donelson, J.E.; Wilson, M.E. 2010: Leishmania infantum chagasi: a genome-based approach to identification of excreted/secreted proteins. Experimental Parasitology 126(4): 582-591
Vasconcellos, R.D.S.; Mariotini-Moura, C.; Gomes, R.S.; Serafim, T.D.; Firmino, R.d.C.ás.; Silva E Bastos, M.; Castro, F.F.d.; Oliveira, C.M.d.; Borges-Pereira, L.; de Souza, A.C.áu.A.; de Souza, R.F.; Gómez, G.A.T.; Pinheiro, A.d.C.; Maciel, T.E.F.; Silva-Júnior, A.; Bressan, G.C.; Almeida, M.ár.R.ér.; Baqui, M.M.A.; Afonso, L.ís.C.C.; Fietto, J.L.R. 2014: Leishmania infantum ecto-nucleoside triphosphate diphosphohydrolase-2 is an apyrase involved in macrophage infection and expressed in infected dogs. Plos Neglected Tropical Diseases 8(11): E3309
Podaliri Vulpiani, M.; Iannetti, L.; Di Mattia, T.; Dalla Villa, P. 2009: Leishmania infantum in a Central Italy dog shelter: retrospective study of serologic reactivity during a 4-year period in a confined dog population subjected to preventive and therapeutic treatment. Veterinary Parasitology 160(3-4): 190-197
Ruiz-Fons, F.; Ferroglio, E.; Gortázar, C. 2013: Leishmania infantum in free-ranging hares, Spain, 2004-2010. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 18(30): 20541
Gazanion, E.; Seblova, V.; Votypka, J.; Vergnes, B.; Garcia, D.éb.; Volf, P.; Sereno, D. 2012: Leishmania infantum nicotinamidase is required for late-stage development in its natural sand fly vector, Phlebotomus perniciosus. International Journal for Parasitology 42(4): 323-327
Rogers, M.E.; Corware, K.; Müller, I.; Bates, P.A. 2010: Leishmania infantum proteophosphoglycans regurgitated by the bite of its natural sand fly vector, Lutzomyia longipalpis, promote parasite establishment in mouse skin and skin-distant tissues. Microbes and Infection 12(11): 875-879
Zhou, X.; Wang, H.; Koles, N.L.; Zhang, A.; Aronson, N.E. 2014: Leishmania infantum-chagasi activates SHP-1 and reduces NFAT5/TonEBP activity in the mouse kidney inner medulla. American Journal of Physiology. Renal Physiology 307(5): F516-F524
Coelho-Finamore, J.M.; Freitas, V.C.; Assis, R.R.; Melo, M.N.; Novozhilova, N.; Secundino, N.F.; Pimenta, P.F.; Turco, S.J.; Soares, R.P. 2011: Leishmania infantum: Lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts. International Journal for Parasitology 41(3-4): 333-342
Ordóñez-Gutiérrez, L.; Martínez, M.; Rubio-Somoza, I.; Díaz, I.; Mendez, S.; Alunda, J.M. 2009: Leishmania infantum: antiproliferative effect of recombinant plant cystatins on promastigotes and intracellular amastigotes estimated by direct counting and real-time PCR. Experimental Parasitology 123(4): 341-346
Maia, C.; Dionísio, Lídia.; Afonso, M.Odete.; Neto, Lís.; Cristóvão, Jé.Manuel.; Campino, L. 2013: Leishmania infection and host-blood feeding preferences of phlebotomine sandflies and canine leishmaniasis in an endemic European area, the Algarve Region in Portugal. Memorias do Instituto Oswaldo Cruz 108(4): 481-487
Penaforte, K.M.; Belo, V.íc.S.; Teixeira-Neto, R.G.ça.; Ribeiro, R.A.N.; de Oliveira, R.B.; Schettini, D.A.; da Silva, E.S. 2013: Leishmania infection in a population of dogs: an epidemiological investigation relating to visceral leishmaniasis control. Revista Brasileira de Parasitologia Veterinaria 22(4): 592-596
Felipe, I.M.A.; Aquino, D.M.C.d.; Kuppinger, O.; Santos, M.D.C.; Rangel, M.íc.E.S.; Barbosa, D.S.; Barral, A.; Werneck, G.L.; Caldas, A.d.J.M. 2011: Leishmania infection in humans, dogs and sandflies in a visceral leishmaniasis endemic area in Maranhão, Brazil. Memorias do Instituto Oswaldo Cruz 106(2): 207-211
Donovan, M.J.; Maciuba, B.Z.; Mahan, C.E.; McDowell, M.A. 2009: Leishmania infection inhibits cycloheximide-induced macrophage apoptosis in a strain-dependent manner. Experimental Parasitology 123(1): 58-64
Faria, M.S.; Reis, F.C.G.; Azevedo-Pereira, R.L.; Morrison, L.S.; Mottram, J.C.; Lima, A.Paula.C.A. 2011: Leishmania inhibitor of serine peptidase 2 prevents TLR4 activation by neutrophil elastase promoting parasite survival in murine macrophages. Journal of Immunology 186(1): 411-422
Ben-Othman, R.; Guizani-Tabbane, L.; Dellagi, K. 2008: Leishmania initially activates but subsequently down-regulates intracellular mitogen-activated protein kinases and nuclear factor-kappaB signaling in macrophages. Molecular Immunology 45(11): 3222-3229
Bhardwaj, S.; Srivastava, N.; Sudan, R.; Saha, B. 2010: Leishmania interferes with host cell signaling to devise a survival strategy. Journal of Biomedicine and Biotechnology 2010: 109189
Lodge, R.; Descoteaux, A. 2008: Leishmania invasion and phagosome biogenesis. Sub-Cellular Biochemistry 47: 174-181
Maubon, D.èl.; Guillou, C.T.; Ravel, C.; Leccia, M.-T.ér.ès.; Pelloux, H.é 2009: Leishmania killicki imported from Tunisian desert. Emerging Infectious Diseases 15(11): 1864-1865
Zappacosta, R.; Claudi, R.; Magnasco, S.; Dell'osa, E. 2010: Leishmania life cycle images in the cutaneous cytologic smear of an immunocompetent patient. Journal of Cytology 27(1): 35-36
Zhu, Y.; Davis, A.; Smith, B.J.; Curtis, J.; Handman, E. 2009: Leishmania major CorA-like magnesium transporters play a critical role in parasite development and virulence. International Journal for Parasitology 39(6): 713-723
Daneshvar, H.; Burchmore, R.; Hagan, P.; Phillips, R.Stephen. 2009: Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major. Parasitology 136(11): 1243-1250
Kumari, S.; Singh, S.; Saha, B.; Paliwal, P.K. 2011: Leishmania major MAP kinase 10 is protective against experimental L. major infection. Vaccine 29(48): 8783-8787
Morales, M.A.; Pescher, P.; Späth, G.F. 2010: Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage. Eukaryotic Cell 9(1): 22-30
Derbali, M.; Chelbi, I.; Ben Hadj Ahmed, S.; Zhioua, E. 2012: Leishmania major Yakimoff et Schokhor, 1914 (Kinetoplastida: Trypanosomatidae) in Meriones shawi Duvernoy, 1842 (Rodentia: Gerbillidae): persistence of the infection in meriones and its infectivity for the sand fly vector (Phlebotomus) papatasi Scopoli, 1786 (Diptera: Psychodidae). Bulletin de la Societe de Pathologie Exotique 105(5): 399-402
Makala, L.H.C.; Baban, B.; Lemos, H.; El-Awady, A.R.; Chandler, P.R.; Hou, D.-Y.; Munn, D.H.; Mellor, A.L. 2011: Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. Journal of Infectious Diseases 203(5): 715-725
Svárovská, A.; Ant, T.H.; Seblová, V.; Jecná, L.; Beverley, S.M.; Volf, P. 2010: Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors. PLOS Neglected Tropical Diseases 4(1): E580
Jayakumar, A.; Donovan, M.J.; Tripathi, V.; Ramalho-Ortigao, M.; McDowell, M.Ann. 2008: Leishmania major infection activates NF-kappaB and interferon regulatory factors 1 and 8 in human dendritic cells. Infection and Immunity 76(5): 2138-2148
Ghawar, W.; Toumi, A.; Snoussi, M.-A.; Chlif, S.; Zâatour, A.; Boukthir, A.ïc.; Hamida, N.B.H.; Chemkhi, J.âa.; Diouani, M.F.; Ben-Salah, A. 2011: Leishmania major infection among Psammomys obesus and Meriones shawi: reservoirs of zoonotic cutaneous leishmaniasis in Sidi Bouzid(central Tunisia). Vector Borne and Zoonotic Diseases 11(12): 1561-1568
Wege, A.Kathrin.; Florian, C.; Ernst, W.; Zimara, N.; Schleicher, U.; Hanses, F.; Schmid, M.; Ritter, U. 2012: Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response. Plos Neglected Tropical Diseases 6(7): E1741
Ricardo-Carter, C.; Favila, M.; Polando, R.E.; Cotton, R.N.; Bogard Horner, K.; Condon, D.; Ballhorn, W.; Whitcomb, J.P.; Yadav, M.; Geister, R.L.; Schorey, J.S.; McDowell, M.A. 2013: Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription. Parasite Immunology 35(12): 409-420
Sansom, F.M.; Tang, L.; Ralton, J.E.; Saunders, E.C.; Naderer, T.; McConville, M.J. 2013: Leishmania major methionine sulfoxide reductase a is required for resistance to oxidative stress and efficient replication in macrophages. Plos one 8(2): E56064
Wenzel, U.Alexander.; Bank, E.; Florian, C.; Förster, S.; Zimara, N.; Steinacker, J.; Klinger, M.; Reiling, N.; Ritter, U.; van Zandbergen, G. 2012: Leishmania major parasite stage-dependent host cell invasion and immune evasion. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 26(1): 29-39
Ben-Othman, R.; Dellagi, K.; Guizani-Tabbane, L. 2009: Leishmania major parasites induced macrophage tolerance: implication of MAPK and NF-kappaB pathways. Molecular Immunology 46(16): 3438-3444
Jasion, V.S.; Poulos, T.L. 2012: Leishmania major peroxidase is a cytochrome c peroxidase. Biochemistry 51(12): 2453-2460
Liu, D.; Kebaier, C.; Pakpour, N.; Capul, A.A.; Beverley, S.M.; Scott, P.; Uzonna, J.E. 2009: Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions. Infection and Immunity 77(8): 3272-3283
Zwerschke, D.; Karrie, S.; Jahn, D.; Jahn, M. 2014: Leishmania major possesses a unique HemG-type protoporphyrinogen IX oxidase. Bioscience Reports 34(4)
Dobson, D.E.; Kamhawi, S.; Lawyer, P.; Turco, S.J.; Beverley, S.M.; Sacks, D.L. 2010: Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern. Plos Pathogens 6(11): E1001185
Campelo, R.; Díaz Lozano, I.; Figarella, K.; Osuna, A.; Ramírez, J.é L. 2015: Leishmania major telomerase TERT protein has a nuclear/mitochondrial eclipsed distribution that is affected by oxidative stress. Infection and Immunity 83(1): 57-66
Ronet, C.; Voigt, H.; Himmelrich, H.; Doucey, M.-A.ès.; Hauyon-La Torre, Y.; Revaz-Breton, M.él.; Tacchini-Cottier, F.; Bron, C.; Louis, J.; Launois, P. 2008: Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c mice. Journal of Immunology 180(7): 4825-4835
Bolhassani, A.; Gholami, E.; Zahedifard, F.; Moradin, N.; Parsi, P.; Doustdari, F.; Seyed, N.; Papadopoulou, B.; Rafati, S. 2011: Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model. Experimental Parasitology 128(1): 9-17
Eissa, M.M.; Amer, E.I.; El Sawy, S.M.F. 2011: Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis. Experimental Parasitology 128(4): 382-390
Ozer, L.; El-On, J.; Golan-Goldhirsh, A.; Gopas, J. 2010: Leishmania major: anti-leishmanial activity of Nuphar lutea extract mediated by the activation of transcription factor NF-κB. Experimental Parasitology 126(4): 510-516
Taheri, T.; Salmanian, A.-H.; Gholami, E.; Doustdari, F.; Zahedifard, F.; Rafati, S. 2010: Leishmania major: disruption of signal peptidase type i and its consequences on survival, growth and infectivity. Experimental Parasitology 126(2): 135-145
Malki-Feldman, L.; Jaffe, C.L. 2009: Leishmania major: effect of protein kinase a and phosphodiesterase activity on infectivity and proliferation of promastigotes. Experimental Parasitology 123(1): 39-44
Kavoosi, G.; Ardestani, S.K.; Kariminia, A.; Zeinali, M.; Alimohammadian, M.H. 2008: Leishmania major: effects of proteophosphoglycan on reactive oxygen species, IL-12, IFN-gamma and IL-10 production in healthy individuals. Experimental Parasitology 120(1): 62-66
Ghaffarifar, F. 2010: Leishmania major: in vitro and in vivo anti-leishmanial effect of cantharidin. Experimental Parasitology 126(2): 126-129
Haber, M.E.; Daher, C.F.; Karam, M.C.; Baroody, G.M. 2009: Leishmania major: interleukin-13 increases the infection-induced hyperalgesia and the levels of interleukin-1beta and interleukin-12 in rats. Experimental Parasitology 121(3): 224-229
Martin, R.; Gonzalez, I.; Fasel, N. 2014: Leishmania metacaspase: an arginine-specific peptidase. Methods in Molecular Biology 1133: 189-202
Serafim, T.D.; Figueiredo, A.B.; Costa, P.A.C.; Marques-da-Silva, E.A.; Gonçalves, R.; de Moura, S.A.L.; Gontijo, N.F.; da Silva, S.M.; Michalick, M.S.M.; Meyer-Fernandes, J.é R.; de Carvalho, R.P.; Uliana, S.R.B.; Fietto, J.L.R.; Afonso, L.ís.C.C. 2012: Leishmania metacyclogenesis is promoted in the absence of purines. Plos Neglected Tropical Diseases 6(9): E1833
Martínez-Salazar, B.; Berzunza-Cruz, M.; Becker, I. 2008: Leishmania mexicana DNA activates murine macrophages and increases their TLR9 expression. Gaceta Medica de Mexico 144(2): 99-104
Rezvan, H.; Rees, R.; Ali, S. 2011: Leishmania mexicana Gp63 cDNA Using Gene Gun Induced Higher Immunity to L. mexicana Infection Compared to Soluble Leishmania Antigen in BALB/C. Iranian Journal of Parasitology 6(4): 60-75
Petritus, P.M.; Manzoni-de-Almeida, D.; Gimblet, C.; Gonzalez Lombana, C.; Scott, P. 2012: Leishmania mexicana induces limited recruitment and activation of monocytes and monocyte-derived dendritic cells early during infection. Plos Neglected Tropical Diseases 6(10): E1858
Buxbaum, L.U. 2013: Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans. Plos Neglected Tropical Diseases 7(5): E2224
Rojas-Bernabé, A.; Garcia-Hernández, O.; Maldonado-Bernal, C.; Delegado-Dominguez, J.; Ortega, E.; Gutiérrez-Kobeh, L.; Becker, I.; Aguirre-Garcia, M. 2014: Leishmania mexicana lipophosphoglycan activates ERK and p38 MAP kinase and induces production of proinflammatory cytokines in human macrophages through TLR2 and TLR4. Parasitology 141(6): 788-800
Delgado-Domínguez, J.; González-Aguilar, H.; Aguirre-García, M.; Gutiérrez-Kobeh, L.; Berzunza-Cruz, M.; Ruiz-Remigio, A.; Robles-Flores, M.; Becker, I. 2010: Leishmania mexicana lipophosphoglycan differentially regulates PKCalpha-induced oxidative burst in macrophages of BALB/c and C57BL/6 mice. Parasite Immunology 32(6): 440-449
Ali, N.O.M.; Ibrahim, M.E.; Grant, K.M.; Mottram, J.C. 2012: Leishmania mexicana: expression; characterization and activity assessment of E. coli-expressed recombinant CRK3. European Review for Medical and Pharmacological Sciences 16(10): 1338-1345
Argueta-Donohué, J.ús.; Carrillo, N.; Valdés-Reyes, L.; Zentella, A.; Aguirre-García, M.; Becker, I.; Gutiérrez-Kobeh, L. 2008: Leishmania mexicana: participation of NF-kappaB in the differential production of IL-12 in dendritic cells and monocytes induced by lipophosphoglycan (LPG). Experimental Parasitology 120(1): 1-9
Castro, H.; Teixeira, F.; Romao, S.; Santos, M.; Cruz, T.ân.; Flórido, M.; Appelberg, R.; Oliveira, P.; Ferreira-da-Silva, F.; Tomás, A.M. 2011: Leishmania mitochondrial peroxiredoxin plays a crucial peroxidase-unrelated role during infection: insight into its novel chaperone activity. Plos Pathogens 7(10): E1002325
Kima, P.E. 2014: Leishmania molecules that mediate intracellular pathogenesis. Microbes and Infection 16(9): 721-726
Gómez, M.A.; Navas, A.; Márquez, R.; Rojas, L.J.; Vargas, D.A.; Blanco, V.M.; Koren, R.; Zilberstein, D.; Saravia, N.G. 2014: Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival. Journal of Antimicrobial ChemoTherapy 69(1): 139-149
Muñoz, G.; Davies, C.R. 2006: Leishmania panamensis transmission in the domestic environment: the results of a prospective epidemiological survey in Santander, Colombia. Biomedica: Revista del Instituto Nacional de Salud 26(Suppl 1): 131-144
Shapira, M.; Zinoviev, A. 2011: Leishmania parasites act as a Trojan horse that paralyzes the translation system of host macrophages. Cell Host and Microbe 9(4): 257-259
Pawlowic, M.C.; Zhang, K. 2012: Leishmania parasites possess a platelet-activating factor acetylhydrolase important for virulence. Molecular and Biochemical Parasitology 186(1): 11-20
Milon, G.èv. 2008: Leishmania parasites: could we consider them as living organisms per se?. Microbes and Infection 10(9): 1077-1081
Ndjamen, B.; Kang, B.-H.; Hatsuzawa, K.; Kima, P.E. 2010: Leishmania parasitophorous vacuoles interact continuously with the host cell's endoplasmic reticulum; parasitophorous vacuoles are hybrid compartments. Cellular Microbiology 12(10): 1480-1494
Arango Duque, G.; Fukuda, M.; Turco, S.J.; Stäger, S.; Descoteaux, A. 2014: Leishmania promastigotes induce cytokine secretion in macrophages through the degradation of synaptotagmin Xi. Journal of Immunology 193(5): 2363-2372
Weingärtner, A.; Kemmer, G.; Müller, F.D.; Zampieri, R.A.; Gonzaga dos Santos, M.; Schiller, J.ür.; Pomorski, T.G.ün. 2012: Leishmania promastigotes lack phosphatidylserine but bind annexin V upon permeabilization or miltefosine treatment. Plos one 7(8): E42070
Moradin, N.; Descoteaux, A. 2012: Leishmania promastigotes: building a safe niche within macrophages. Frontiers in Cellular and Infection Microbiology 2: 121
Cortez, M.; Huynh, C.; Fernandes, M.C.; Kennedy, K.A.; Aderem, A.; Andrews, N.W. 2011: Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200. Cell Host and Microbe 9(6): 463-471
Cojean, S.; Houzé, S.; Haouchine, D.; Huteau, F.ço.; Lariven, S.; Hubert, V.ér.; Michard, F.; Bories, C.; Pratlong, F.; Le Bras, J.; Loiseau, P.M.; Matheron, S. 2012: Leishmania resistance to miltefosine associated with genetic marker. Emerging Infectious Diseases 18(4): 704-706
Unlü, R.E.; Altun, S.; Ssensöz, O. 2007: Leishmania scar: a risk factor for the development of basal cell carcinomas. Journal of Craniofacial Surgery 18(3): 708-710
Silva, S.d.O.; Wu, A.A.; Evans, D.A.; Vieira, L.Q.; Melo, M.N. 2009: Leishmania sp. isolated from human cases of cutaneous leishmaniasis in Brazil characterized as Leishmania major-like. Acta Tropica 112(3): 239-248
Kato, H.; Watanabe, J.; Mendoza Nieto, I.; Korenaga, M.; Hashiguchi, Y. 2011: Leishmania species identification using FTA card sampling directly from patients' cutaneous lesions in the state of Lara, Venezuela. Transactions of the Royal Society of Tropical Medicine and Hygiene 105(10): 561-567
Akhavan, A.A.; Mirhendi, H.; Khamesipour, A.; Alimohammadian, M.H.; Rassi, Y.; Bates, P.; Kamhawi, S.; Valenzuela, J.G.; Arandian, M.H.; Abdoli, H.; Jalali-zand, N.; Jafari, R.; Shareghi, N.; Ghanei, M.; Yaghoobi-Ershadi, M.R. 2010: Leishmania species: detection and identification by nested PCR assay from skin samples of rodent reservoirs. Experimental Parasitology 126(4): 552-556
Kumar, R.; Singh, N.; Gautam, S.; Singh, O.P.; Gidwani, K.; Rai, M.; Sacks, D.; Sundar, S.; Nylén, S. 2014: Leishmania specific CD4 T cells release IFNγ that limits parasite replication in patients with visceral leishmaniasis. Plos Neglected Tropical Diseases 8(10): E3198
Aebischer, T. 2014: Leishmania spp. Proteome Data Sets: a Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis. Frontiers in Immunology 5: 260
Troncarelli, M.Z.; Camargo, J.ín.B.; Machado, J.G.; Lucheis, S.B.; Langoni, H. 2009: Leishmania spp. and/or Trypanosoma cruzi diagnosis in dogs from endemic and nonendemic areas for canine visceral leishmaniasis. Veterinary Parasitology 164(2-4): 118-123
López-Céspedes, A.; Longoni, S.S.; Sauri-Arceo, C.H.; Sánchez-Moreno, M.; Rodríguez-Vivas, R.I.; Escobedo-Ortegón, F.J.; Barrera-Pérez, M.A.; Bolio-González, M.E.; Marín, C. 2012: Leishmania spp. epidemiology of canine leishmaniasis in the Yucatan Peninsula. Thescientificworldjournal 2012: 945871
Oliveira, M.A.P.d.; Pires, A.d.S.; de Bastos, R.P.; Lima, G.ór.M.C.d.A.; Pinto, S.ão.A.; Pereira, L.I.ác.d.A.; Pereira, A.J.C.S.; Abrahamsohn, I.d.A.; Dorta, M.L.; Ribeiro-Dias, F.át. 2010: Leishmania spp. parasite isolation through inoculation of patient biopsy macerates in interferon gamma knockout mice. Revista do Instituto de Medicina Tropical de Sao Paulo 52(2): 83-88
Sarkar, A.; Ghosh, S.; Pakrashi, S.; Roy, D.; Sen, S.; Chatterjee, M. 2012: Leishmania strains causing self-healing cutaneous leishmaniasis have greater susceptibility towards oxidative stress. Free Radical Research 46(5): 665-673
Swenerton, R.K.; Knudsen, G.M.; Sajid, M.; Kelly, B.L.; McKerrow, J.H. 2010: Leishmania subtilisin is a maturase for the trypanothione reductase system and contributes to disease pathology. Journal of Biological Chemistry 285(41): 31120-31129
Taylor, V.M.; Muñoz, D.L.; Cedeño, D.L.; Vélez, I.án.D.; Jones, M.A.; Robledo, S.M. 2010: Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents. Experimental Parasitology 126(4): 471-475
Van der Auwera, G.; Fraga, J.; Montalvo, A.Margarita.; Dujardin, J-Claude. 2011: Leishmania taxonomy up for promotion?. Trends in Parasitology 27(2): 49-50
Talmi-Frank, D.; Jaffe, C.L.; Nasereddin, A.; Baneth, G. 2012: Leishmania tropica experimental infection in the rat using luciferase-transfected parasites. Veterinary Parasitology 187(1-2): 57-62
Solomon, M.; Schwartz, E.; Pavlotsky, F.; Sakka, N.; Barzilai, A.; Greenberger, S. 2014: Leishmania tropica in children: a retrospective study. Journal of the American Academy of Dermatology 71(2): 271-277
Talmi-Frank, D.; Jaffe, C.L.; Nasereddin, A.; Warburg, A.; King, R.; Svobodova, M.; Peleg, O.; Baneth, G. 2010: Leishmania tropica in rock hyraxes (Procavia capensis) in a focus of human cutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene 82(5): 814-818
Talmi-Frank, D.; Kedem-Vaanunu, N.; King, R.; Bar-Gal, G.K.; Edery, N.; Jaffe, C.L.; Baneth, G. 2010: Leishmania tropica infection in golden jackals and red foxes, Israel. Emerging Infectious Diseases 16(12): 1973-1975
Weiss, F.; Vogenthaler, N.; Franco-Paredes, C.; Parker, S.R.S. 2009: Leishmania tropica-induced cutaneous and presumptive concomitant viscerotropic leishmaniasis with prolonged incubation. Archives of Dermatology 145(9): 1023-1026
Sagher, F. 1947: Leishmania vaccine test in leishmaniasis of the skin (Oriental sore); quantitative experiments. Archives of Dermatology and Syphilology 55(5): 658-663
Dahroug, M.A.A.; Almeida, A.B.P.F.; Sousa, V.ér.R.F.; Dutra, V.ér.; Turbino, N.ív.C.M.R.; Nakazato, L.; de Souza, R.L. 2010: Leishmania(Leishmania) chagasi in captive wild felids in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 104(1): 73-74
Scott, P. 2011: Leishmania--a parasitized parasite. New England Journal of Medicine 364(18): 1773-1774
Cota, Gáucia.F.; de Sousa, M.R.; de Mendonça, A.Laender.Pessoa.; Patrocinio, A.; Assunção, L.Siqueira.; de Faria, S.Rodrigues.; Rabello, A. 2014: Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil. Plos Neglected Tropical Diseases 8(4): E2816
Beattie, L.; Kaye, P.M. 2011: Leishmania-host interactions: what has imaging taught us?. Cellular Microbiology 13(11): 1659-1667
Abu-Dayyeh, I.; Shio, M.T.; Sato, S.; Akira, S.; Cousineau, B.; Olivier, M. 2008: Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif. Plos Neglected Tropical Diseases 2(12): E305
Majumder, S.; Dey, R.; Bhattacharjee, S.; Rub, A.; Gupta, G.; Bhattacharyya Majumdar, S.; Saha, B.; Majumdar, S. 2012: Leishmania-induced biphasic ceramide generation in macrophages is crucial for uptake and survival of the parasite. Journal of Infectious Diseases 205(10): 1607-1616
Contreras, I.ú; Gómez, M.ía.A.; Nguyen, O.; Shio, M.T.; McMaster, R.W.; Olivier, M. 2010: Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. Plos Pathogens 6(10): E1001148
Farrow, A.L.; Rana, T.; Mittal, M.K.; Misra, S.; Chaudhuri, G. 2011: Leishmania-induced repression of selected non-coding RNA genes containing B-box element at their promoters in alternatively polarized M2 macrophages. Molecular and Cellular Biochemistry 350(1-2): 47-57
Resende, M.; Moreira, D.; Augusto, J.; Cunha, J.; Neves, B.; Cruz, M.T.; Estaquier, J.ér.ôm.; Cordeiro-da-Silva, A.; Silvestre, R. 2013: Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-γ+ IL-10+ phenotype. Journal of Immunology 191(1): 262-273
Prajeeth, C.K.; Haeberlein, S.; Sebald, H.; Schleicher, U.; Bogdan, C. 2011: Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity. Infection and Immunity 79(7): 2699-2708
Van Assche, T.; Deschacht, M.; da Luz, R.A.I.ên.; Maes, L.; Cos, P. 2011: Leishmania-macrophage interactions: insights into the redox biology. Free Radical Biology and Medicine 51(2): 337-351
Ben-Othman, R.; Flannery, A.R.; Miguel, D.C.; Ward, D.M.; Kaplan, J.; Andrews, N.W. 2014: Leishmania-mediated inhibition of iron export promotes parasite replication in macrophages. Plos Pathogens 10(1): E1003901
Depledge, D.P.; MacLean, L.M.; Hodgkinson, M.R.; Smith, B.A.; Jackson, A.P.; Ma, S.; Uliana, S.R.B.; Smith, D.F. 2010: Leishmania-specific surface antigens show sub-genus sequence variation and immune recognition. Plos Neglected Tropical Diseases 4(9): E829
Chatterjee, N.; Das, S.; Bose, D.; Banerjee, S.; Jha, T.; Saha, K.D. 2014: Leishmanial lipid suppresses the bacterial endotoxin-induced inflammatory response with attenuation of tissue injury in sepsis. Journal of Leukocyte Biology 96(2): 325-336
Majumdar, K.Nayan.; Banerjee, A.; Ratha, J.; Mandal, M.; Sarkar, R.Nath.; Saha, K.Das. 2008: Leishmanial lipid suppresses tumor necrosis factor alpha, interleukin-1beta, and nitric oxide production by adherent synovial fluid mononuclear cells in rheumatoid arthritis patients and induces apoptosis through the mitochondrial-mediated pathway. Arthritis and Rheumatism 58(3): 696-706
Hinojosa, M.C.; González, M.I.; Martínez, G.; Ginés, A. 2011: Leishmanial parasitation of Kaposi's sarcoma in a HIV patient. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 24(1): 54-55
Mazeris, A.; Soteriadou, K.; Dedet, J.P.; Haralambous, C.; Tsatsaris, A.; Moschandreas, J.; Messaritakis, I.; Christodoulou, V.; Papadopoulos, B.; Ivovic, V.; Pratlong, F.; Loucaides, F.; Antoniou, M. 2010: Leishmaniases and the Cyprus paradox. American Journal of Tropical Medicine and Hygiene 82(3): 441-448
Bastien, P. 2011: Leishmaniases control: what part for development and what part for research?. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 17(10): 1449-1450
García, A.L.; Parrado, R.; Rojas, E.; Delgado, R.úl.; Dujardin, J.-C.; Reithinger, R. 2009: Leishmaniases in Bolivia: comprehensive review and current status. American Journal of Tropical Medicine and Hygiene 80(5): 704-711
Marty, P.; Pomares-Estran, C.; Hasseine, L.; Delaunay, P.; Haas, H.; Rosenthal, E. 2009: Leishmaniases in France: an update. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 16 Suppl. 2: S96-100
Ntais, P.; Sifaki-Pistola, D.; Christodoulou, V.; Messaritakis, I.; Pratlong, F.; Poupalos, G.; Antoniou, M. 2013: Leishmaniases in Greece. American Journal of Tropical Medicine and Hygiene 89(5): 906-915
Chaara, D.; Haouas, N.; Dedet, J.P.; Babba, H.; Pratlong, F. 2014: Leishmaniases in Maghreb: an endemic neglected disease. Acta Tropica 132: 80-93
Reithinger, R. 2008: Leishmaniases' burden of disease: ways forward for getting from speculation to reality. Plos Neglected Tropical Diseases 2(10): E285
Kedzierski, L. 2011: Leishmaniasis. Human Vaccines 7(11): 1204-1214
Tadesse, A.; Hurissa, Z. 2009: Leishmaniasis (PKDL) as a case of immune reconstitution inflammatory syndrome (IRIS) in HIV-positive patient after initiation of anti-retroviral therapy (ART). Ethiopian Medical Journal 47(1): 77-79
Kedzierski, L. 2010: Leishmaniasis Vaccine: Where are we Today?. Journal of Global Infectious Diseases 2(2): 177-185
Ehehalt, U.; Schunk, M.; Jensenius, M.; van Genderen, P.J.J.; Gkrania-Klotsas, E.; Chappuis, F.ço.; Schlagenhauf, P.; Castelli, F.; Lopez-Velez, R.; Parola, P.; Burchard, G.D.; Cramer, J.P. 2014: Leishmaniasis acquired by travellers to endemic regions in Europe: a EuroTravNet multi-centre study. Travel Medicine and Infectious Disease 12(2): 167-172
Hozannah, A.; Santos, M.; Chrusciak-Talhari, A.; Talhari, C. 2013: Leishmaniasis and AIDS coinfection. Anais Brasileiros de Dermatologia 88(6): 992-993
Nozzi, M.; Del Torto, M.; Chiarelli, F.; Breda, L. 2014: Leishmaniasis and autoimmune diseases in pediatric age. Cellular Immunology 292(1-2): 9-13
Cascio, A.; Iaria, M.; Iaria, C. 2010: Leishmaniasis and biologic therapies for rheumatologic diseases. Seminars in Arthritis and Rheumatism 40(3): E3-E5
Santamaría, M.; Carrillo, J.; Pérez-Navero, J.; Mateos, E.; Ibarra, I.; Fernández, S.; Ortega, C. 2008: Leishmaniasis and concurrent hemophagocytosis with or without transient perforin expression perturbation. Pediatric Blood and Cancer 51(2): 310
García-Río, I.; Daudén, E.; Ballestero-Díez, M.; Fraga, J.; García-Díez, A. 2010: Leishmaniasis and rheumatoid nodulosis in a patient with HIV infection. Actas Dermo-Sifiliograficas 101(2): 164-167
Badaró, R.; Gonçalves, L.O.; Gois, L.L.; Maia, Z.Pereira.Gusmão.; Benson, C.; Grassi, M.Fernanda.Rios. 2015: Leishmaniasis as a Manifestation of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-Infected Patients: A Literature Review. Journal of the International Association of Providers of Aids Care 14(5): 402-407
Almeida, B.F.M.; Narciso, L.G.; Melo, L.M.; Preve, P.P.; Bosco, A.M.; Lima, V.M.F.; Ciarlini, P.C. 2013: Leishmaniasis causes oxidative stress and alteration of oxidative metabolism and viability of neutrophils in dogs. Veterinary Journal 198(3): 599-605
Croft, S.L.; Olliaro, P. 2011: Leishmaniasis chemotherapy--challenges and opportunities. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 17(10): 1478-1483
Montalvo, A.M.; Fraga, J.; Monzote, L.; García, M.; Fonseca, L. 2012: Leishmaniasis diagnosis: going from microscopic observation of parasite to DNA detection. Revista Cubana de Medicina Tropical 64(2): 108-131
Adams, E.R.; Jacquet, D.; Schoone, G.; Gidwani, K.; Boelaert, M.; Cunningham, J. 2012: Leishmaniasis direct agglutination test: using pictorials as training materials to reduce inter-reader variability and improve accuracy. Plos Neglected Tropical Diseases 6(12): E1946
Rongioletti, F.; Cannata, G.E.; Parodi, A. 2009: Leishmaniasis due to L. infantum presenting as macrocheilitis and responding to liposomal amphotericin B. European Journal of Dermatology: Ejd 19(3): 281-282
Ready, P.D. 2008: Leishmaniasis emergence and climate change. Revue Scientifique et Technique 27(2): 399-412
Andrade-Narvaez, F.; Canto-Lara, S.B.; Del Rosario Garcia-Miss, M. 2009: Leishmaniasis entomological field studies: ethical issues. Developing World Bioethics 9(3): 157-160
Den Boer, M.; Argaw, D.; Jannin, J.; Alvar, J. 2011: Leishmaniasis impact and treatment access. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 17(10): 1471-1477
Rojas, E.; Parrado, R.; Delgado, R.úl.; Reithinger, R.; Garcia, A.L. 2009: Leishmaniasis in Chaparé, Bolivia. Emerging Infectious Diseases 15(4): 678-680
Fendri, A.H.; Beldjoudi, W.; Ahraou, S.; Djaballah, M. 2012: Leishmaniasis in Constantine (Algeria): review of five years (2006-2010) at the University Hospital. Bulletin de la Societe de Pathologie Exotique 105(1): 46-48
Malamos, B. 1946: Leishmaniasis in Greece. Proceedings of the Royal Society of Medicine 39(12): 799-801
Kluger, N. 2010: Leishmaniasis in Spanish tattoos. Enfermedades Infecciosas y Microbiologia Clinica 28(9): 667
Toz, S.O.; Nasereddin, A.; Ozbel, Y.; Ertabaklar, H.; Culha, G.; Sevil, N.; Ziya Alkan, M.; Jaffe, C.L. 2009: Leishmaniasis in Turkey: molecular characterization of Leishmania from human and canine clinical samples. Tropical Medicine and International Health: Tm and Ih 14(11): 1401-1406
Olobo-Okao, J.; Sagaki, P. 2014: Leishmaniasis in Uganda: historical account and a review of the literature. Pan African Medical Journal 18: 16
Freeman, K.S.; Miller, M.D.; Breitschwerdt, E.B.; Lappin, M.R. 2010: Leishmaniasis in a dog native to Colorado. Journal of the American Veterinary Medical Association 237(11): 1288-1291
Van Griensven, J.; Carrillo, E.; López-Vélez, R.; Lynen, L.; Moreno, J. 2014: Leishmaniasis in immunosuppressed individuals. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 20(4): 286-299
Pizzorni, C.; Secchi, M.E.; Cutolo, M. 2007: Leishmaniasis in rheumatoid arthritis. Reumatismo 59(3): 235-239
Bogdan, C. 2012: Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats. Annals of the Rheumatic Diseases 71(Suppl 2): I60-I66
Murray, H.W. 2012: Leishmaniasis in the United States: treatment in 2012. American Journal of Tropical Medicine and Hygiene 86(3): 434-440
Postigo, J.A.R. 2010: Leishmaniasis in the World Health Organization Eastern Mediterranean Region. International Journal of Antimicrobial Agents 36(Suppl 1): S62-S65
Zanger, P.; Gabrysch, S. 2013: Leishmaniasis in the era of tumor necrosis factor alpha antagonist therapy--a research agenda for Europe. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 18(30): 20542
Salam, N.; Al-Shaqha, W.M.; Azzi, A. 2014: Leishmaniasis in the middle East: incidence and epidemiology. Plos Neglected Tropical Diseases 8(10): E3208
Leitner, V.; Weingast, J.; Harmankaya, K.; Walochnik, J.; Pehamberger, H.; Petzelbauer, P.; Auer, H.; Binder, M. 2010: Leishmaniasis in the tongue of an immunocompetent man. American Journal of Tropical Medicine and Hygiene 82(4): 597-599
Mansueto, P.; Seidita, A.; Vitale, G.; Cascio, A. 2014: Leishmaniasis in travelers: a literature review. Travel Medicine and Infectious Disease 12(6 Pt A): 563-581
Kaltoft, M.; Munch-Petersen, H.R.; Møller, H. 2010: Leishmaniasis isolated to the larynx as cause of chronic laryngitis. Ugeskrift for Laeger 172(42): 2898-2899
Christopherson, J.B. 1923: Leishmaniasis of the Skin resembling Lupus Vulgaris. Proceedings of the Royal Society of Medicine 16(Dermatol Sect): 48-50
Sabri, A.; Khatib, L.; Kanj-Sharara, S.; Husseini, S.T.; Nuwayri-Salti, N.; Semaan, R.; Rameh, C. 2009: Leishmaniasis of the auricle mimicking carcinoma. American Journal of Otolaryngology 30(4): 285-287
Veraldi, S.; Bottini, S.; Currò, N.; Gianotti, R. 2010: Leishmaniasis of the eyelid mimicking an infundibular cyst and review of the literature on ocular leishmaniasis. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14 Suppl. 3: E230-E232
Voisin, C.; Bianchi, F.; Parent, D.; Evrard, L. 2011: Leishmaniasis of the lip : report of a case. Bulletin du Groupement International Pour la Recherche Scientifique en Stomatologie and Odontologie 50(1): 6-10
Vasudevan, B.; Bahal, A. 2011: Leishmaniasis of the lip diagnosed by lymph node aspiration and treated with a combination of oral ketaconazole and intralesional sodium stibogluconate. Indian Journal of Dermatology 56(2): 214-216
De Castro, M. 1949: Leishmaniasis of the lower lip with clinical aspect of cancer. Anais Paulistas de Medicina E Cirurgia 57(2): 120
Vargas Laguna, E.; Aguilar Martinez, A.; Fernández Cogolludo, E.; Martín, L.; Merano, F.; Gallego Valdés, M.A. 2008: Leishmaniasis of the tongue due to leishmania infantum. European Journal of Dermatology: Ejd 18(4): 472-473
López-Medrano, F.; Costa, J.é R.ón.; Rodríguez-Peralto, J.é L.; Aguado, J.é M.ía. 2010: Leishmaniasis over a tattoo in a patient infected with human immunodeficiency virus. Enfermedades Infecciosas y Microbiologia Clinica 28(7): 482-483
Santangeli, L.; McCluney, N.A.; Hathorn, I.; Shakeel, M.; Anderson, C. 2009: Leishmaniasis presenting to the otolaryngologist: a rare but important cause of persistent hoarseness. Journal of Laryngology and Otology 123(10): 1181-1183
Calvopiña, M.; Kato, H.; Hashiguchi, Y. 2013: Leishmaniasis recidiva cutis and its topical treatment in ecuador. Tropical Medicine and Health 41(3): 93-94
Sharifi, I.; Fekri, A.Reza.; Aflatoonian, M.Reza.; Khamesipour, A.; Mahboudi, F.; Dowlati, Y.; Nadim, A.; Modabber, F. 2010: Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006. International journal of dermatology 49(5): 557-561
Al-Jawabreh, A.; Nasereddin, A. 2007: Leishmaniasis recidivans in a Palestinian Bedouin child. Skinmed 6(5): 250-252
Niscola, P.; Palombi, M.; Fratoni, S.; Trawinska, M.M.; Scaramucci, L.; Tolu, B.; Perrotti, A.P.; de Fabritiis, P. 2009: Leishmaniasis resembling hematological malignancies. the concern of differential diagnosis. Saudi Medical Journal 30(2): 304
Cortés, L.A. 2006: Leishmaniasis transmission focus in El Hobo, Carmen de Bolívar, Bolívar, Colombia. Biomedica: Revista del Instituto Nacional de Salud 26(Suppl 1): 236-241
Carvalho, B.M.; Maximo, M.; Costa, W.A.; de Santana, A.L.ís.F.; da Costa, S.M.; da Costa Rego, T.A.N.; de Pita Pereira, D.; Rangel, E.F. 2013: Leishmaniasis transmission in an ecotourism area: potential vectors in Ilha Grande, Rio de Janeiro State, Brazil. Parasites and Vectors 6(1): 325
Samy, A.M.; Campbell, L.P.; Peterson, A.T. 2014: Leishmaniasis transmission: distribution and coarse-resolution ecology of two vectors and two parasites in Egypt. Revista da Sociedade Brasileira de Medicina Tropical 47(1): 57-62
Minodier, P.; Jurquet, A.-L.; Noël, G.; Uters, M.; Laporte, R.; Garnier, J.-M. 2010: Leishmaniasis treatment. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 17(6): 838-839
Modabber, F. 2010: Leishmaniasis vaccines: past, present and future. International Journal of Antimicrobial Agents 36(Suppl 1): S58-S61
Costa, O.G. 1947: Leishmaniasis verrucosa of the face. Archives of Dermatology and Syphilology 55(3): 358
Alvar, J.; Vélez, I.án.D.; Bern, C.; Herrero, M.é; Desjeux, P.; Cano, J.; Jannin, J.; den Boer, M.; Argaw, D.; Bhattacharya, S.; Ejov, M.; Elkhouri, A.N.; Ruiz-Postigo, J.é A.; Serrano, J. 2012: Leishmaniasis worldwide and global estimates of its incidence. Plos one 7(5): E35671
Van der Meide, W.; de Vries, H.; Pratlong, F.; van der Wal, A.; Sabajo, L. 2008: Leishmaniasis, Suriname. Emerging Infectious Diseases 14(5): 857-859
Neghina, R.; Neghina, A.M. 2010: Leishmaniasis, a global concern for travel medicine. Scandinavian Journal of Infectious Diseases 42(8): 563-570
Pavli, A.; Maltezou, H.C. 2010: Leishmaniasis, an emerging infection in travelers. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(12): E1032-E1039
Xynos, I.D.; Tektonidou, M.G.; Pikazis, D.; Sipsas, N.V. 2009: Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe. Emerging Infectious Diseases 15(6): 956-959
Kautz-Neu, K.; Meyer, R.G.; Clausen, B.ör.E.; von Stebut, E. 2010: Leishmaniasis, contact hypersensitivity and graft-versus-host disease: understanding the role of dendritic cell subsets in balancing skin immunity and tolerance. Experimental Dermatology 19(8): 760-771
Alexa, T.; Luca, A.; Crăcană, I.; Merticariu, A.; Dănăilă, C. 2014: Leishmaniasis--an unusual cause of splenomegaly in Romania. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 118(1): 101-106
McDowell, M.A.; Rafati, S.; Ramalho-Ortigao, M.; Ben Salah, A. 2011: Leishmaniasis: Middle East and North Africa research and development priorities. Plos Neglected Tropical Diseases 5(7): E1219
Nazzaro, G.; Rovaris, M.; Veraldi, S. 2014: Leishmaniasis: a disease with many names. JAMA Dermatology 150(11): 1204
Dedet, J.-P. 2007: Leishmaniasis: a growing problem due to environmental changes and human behaviours. Bulletin de l'Academie Nationale de Medecine 191(8): 1579-1587; Discussion: 1587-1588
Mei, Q.-X.; Huang, C.-L.; Luo, S.-Z.; Zhang, X.-M.; Zeng, Y.; Lu, Y.-Y. 2018: Characterization of the duodenal bacterial microbiota in patients with pancreatic head cancer vs. healthy controls. Pancreatology: Official Journal of the International Association of Pancreatology . 18(4): 438-445
Terhorst, D.; Blume-Peytavi, U.; Schönian, G.; Schewe, C.; Haas, N.; Burbach, G.J. 2012: Leishmaniasis: a reminder in the face of forgotten travel. Journal of Pediatrics 161(5): 966
Sundar, S.; Chakravarty, J. 2013: Leishmaniasis: an update of current pharmacotherapy. Expert Opinion on PharmacoTherapy 14(1): 53-63
Singh, N.; Kumar, M.; Singh, R.K. 2012: Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pacific Journal of Tropical Medicine 5(6): 485-497
Polonio, T.; Efferth, T. 2008: Leishmaniasis: drug resistance and natural products (review). International Journal of Molecular Medicine 22(3): 277-286
Doroud, D.; Rafati, S. 2012: Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems. Expert Review of Vaccines 11(1): 69-86
Bellido-Blasco, J.B.; Arnedo-Pena, A.; Romeo-García, M.A.; Herrero-Carot, C. 2009: Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. a disease that is still with us. Enfermedades Infecciosas y Microbiologia Clinica 27(2): 136-137
Anonymous 1971: Leishmaniasis: introduction. Bulletin of the World Health Organization 44(4): 471-472
Tolouei, S.; Hasheminia, S.; Narimani, M.; Khamesipour, A.; Shatalebi, M.; Hejazi, S. 2011: Leishmanicidal Activity of Films Containing Paromomycin and Gentamicin Sulfate both in Vitro and in Vivo. Iranian Journal of Parasitology 6(3): 60-65
Begum, S.; Ayub, A.; Qamar Zehra, S.; Shaheen Siddiqui, B.; Iqbal Choudhary, M.; Samreen 2014: Leishmanicidal Triterpenes from Lantana camara. Chemistry and Biodiversity 11(5): 709-718
Suzuki, A.; Shirota, O.; Mori, K.; Sekita, S.; Fuchino, H.; Takano, A.; Kuroyanagi, M. 2009: Leishmanicidal active constituents from Nepalese medicinal plant Tulsi (Ocimum sanctum L.). Chemical and Pharmaceutical Bulletin 57(3): 245-251
Kuroyanagi, M.; Murata, M.; Nakane, T.; Shirota, O.; Sekita, S.; Fuchino, H.; Shinwari, Z.K. 2012: Leishmanicidal active withanolides from a pakistani medicinal plant, Withania coagulans. Chemical and Pharmaceutical Bulletin 60(7): 892-897
Mori-Yasumoto, K.; Izumoto, R.; Fuchino, H.; Ooi, T.; Agatsuma, Y.; Kusumi, T.; Satake, M.; Sekita, S. 2012: Leishmanicidal activities and cytotoxicities of bisnaphthoquinone analogues and naphthol derivatives from Burman Diospyros burmanica. Bioorganic and Medicinal Chemistry 20(17): 5215-5219
Dutra, L.A.ôn.; de Almeida, L.íc.; Passalacqua, T.G.; Reis, J.S.; Torres, F.A.E.; Martinez, I.; Peccinini, R.G.ça.; Chin, C.M.; Chegaev, K.; Guglielmo, S.; Fruttero, R.; Graminha, M.A.S.; dos Santos, J.L. 2014: Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives. Antimicrobial Agents and ChemoTherapy 58(8): 4837-4847
Vila-Nova, N.S.; Morais, S.M.; Falcão, M.J.é C.; Machado, L.K.A.; Beviláqua, C.áu.M.L.; Costa, I.R.S.; Brasil, N.V.G.P.d.S.; Andrade Júnior, H.F. 2011: Leishmanicidal activity and cytotoxicity of compounds from two Annonacea species cultivated in Northeastern Brazil. Revista da Sociedade Brasileira de Medicina Tropical 44(5): 567-571
Zampa, M.F.; Araújo, I.ês.M.S.; Costa, V.; Nery Costa, C.H.; Santos, J.é R.; Zucolotto, V.; Eiras, C.; Leite, J.é R.S.A. 2009: Leishmanicidal activity and immobilization of dermaseptin 01 antimicrobial peptides in ultrathin films for nanomedicine applications. Nanomedicine: Nanotechnology Biology and Medicine 5(3): 352-358
Accioly, M.Parissi.; Bevilaqua, C.Maria.Leal.; Rondon, F.C.M.; de Morais, S.Maia.; Machado, L.K.A.; Almeida, C.A.; de Andrade, H.Franco.; Cardoso, R.P.A. 2012: Leishmanicidal activity in vitro of Musa paradisiaca L. and Spondias mombin L. fractions. Veterinary Parasitology 187(1-2): 79-84
Cruz, E.éz.d.M.; da Silva, E.R.; Maquiaveli, C.d.C.; Alves, E.S.S.; Lucon, J.ão.F.; dos Reis, M.B.G.ça.; de Toledo, C.E.M.; Cruz, F.G.é; Vannier-Santos, M.A.é 2013: Leishmanicidal activity of Cecropia pachystachya flavonoids: arginase inhibition and altered mitochondrial DNA arrangement. Phytochemistry 89: 71-77
Parra, M.G.ía.; Fidalgo, L.M.; Martinez, J.M.; Alvarez, A.M.M.; Iglesias, O.V.és. 2010: Leishmanicidal activity of Echinaster (Othilia) echinophorus crude extract. Revista do Instituto de Medicina Tropical de Sao Paulo 52(2): 89-93
Soares, D.C.; Andrade, A.L.S.; Delorenzi, J.C.; Silva, J.R.A.; Freire-de-Lima, L.; Falcão, C.A.B.; Pinto, A.C.; Rossi-Bergmann, B.; Saraiva, E.M. 2010: Leishmanicidal activity of Himatanthus sucuuba latex against Leishmania amazonensis. Parasitology International 59(2): 173-177
Getti, G.; Durgadoss, P.; Domínguez-Carmona, D.; Martin-Quintal, Z.; Peraza-Sánchez, S.; Peña-Rodriguez, L.M.; Humber, D. 2009: Leishmanicidal activity of Yucatecan medicinal plants on Leishmania species responsible for cutaneous leishmaniasis. Journal of Parasitology 95(2): 456-460
Rojas-Silva, P.; Graziose, R.; Vesely, B.; Poulev, A.; Mbeunkui, F.; Grace, M.H.; Kyle, D.E.; Lila, M.A.; Raskin, I. 2014: Leishmanicidal activity of a daucane sesquiterpene isolated from Eryngium foetidum. Pharmaceutical Biology 52(3): 398-401
Castaño, M.; Cardona, W.; Quiñones, W.; Robledo, S.; Echeverri, F. 2009: Leishmanicidal activity of aliphatic and aromatic lactones: correlation structure-activity. Molecules 14(7): 2491-2500
De Oliveira, A.; Mesquita, J.T.; Tempone, A.é G.; Lago, J.ão.H.G.; Guimarães, E.F.; Kato, M.J. 2012: Leishmanicidal activity of an alkenylphenol from Piper malacophyllum is related to plasma membrane disruption. Experimental Parasitology 132(3): 383-387
Pereira, I.O.; Marques, M.J.; Pavan, A.L.R.; Codonho, B.S.; Barbiéri, C.L.; Beijo, L.A.; Doriguetto, A.C.; D'Martin, E.C.; dos Santos, M.H. 2010: Leishmanicidal activity of benzophenones and extracts from Garcinia brasiliensis Mart. fruits. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 17(5): 339-345
Farias-Junior, P.A.; Rios, M.C.; Moura, T.A.; Almeida, R.P.; Alves, P.B.; Blank, A.F.; Fernandes, R.P.M.; Scher, R. 2012: Leishmanicidal activity of carvacrol-rich essential oil from Lippia sidoides Cham. Biological Research 45(4): 399-402
Riente, R.R.; Souza, V.P.; Carvalho, S.A.; Kaiser, M.; Brun, R.; da Silva, E.F. 2009: Leishmanicidal activity of new megazol derivatives. Medicinal Chemistry 5(4): 392-397
Ramírez-Macías, I.; Marín, C.; Díaz, J.ús.G.; Rosales, M.ía.J.é; Gutiérrez-Sánchez, R.ón.; Sánchez-Moreno, M. 2012: Leishmanicidal activity of nine novel flavonoids from Delphinium staphisagria. Thescientificworldjournal 2012: 203646
Cardona, W.; Quiñones, W.; Echeverri, F. 2004: Leishmanicidal activity of passifloricin a and derivatives. Molecules 9(8): 666-672
Isaac-Márquez, A.él.P.; McChesney, J.D.; Nanayakara, N.P.D.; Satoskar, A.R.; Lezama-Dávila, C.M. 2010: Leishmanicidal activity of racemic +/- 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline. Natural Product Communications 5(3): 387-390
Khanna, V.Gopiesh.; Kannabiran, K.; Getti, G. 2009: Leishmanicidal activity of saponins isolated from the leaves of Eclipta prostrata and Gymnema sylvestre. Indian Journal of Pharmacology 41(1): 32-35
Pérez-Cordero, J.é J.án.; Lozano, J.é M.; Cortés, J.; Delgado, G. 2011: Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells. Peptides 32(4): 683-690
De Mello, T.F.P.; Bitencourt, H.R.; Pedroso, R.B.; Aristides, S.M.A.; Lonardoni, M.V.C.; Silveira, T.G.V. 2014: Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis. Experimental Parasitology 136: 27-34
De Albuquerque Melo, G.M.; Silva, M.C.R.; Guimarães, T.ís.P.; Pinheiro, K.át.M.; da Matta, C.B.B.; de Queiroz, A.C.; Pivatto, M.; Bolzani, V.d.S.; Alexandre-Moreira, M.S.; Viegas, C. 2014: Leishmanicidal activity of the crude extract, fractions and major piperidine alkaloids from the flowers of Senna spectabilis. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 21(3): 277-281
Lezama-Dávila, C.M.; Isaac-Márquez, A.P.; Kapadia, G.; Owens, K.; Oghumu, S.; Beverley, S.; Satoskar, A.R. 2012: Leishmanicidal activity of two naphthoquinones against Leishmania donovani. Biological and Pharmaceutical Bulletin 35(10): 1761-1764
Lai, T.K.; Biswas, G.; Chatterjee, S.; Dutta, A.; Pal, C.; Banerji, J.; Bhuvanesh, N.; Reibenspies, J.H.; Acharya, K. 2012: Leishmanicidal and anticandidal activity of constituents of Indian edible mushroom Astraeus hygrometricus. Chemistry and Biodiversity 9(8): 1517-1524
Elamin, M.H.; AL-Maliki, S.S. 2014: Leishmanicidal and apoptotic activities of oleuropein on Leishmania major. International Journal of Clinical Pharmacology and Therapeutics 52(10): 880-888
Lenta, B.N.; Vonthron-Sénécheau, C.; Weniger, B.; Devkota, K.P.; Ngoupayo, J.; Kaiser, M.; Naz, Q.; Choudhary, M.I.; Tsamo, E.; Sewald, N. 2007: Leishmanicidal and cholinesterase inhibiting activities of phenolic compounds from Allanblackia monticola and Symphonia globulifera. Molecules 12(8): 1548-1557
Sánchez-Suárez, J.; Coy-Barrera, E.; Cuca, L.E.; Delgado, G. 2011: Leishmanicidal and cytotoxic activities of extracts and naturally-occurring compounds from two Lauraceae species. Natural Product Communications 6(2): 231-234
Cabanillas, B.Joel.; Le Lamer, A-Cécile.; Olagnier, D.; Castillo, D.; Arevalo, J.; Valadeau, Céline.; Coste, Aès.; Pipy, B.; Bourdy, Gève.; Sauvain, M.; Fabre, N. 2014: Leishmanicidal compounds and potent PPARγ activators from Renealmia thyrsoidea (Ruiz & Pav.) Poepp. & Endl. Journal of Ethnopharmacology 15(7): 149-155
Dos Santos, R.A.N.; Batista, J.ão.; Rosa, S.I.G.; Torquato, H.F.; Bassi, C.L.úc.; Ribeiro, T.A.N.; De Sousa, P.T.; Bessera, A.M.ár.S.E.S.; Fontes, C.J.F.; Da Silva, L.E.; Piuvezam, M.ár.R. 2011: Leishmanicidal effect of Spiranthera odoratíssima (Rutaceae) and its isolated alkaloid skimmianine occurs by a nitric oxide dependent mechanism. Parasitology 138(10): 1224-1233
Ferreira, C.; Soares, D.C.; Barreto-Junior, C.B.; Nascimento, M.T.; Freire-de-Lima, L.; Delorenzi, J.C.; Lima, M.E.F.; Atella, G.C.; Folly, E.; Carvalho, T.M.U.; Saraiva, E.M.; Pinto-da-Silva, L.H. 2011: Leishmanicidal effects of piperine, its derivatives, and analogues on Leishmania amazonensis. Phytochemistry 72(17): 2155-2164
Callejon, D.R.; Riul, T.B.; Feitosa, L.G.P.; Guaratini, T.; Silva, D.B.; Adhikari, A.; Shrestha, R.L.S.; Marques, L.M.M.; Baruffi, M.D.; Lopes, J.ão.L.C.; Lopes, N.P. 2014: Leishmanicidal evaluation of tetrahydroprotoberberine and spirocyclic erythrina-alkaloids. Molecules 19(5): 5692-5703
Campos, F.F.; Rosa, L.H.; Cota, B.B.; Caligiorne, R.B.; Rabello, A.L.úc.T.; Alves, T.ân.M.A.; Rosa, C.A.; Zani, C.L. 2008: Leishmanicidal metabolites from Cochliobolus sp., an endophytic fungus isolated from Piptadenia adiantoides (Fabaceae). Plos Neglected Tropical Diseases 2(12): E348
Gontijo, V.S.; Judice, W.A.S.; Codonho, B.; Pereira, I.O.; Assis, D.M.; Januário, J.P.; Caroselli, E.E.; Juliano, M.A.; de Carvalho Dosatti, A.; Marques, M.J.é; Viegas Junior, C.; Henrique dos Santos, M. 2012: Leishmanicidal, antiproteolytic and antioxidant evaluation of natural biflavonoids isolated from Garcinia brasiliensis and their semisynthetic derivatives. European Journal of Medicinal Chemistry 58: 613-623
Rosa, L.H.; Gonçalves, V.ív.N.; Caligiorne, R.B.; Alves, T.ân.M.A.; Rabello, A.; Sales, P.A.; Romanha, A.J.; Sobral, M.E.G.; Rosa, C.A.; Zani, C.L. 2010: Leishmanicidal, trypanocidal, and cytotoxic activities of endophytic fungi associated with bioactive plants in Brazil. Brazilian Journal of Microbiology: 41(2): 420-430
Ramos E Silva, J. 1949: Leishmanides; considerations upon the generalized form of American tegumentary leishmanides. Brasil-Medico 63(4-5): 23-26
Pennisi, M.Grazia.; Hartmann, K.; Lloret, A.; Addie, D.; Belák, Sándor.; Boucraut-Baralon, C.; Egberink, H.; Frymus, T.; Gruffydd-Jones, T.; Hosie, M.J.; Lutz, H.; Marsilio, F.; Möstl, K.; Radford, A.D.; Thiry, E.; Truyen, U.; Horzinek, M.C. 2013: Leishmaniosis in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 15(7): 638-642
Pereira, F.M.; Dias, F.A.; Elias, C.G.R.; d'Avila-Levy, C.M.; Silva, C.S.; Santos-Mallet, J.R.; Branquinha, M.H.; Santos, A.é L.S. 2010: Leishmanolysin-like molecules in Herpetomonas samuelpessoai mediate hydrolysis of protein substrates and interaction with insect. Protist 161(4): 589-602
Silva-Almeida, M.; Carvalho, L.O.P.; Abreu-Silva, A.L.; d'Escoffier, L.N.; Calabrese, K.S. 2010: Leishsmania (Leishmania) amazonensis infection: Muscular involvement in BALB/c and C3H.HeN mice. Experimental Parasitology 124(3): 315-318
Vandecandelaere, I.; Segaert, E.; Mollica, A.; Faimali, M.; Vandamme, P. 2008: Leisingera aquimarina sp. nov., isolated from a marine electroactive biofilm, and emended descriptions of Leisingera methylohalidivorans Schaefer et al. 2002, Phaeobacter daeponensis Yoon et al. 2007 and Phaeobacter inhibens Martens et al. 2006. International Journal of Systematic and Evolutionary Microbiology 58(Part 12): 2788-2793
Sun, F.; Wang, B.; Liu, X.; Lai, Q.; Du, Y.; Li, G.; Luo, J.; Shao, Z. 2010: Leisingera nanhaiensis sp. nov., isolated from marine sediment. International Journal of Systematic and Evolutionary Microbiology 60(Part 2): 275-280
Momenan, A.A.; Delshad, M.; Mirmiran, P.; Ghanbarian, A.; Azizi, F. 2011: Leisure time Physical Activity and its Determinants among Adults in Tehran: Tehran Lipid and Glucose Study. International Journal of Preventive Medicine 2(4): 243-251
Cheng, S-Tak.; Chow, P.K.; Yu, E.C.S.; Chan, A.C.M. 2012: Leisure activities alleviate depressive symptoms in nursing home residents with very mild or mild dementia. American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry 20(10): 904-908
Boggatz, T. 2013: Leisure activities among older Germans - a qualitative study. International Journal of Older people Nursing 8(2): 174-185
Trainor, S.; Delfabbro, P.; Anderson, S.; Winefield, A. 2010: Leisure activities and adolescent psychological well-being. Journal of Adolescence 33(1): 173-186
Verghese, J.; Cuiling Wang; Katz, M.J.; Sanders, A.; Lipton, R.B. 2009: Leisure activities and risk of vascular cognitive impairment in older adults. Journal of Geriatric Psychiatry and Neurology 22(2): 110-118
Akbaraly, T.N.; Portet, F.; Fustinoni, S.; Dartigues, J.-F.; Artero, S.; Rouaud, O.; Touchon, J.; Ritchie, K.; Berr, C. 2009: Leisure activities and the risk of dementia in the elderly: results from the Three-City Study. Neurology 73(11): 854-861
Park, S. 2014: Leisure activities as dementia care strategy. American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 22(5): 524
Anonymous 2008: Leisure activities could help reduce AFib risk. Keeping in shape can help you avoid this "nuisance" arrhythmia. Heart advisor 11(12): 6
Couture, M.él.; Caron, C.D.; Desrosiers, J. 2010: Leisure activities following a lower limb amputation. Disability and Rehabilitation 32(1): 57-64
Colver, A. 2010: Leisure activities for 6 to 12-year-old children with cerebral palsy. Developmental Medicine and Child Neurology 52(2): 115-116
Dykens, E.M. 2014: Leisure activities in Prader-Wili syndrome: implications for health, cognition and adaptive functioning. Journal of Autism and Developmental Disorders 44(2): 294-302
Paillard-Borg, S.ép.; Fratiglioni, L.; Winblad, B.; Wang, H.-X. 2009: Leisure activities in late life in relation to dementia risk: principal component analysis. Dementia and Geriatric Cognitive Disorders 28(2): 136-144
Engel-Yeger, B. 2012: Leisure activities preference of Israeli Jewish children from secular versus Orthodox families. Scandinavian Journal of Occupational Therapy 19(4): 341-349
Finlay, A.K.; Ram, N.; Maggs, J.L.; Caldwell, L.L. 2012: Leisure activities, the social weekend, and alcohol use: evidence from a daily study of first-year college students. Journal of studies on alcohol and drugs 73(2): 250-259
Zimmer, Z.; Lin, H.S. 1996: Leisure activity and well-being among the elderly in Taiwan: Testing hypotheses in an Asian setting. Journal of Cross-Cultural Gerontology 11(2): 167-186
Gow, A.J.; Avlund, K.; Mortensen, E.L. 2014: Leisure activity associated with cognitive ability level, but not cognitive change. Frontiers in Psychology 5: 1176
Lee, J.H.; Lee, J.H.; Park, S.H. 2014: Leisure activity participation as predictor of quality of life in Korean urban-dwelling elderly. Occupational Therapy International 21(3): 124-132
Lajunen, H-Reetta.; Keski-Rahkonen, A.; Pulkkinen, L.; Rose, R.J.; Rissanen, A.; Kaprio, J. 2009: Leisure activity patterns and their associations with overweight: a prospective study among adolescents. Journal of Adolescence 32(5): 1089-1103
Majnemer, A.; Shikako-Thomas, K.; Chokron, N.; Law, M.; Shevell, M.; Chilingaryan, G.; Poulin, C.; Rosenbaum, P. 2010: Leisure activity preferences for 6- to 12-year-old children with cerebral palsy. Developmental Medicine and Child Neurology 52(2): 167-173
Lee, T.; Lipnicki, D.M.; Crawford, J.D.; Henry, J.D.; Trollor, J.N.; Ames, D.; Wright, M.J.; Sachdev, P.S. 2014: Leisure activity, health, and medical correlates of neurocognitive performance among monozygotic twins: the Older Australian Twins Study. Journals of Gerontology. Series B Psychological Sciences and Social Sciences 69(4): 514-522
Saunders, J.B. 1932: Leisure and Ethics. California and Western Medicine 36(3): 175-176
Maccari, N.S. 2001: Leisure and colonization: confluences. Historia Questoes and Debates: Revista da Associacao Paranaense de Historia 18(35): 305-321
Binet, P. 1975: Leisure and culture. "Escande or the skin of others". Cahiers d'Odonto-Stomatologie 7(3): 70-71
Luo Lu 2011: Leisure and depression in midlife: a Taiwanese national survey of middle-aged adults. Journal of Health Psychology 16(1): 137-147
Losada, A.és.; Pérez-Peñaranda, A.íb.; Rodriguez-Sanchez, E.; Gomez-Marcos, M.A.; Ballesteros-Rios, C.; Ramos-Carrera, I.R.; Campo-de la Torre, M.A.; García-Ortiz, L. 2010: Leisure and distress in caregivers for elderly patients. Archives of Gerontology and Geriatrics 50(3): 347-350
Baldissera, V.Denardi.Antoniassi.; Bueno, S.Maria.Villela. 2012: Leisure and mental health in people with hypertension: convergence in health education. Revista da Escola de Enfermagem da U S P 46(2): 380-387
Gerdle, B. 1987: Leisure and muscular performance in health and disease A study of 40-64-year-old northern Swedes. Clinical Biomechanics 2(1): 22-23
Iwasaki, Y.; Coyle, C.P.; Shank, J.W. 2010: Leisure as a context for active living, recovery, health and life quality for persons with mental illness in a global context. Health Promotion International 25(4): 483-494
Hutchinson, S.L.; Nimrod, G. 2012: Leisure as a resource for successful aging by older adults with chronic health conditions. International Journal of Aging and Human Development 74(1): 41-65
Turner, H.; Chapman, S.; McSherry, A.; Krishnagiri, S.; Watts, J. 2000: Leisure assessment in occupational therapy: an exploratory study. Occupational Therapy in Health Care 12(2-3): 73-85
Rako, N.; Fortuna, C.Maria.; Holcer, Dško.; Mackelworth, P.; Nimak-Wood, M.; Pleslić, G.; Sebastianutto, L.; Vilibić, I.; Wiemann, A.; Picciulin, M. 2013: Leisure boating noise as a trigger for the displacement of the bottlenose dolphins of the Cres-Lošinj archipelago (northern Adriatic Sea, Croatia). Marine Pollution Bulletin 68(1-2): 77-84
Wegner, L.; Flisher, A.J.; Chikobvu, P.; Lombard, C.; King, G. 2008: Leisure boredom and high school dropout in Cape Town, South Africa. Journal of Adolescence 31(3): 421-431
Chang, L-Chih. 2014: Leisure education reduces stress among older adults. Aging and Mental Health 18(6): 754-758
Fransson, U.; Hartig, T. 2010: Leisure home ownership and early death: a longitudinal study in Sweden. Health and Place 16(1): 71-78
Akyeampong, E.; Ambler, C. 2002: Leisure in African history: an introduction. International Journal of African Historical Studies 35(1): 1-16
Cavallo, S.; April, K.T.; Grandpierre, V.; Majnemer, A.; Feldman, D.E. 2014: Leisure in children and adolescents with juvenile idiopathic arthritis: a systematic review. Plos one 9(10): E104642
Sheail, J. 2001: Leisure in the English countryside: policy making in the 1960s. Planning Perspectives: Pp 16(1): 67-84
Sevilla, A.; Gimenez-Nadal, J.I.; Gershuny, J. 2012: Leisure inequality in the United States: 1965-2003. Demography 49(3): 939-964
Beach, E.F.; Gilliver, M.; Williams, W. 2013: Leisure noise exposure: participation trends, symptoms of hearing damage, and perception of risk. International Journal of Audiology 52(Suppl 1): S20-S25
O'Brien, A.; Renwick, R.; Yoshida, K. 2008: Leisure participation for individuals living with acquired spinal cord injury. International Journal of Rehabilitation Research. Internationale Zeitschrift für Rehabilitationsforschung. Revue Internationale de Recherches de Readaptation 31(3): 225-230
Oates, A.; Bebbington, A.; Bourke, J.; Girdler, S.; Leonard, H. 2011: Leisure participation for school-aged children with down syndrome. Disability and Rehabilitation 33(19-20): 1880-1889
Tung, H.-H.; Chen, Y.-C.; Wei, J.; Liu, C.-Y.; Chang, C.-Y.; Wang, T.-J. 2010: Leisure physical activity and quality of life after coronary artery bypass graft surgery for patients with metabolic syndrome in Taiwan. Heart and Lung: the Journal of Critical Care 39(5): 410-420
Simons, R.; Maher, D.; Stüben, U.; Herbert, K.C. 2009: Leisure pilot license proposed for Europe: do you want such pilots crossing your flight path?. Aviation Space and Environmental Medicine 80(7): 663-664
Watson, E.M. 2014: Leisure reading collections in academic health sciences and science libraries: results of visits to seven libraries. Health Information and Libraries Journal 31(1): 20-31
Lundström, U.; Lilja, M.; Petersson, I.; Lexell, J.; Isaksson, G. 2014: Leisure repertoire among persons with a spinal cord injury: interests, performance, and well-being. Journal of Spinal Cord Medicine 37(2): 186-192
Ege, M.Refiker.; Acıkgoz, S.; Yucel, O. 2011: Leisure sport activity as a trigger for acute coronary events in men without known coronary artery disease. Herz 36(8): 728; Author Reply 729
Cuneo, A.; Oeckinghaus, R.; Tebbe, U. 2011: Leisure sport activity as a trigger for acute coronary events in men without known coronary artery disease : a single-center case study. Herz 36(7): 637-642
Krampe, R.T.; Smolders, C.; Doumas, M. 2014: Leisure sports and postural control: can a black belt protect your balance from aging?. Psychology and Aging 29(1): 95-102
Prini-Guadalupe, L.; Pérez-Ríos, M.ón.; Ruano-Ravina, A.; Arca, J.é A.; Barros-Dios, J.M. 2012: Leisure time activities and lung cancer. Epidemiology 23(2): 352-353
Brandes, A.Hall. 2007: Leisure time activities and obesity in school-aged inner city African American and Hispanic children. Pediatric nursing 33(2): 97-102
Ruano-Ravina, A.; García-Lavandeira, J.é A.; Torres-Durán, M.ía.; Prini-Guadalupe, L.; Parente-Lamelas, I.; Leiro-Fernández, V.; Montero-Martínez, C.; González-Barcala, F.J.; Golpe-Gómez, A.; Martínez, C.; Castro-Añón, O.; Mejuto-Martí, M.ía.J.é; Barros-Dios, J.M. 2014: Leisure time activities related to carcinogen exposure and lung cancer risk in never smokers. a case-control study. Environmental Research 132: 33-37
Schaub, M.; Gmel, G.; Annaheim, B.; Mueller, M.; Schwappach, D. 2010: Leisure time activities that predict initiation, progression and reduction of cannabis use: a prospective, population-based panel survey. Drug and Alcohol Review 29(4): 378-384
Tomcikova, Z.; Veselska, Z.; Madarasova Geckova, A.; van Dijk, J.P.; Reijneveld, S.A. 2013: Leisure time activities, parental monitoring and drunkenness in adolescents. European Addiction Research 19(3): 141-145
Marquez, D.X.; Neighbors, C.J.; Bustamante, E.E. 2010: Leisure time and occupational physical activity among racial or ethnic minorities. Medicine and Science in Sports and Exercise 42(6): 1086-1093
Larsson, C.A.; Krøll, L.; Bennet, L.; Gullberg, B.; Råstam, L.; Lindblad, U. 2012: Leisure time and occupational physical activity in relation to obesity and insulin resistance: a population-based study from the Skaraborg Project in Sweden. Metabolism, Clinical and Experimental 61(4): 590-598
Fernandes, R.A.; Christofaro, D.G.D.; Casonato, J.; Costa Rosa, C.S.; Costa, F.F.; Freitas Júnior, I.F.; Luiz Monteiro, H.; Ramos DE Oliveira, A. 2010: Leisure time behaviors: prevalence, correlates and associations with overweight in Brazilian adults. A cross-sectional analysis. Revista Medica de Chile 138(1): 29-35
Piira, O.-P.; Mustonen, P.E.; Miettinen, J.A.; Huikuri, H.V.; Tulppo, M.P. 2012: Leisure time emotional excitement increases endothelin-1 and interleukin-6 in cardiac patients. Scandinavian Cardiovascular Journal: Scj 46(1): 7-15
Sendi, P.; Brouwer, W. 2004: Leisure time in economic evaluation: theoretical and practical considerations. Expert Review of Pharmacoeconomics and Outcomes Research 4(1): 1-3
Chiang, P.-H.; Wahlqvist, M.L.; Huang, L.-Y.; Chang, Y.-C. 2013: Leisure time physical activities and dietary quality of the general and indigenous Taiwanese populations are associated with fat distribution and sarcopenia. Asia Pacific Journal of Clinical Nutrition 22(4): 599-613
Gunnell, A.S.; Knuiman, M.W.; Divitini, M.L.; Cormie, P. 2014: Leisure time physical activity and long-term cardiovascular and cancer outcomes: the Busselton Health Study. European Journal of Epidemiology 29(11): 851-857
Johnsen, N.F.øn.; Ekblond, A.; Thomsen, B.L.; Overvad, K.; Tjønneland, A. 2013: Leisure time physical activity and mortality. Epidemiology 24(5): 717-725
Annear, M.J.; Cushman, G.; Gidlow, B. 2009: Leisure time physical activity differences among older adults from diverse socioeconomic neighborhoods. Health and Place 15(2): 482-490
Hegaard, H.K.; Pedersen, B.K.; Nielsen, B.Bruun.; Damm, P. 2007: Leisure time physical activity during pregnancy and impact on gestational diabetes mellitus, pre-eclampsia, preterm delivery and birth weight: a review. Acta Obstetricia et Gynecologica Scandinavica 86(11): 1290-1296
Amin, T.T.; Al Khoudair, A.S.; Al Harbi, M.A.; Al Ali, A.R. 2012: Leisure time physical activity in Saudi Arabia: prevalence, pattern and determining factors. Asian Pacific Journal of Cancer Prevention: Apjcp 13(1): 351-360
Ginis, K.A.M.; Latimer, A.E.; Arbour-Nicitopoulos, K.P.; Buchholz, A.C.; Bray, S.R.; Craven, B.C.; Hayes, K.C.; Hicks, A.L.; McColl, M.A.; Potter, P.J.; Smith, K.; Wolfe, D.L. 2010: Leisure time physical activity in a population-based sample of people with spinal cord injury part I: demographic and injury-related correlates. Archives of Physical Medicine and Rehabilitation 91(5): 722-728
Ginis, K.A.M.; Arbour-Nicitopoulos, K.P.; Latimer, A.E.; Buchholz, A.C.; Bray, S.R.; Craven, B.C.; Hayes, K.C.; Hicks, A.L.; McColl, M.A.; Potter, P.J.; Smith, K.; Wolfe, D.L. 2010: Leisure time physical activity in a population-based sample of people with spinal cord injury part II: activity types, intensities, and durations. Archives of Physical Medicine and Rehabilitation 91(5): 729-733
Morseth, B.; Emaus, N.; Wilsgaard, T.; Jacobsen, B.K.; Jørgensen, L. 2010: Leisure time physical activity in adulthood is positively associated with bone mineral density 22 years later. the Tromsø study. European Journal of Epidemiology 25(5): 325-331
Karjalainen, J.; Peltonen, M.; Vanhala, M.; Korpi-Hyövälti, E.; Puolijoki, H.; Saltevo, J.; Oksa, H.; Saaristo, T.; Tuomilehto, J.; Kujala, U.M. 2008: Leisure time physical activity in individuals with screen-detected type 2 diabetes compared to those with known type 2 diabetes. Diabetes Research and Clinical Practice 81(1): 110-116
Han, K.; Choi-Kwon, S.; Lee, S.-K. 2011: Leisure time physical activity in patients with epilepsy in Seoul, South Korea. Epilepsy and Behavior: E&b 20(2): 321-325
Moore, S.C.; Patel, A.V.; Matthews, C.E.; Berrington de Gonzalez, A.; Park, Y.; Katki, H.A.; Linet, M.S.; Weiderpass, E.; Visvanathan, K.; Helzlsouer, K.J.; Thun, M.; Gapstur, S.M.; Hartge, P.; Lee, I.-M. 2012: Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. Plos Medicine 9(11): E1001335
Kim, I.Taek.; Mun, J.Hyun.; Jun, P.Sung.; Kim, G.Chan.; Sim, Y-Joo.; Jeong, H.Joong. 2011: Leisure time physical activity of people with spinal cord injury: mainly with clubs of spinal cord injury patients in busan-kyeongnam, Korea. Annals of Rehabilitation Medicine 35(5): 613-626
Zadarko, E.; Barabasz, Z.; Nizioł-Babiarz, E.; Zadarko Domaradzka, M.; Barabasz, M.; Sobolewski, M.; Palanska, A.; Bergier, J.óz.; Junger, J. 2014: Leisure time physical activity of young women from the Carpathian Euroregion in relation to the Body Mass Index. Annals of Agricultural and Environmental Medicine: Aaem 21(3): 622-626
Hamer, M.; Molloy, G.J.; de Oliveira, C.; Demakakos, P. 2009: Leisure time physical activity, risk of depressive symptoms, and inflammatory mediators: the English Longitudinal Study of Ageing. Psychoneuroendocrinology 34(7): 1050-1055
Mota, J.; Gomes, H.; Almeida, M.; Ribeiro, J.é C.; Santos, M.P. 2007: Leisure time physical activity, screen time, social background, and environmental variables in adolescents. Pediatric Exercise Science 19(3): 279-290
Madsen, M.; Jørgensen, T.; Jensen, M.Lundsby.; Juhl, M.; Olsen, Jørn.; Andersen, P.Kragh.; Andersen, A-Marie.Nybo. 2008: Leisure time physical exercise during pregnancy and the risk of miscarriage: a study within the Danish National Birth Cohort--secondary publication. Ugeskrift for Laeger 170(36): 2772-2775
Sisson, S.B.; Camhi, S.M.; Church, T.S.; Martin, C.K.; Tudor-Locke, C.; Bouchard, C.; Earnest, C.P.; Smith, S.R.; Newton, R.L.; Rankinen, T.; Katzmarzyk, P.T. 2009: Leisure time sedentary behavior, occupational/domestic physical activity, and metabolic syndrome in U.S. men and women. Metabolic Syndrome and Related Disorders 7(6): 529-536
Patel, A.V.; Bernstein, L.; Deka, A.; Feigelson, H.S.; Campbell, P.T.; Gapstur, S.M.; Colditz, G.A.; Thun, M.J. 2010: Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. American Journal of Epidemiology 172(4): 419-429
Pernsteiner, J. 2011: Leisure time stress is responsible for headaches in children. Behavior of parents has a great effect on the health of the children. Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 30(3): 119
Bhattacharya, N. 2013: Leisure, economy and colonial urbanism: Darjeeling, 1835-1930. Urban history 40(3)
Ouyang, Z.; Chong, A.M.L.; Ng, T.Kin.; Liu, S. 2015: Leisure, functional disability and depression among older Chinese living in residential care homes. Aging and Mental Health 19(8): 723-730
Fitzpatrick, T.R.; Farone, D.W. 2011: Leisure, household activities, and health among Mexican American elders with cancer. Journal of psychosocial oncology 29(2): 199-214
Caldwell, L.L.; Witt, P.A. 2011: Leisure, recreation, and play from a developmental context. New Directions for Youth Development 130: 13-27
Kobza, R.; Duru, F.; Erne, P. 2008: Leisure-time activities of patients with ICDs: findings of a survey with respect to sports activity, high altitude stays, and driving patterns. Pacing and Clinical Electrophysiology: Pace 31(7): 845-849
Zhao, G.; Li, C.; Ford, E.S.; Fulton, J.E.; Carlson, S.A.; Okoro, C.A.; Wen, X.J.; Balluz, L.S. 2014: Leisure-time aerobic physical activity, muscle-strengthening activity and mortality risks among US adults: the NHANES linked mortality study. British Journal of Sports Medicine 48(3): 244-249
Del Duca, G.ân.F.; Nahas, M.V.; Hallal, P.C.; Peres, K.G. 2014: Leisure-time physical activities among adults in Florianopolis, state of Santa Catarina, Brazil: a population-based study on the characteristics of the practices and the practitioners. Ciencia and Saude Coletiva 19(11): 4595-4604
Lin, Y.-C.; Huang, L.-H.; Yeh, M.C.; Tai, J.J. 2011: Leisure-time physical activities for community older people with chronic diseases. Journal of Clinical Nursing 20(7-8): 940-949
Bauman, A.; Allman-Farinelli, M.; Huxley, R.; James, W.P.T. 2008: Leisure-time physical activity alone may not be a sufficient public health approach to prevent obesity--a focus on China. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 9 Suppl. 1: 119-126
Hughes, J.P.; McDowell, M.A.; Brody, D.J. 2008: Leisure-time physical activity among US adults 60 or more years of age: results from NHANES 1999-2004. Journal of Physical Activity and Health 5(3): 347-358
Siqueira, F.V.; Facchini, L.A.; Silveira, D.S.; Piccini, R.X.; Tomasi, E.; Halla, P.C. 2011: Leisure-time physical activity among adult and elderly individuals in Brazil: a countrywide analysis. Journal of Physical Activity and Health 8(7): 891-897
Lahti, J.; Holstila, A.; Lahelma, E.; Rahkonen, O. 2014: Leisure-time physical activity and all-cause mortality. Plos one 9(7): E101548
Bembom, O.; van der Laan, M.; Haight, T.; Tager, I. 2009: Leisure-time physical activity and all-cause mortality in an elderly cohort. Epidemiology 20(3): 424-430
Leskinen, T.; Usenius, J.-P.; Alen, M.; Kainulainen, H.; Kaprio, J.; Kujala, U.M. 2011: Leisure-time physical activity and artery lumen diameters: a monozygotic co-twin control study. Scandinavian Journal of Medicine and Science in Sports 21(6): E208-E214
Suzuki, R.; Iwasaki, M.; Kasuga, Y.; Yokoyama, S.; Onuma, H.; Nishimura, H.; Kusama, R.; Shimazu, T.; Tsugane, S. 2010: Leisure-time physical activity and breast cancer risk by hormone receptor status: effective life periods and exercise intensity. Cancer Causes and Control: Ccc 21(11): 1787-1798
Suzuki, R.; Iwasaki, M.; Yamamoto, S.; Inoue, M.; Sasazuki, S.; Sawada, N.; Yamaji, T.; Shimazu, T.; Tsugane, S.; Tsugane, S.; Inoue, M.; Sobue, T.; Hanaoka, T.; Ogata, J.; Baba, S.; Mannami, T.; Okayama, A.; Kokubo, Y.; Miyakawa, K.; Saito, F.; Koizumi, A.; Sano, Y.; Hashimoto, I.; Ikuta, T.; Miyajima, Y.; Suzuki, N.; Nagasawa, S.; Furusugi, Y.; Nagai, N.; Sanada, H.; Hatayama, Y.; Kobayashi, F.; Uchino, H.; Shirai, Y.; Kondo, T.; Sasaki, R.; Watanabe, Y.; Miyagawa, Y.; Kobayashi, Y.; Kishimoto, Y.; Takara, E.; Fukuyama, T.; Kinjo, M.; Irei, M.; Sakiyama, H.; Imoto, K.; Yazawa, H.; Seo, T.; Seiko, A.; Ito, F.; Shoji, F.; Murata, A.; Minato, K.; Motegi, K.; Fujieda, T.; Matsui, K.; Abe, T.; Katagiri, M.; Suzuki, M.; Doi, M.; Terao, A.; Ishi 2011: Leisure-time physical activity and breast cancer risk defined by estrogen and progesterone receptor status--the Japan Public Health Center-based Prospective Study. Preventive Medicine 52(3-4): 227-233
Cárdenas-Cárdenas, L.M.; Burguete-Garcia, A.I.; Estrada-Velasco, B.I.; López-Islas, C.; Peralta-Romero, J.ús.; Cruz, M.; Galván-Portillo, M. 2015: Leisure-time physical activity and cardiometabolic risk among children and adolescents. Jornal de Pediatria 91(2): 136-142
Cicero, A.F.G.; D'Addato, S.; Santi, F.; Ferroni, A.; Borghi, C. 2012: Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study. Journal of Cardiovascular Medicine 13(9): 559-564
Sallis, J.F. 2011: Leisure-time physical activity and depression in adolescence. Clinical Journal of Sport Medicine: Official Journal of the Canadian Academy of Sport Medicine 21(1): 72
Lahti, J.; Rahkonen, O.; Lahelma, E.; Laaksonen, M. 2013: Leisure-time physical activity and disability retirement: a prospective cohort study. Journal of Physical Activity and Health 10(5): 669-675
Keum, N.; Ju, W.; Lee, D.H.; Ding, E.L.; Hsieh, C.C.; Goodman, J.E.; Giovannucci, E.L. 2014: Leisure-time physical activity and endometrial cancer risk: dose-response meta-analysis of epidemiological studies. International Journal of Cancer 135(3): 682-694
Faam, B.; Hosseinpanah, F.; Amouzegar, A.; Ghanbarian, A.; Asghari, G.; Azizi, F. 2013: Leisure-time physical activity and its association with metabolic risk factors in Iranian adults: Tehran Lipid and Glucose Study, 2005-2008. Preventing chronic disease 10: E36
Wang, F.; DesMeules, M.; Luo, W.; Dai, S.; Lagace, C.; Morrison, H. 2011: Leisure-time physical activity and marital status in relation to depression between men and women: a prospective study. Health Psychology: Official Journal of the Division of Health Psychology American Psychological Association 30(2): 204-211
Korniloff, K.; Katariina, K.; Häkkinen, A.; Arja, H.äk.; Kautiainen, H.; Hannu, K.; Koponen, H.; Hannu, K.; Peltonen, M.; Markku, P.; Mäntyselkä, P.; Pekka, M.än.ä; Oksa, H.; Heikki, O.; Kampman, O.; Olli, K.; Vanhala, M.; Mauno, V. 2010: Leisure-time physical activity and metabolic syndrome plus depressive symptoms in the FIN-D2D survey. Preventive Medicine 51(6): 466-470
Chiu, Y.-C.; Kolanowski, A.M.; Huang, C.-Y.; Lin, L.-J.; Chang, T.-H.; Hsu, K.-H.; Hu, C.-J.; Chen, Y.-J. 2014: Leisure-time physical activity and neuropsychiatric symptoms of community-dwelling persons with cognitive impairment. Geriatric Nursing 35(5): 345-350
Rintala, M.; Lyytikäinen, A.; Leskinen, T.; Alen, M.; Pietiläinen, K.H.; Kaprio, J.; Kujala, U.M. 2011: Leisure-time physical activity and nutrition: a twin study. Public Health Nutrition 14(5): 846-852
Li, K.; Seo, D.-C.; Torabi, M.R.; Peng, C.-Y.J.; Kay, N.S.; Kolbe, L.J. 2010: Leisure-time physical activity and obesity in black adults in Indianapolis. American Journal of Health Behavior 34(4): 442-452
Tudor-Locke, C.; Burton, N.W.; Brown, W.J. 2009: Leisure-time physical activity and occupational sitting: Associations with steps/day and BMI in 54-59 year old Australian women. Preventive medicine 48(1): 64-68
Molina-García, J.; Castillo, I.; Queralt, A. 2011: Leisure-time physical activity and psychological well-being in university students. Psychological Reports 109(2): 453-460
Brouwer, B.G.; van der Graaf, Y.; Soedamah-Muthu, S.S.; Wassink, A.M.J.; Visseren, F.L.J.; Pijl, A.G.; Algra, A.; van der Graaf, Y.; Grobbee, D.E.; Rutten, G.E.H.M.; Visseren, F.L.J.; Moll, F.L.; Kappelle, L.J.; Mali, W.P.T.M.; Doevendans, P.A. 2010: Leisure-time physical activity and risk of type 2 diabetes in patients with established vascular disease or poorly controlled vascular risk factors. Diabetes Research and Clinical Practice 87(3): 372-378
Chen, X.-r.; Jiang, Y.; Wang, L.-m.; Li, Y.-c.; Zhang, M.; Hu, N.; Zhao, W.-h. 2012: Leisure-time physical activity and sedentary behaviors among Chinese adults in 2010. Zhonghua Yu Fang Yi Xue Za Zhi 46(5): 399-403
Da Silva, I.C.M.; Azevedo, M.R.; Gonçalves, H. 2013: Leisure-time physical activity and social support among Brazilian adults. Journal of Physical Activity and Health 10(6): 871-879
Ilanne-Parikka, P.; Laaksonen, D.E.; Eriksson, J.G.; Lakka, T.A.; Lindstr, Jöm.; Peltonen, M.; Aunola, S.; Keinánen-Kiukaanniemi, S.; Uusitupa, M.; Tuomilehto, J. 2010: Leisure-time physical activity and the metabolic syndrome in the Finnish diabetes prevention study. Diabetes Care 33(7): 1610-1617
Huang, Y.; Liu, X. 2014: Leisure-time physical activity and the risk of metabolic syndrome: meta-analysis. European Journal of Medical Research 19: 22
Waller, K.; Kaprio, J.; Lehtovirta, M.; Silventoinen, K.; Koskenvuo, M.; Kujala, U.M. 2010: Leisure-time physical activity and type 2 diabetes during a 28 year follow-up in twins. Diabetologia 53(12): 2531-2537
Seo, D-Chul.; Li, K. 2010: Leisure-time physical activity dose-response effects on obesity among US adults: results from the 1999-2006 National Health and Nutrition Examination Survey. Journal of epidemiology and community health 64(5): 426-431
Mattran, K.; Mudd, L.M.; Rudey, R.A.; Kelly, J.S.C. 2011: Leisure-time physical activity during pregnancy and offspring size at 18 to 24 months. Journal of Physical Activity and Health 8(5): 655-662
Tolppanen, A.-M.; Solomon, A.; Kulmala, J.; Kåreholt, I.; Ngandu, T.; Rusanen, M.; Laatikainen, T.; Soininen, H.; Kivipelto, M. 2015: Leisure-time physical activity from mid- to late life, body mass index, and risk of dementia. Alzheimer's and Dementia: the Journal of the Alzheimer's Association 11(4): 434-443.E6
Mack, D.E.; Wilson, P.M.; Gilmore, J.C.; Gunnell, K.E. 2011: Leisure-time physical activity in Canadians living with Crohn disease and ulcerative colitis: population-based estimates. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 34(4): 288-294
Meseguer, C.M.; Galán, I.ña.; Herruzo, R.; Zorrilla, B.én.; Rodríguez-Artalejo, F. 2009: Leisure-time physical activity in a southern European mediterranean country: adherence to recommendations and determining factors. Revista Espanola de Cardiologia 62(10): 1125-1133
McKenzie, T.L.; Crespo, N.C.; Baquero, B.; Elder, J.P. 2010: Leisure-time physical activity in elementary schools: analysis of contextual conditions. Journal of School Health 80(10): 470-477
Strøm, M.; Mortensen, E.L.; Halldorson, Tórhallur.I.; Osterdal, M.Louise.; Olsen, Súrdur.F. 2009: Leisure-time physical activity in pregnancy and risk of postpartum depression: a prospective study in a large national birth cohort. Journal of Clinical Psychiatry 70(12): 1707-1714
Mudd, L.M.; Pivarnik, J.; Holzman, C.B.; Paneth, N.; Pfeiffer, K.; Chung, H. 2012: Leisure-time physical activity in pregnancy and the birth weight distribution: where is the effect?. Journal of Physical Activity and Health 9(8): 1168-1177
Andreassen, M.; Jørgensen, L.; Jacobsen, B.K. 2007: Leisure-time physical activity in the Norwegian county Nordland. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 127(24): 3213-3216
Sone, H.; Tanaka, S.; Tanaka, S.; Suzuki, S.; Seino, H.; Hanyu, O.; Sato, A.; Toyonaga, T.; Okita, K.; Ishibashi, S.; Kodama, S.; Akanuma, Y.; Yamada, N. 2013: Leisure-time physical activity is a significant predictor of stroke and total mortality in Japanese patients with type 2 diabetes: analysis from the Japan Diabetes Complications Study (JDCS). Diabetologia 56(5): 1021-1030
Cho, E.R.; Shin, A.; Kim, J.; Jee, S.H.; Sung, J. 2009: Leisure-time physical activity is associated with a reduced risk for metabolic syndrome. Annals of Epidemiology 19(11): 784-792
Dregan, A.; Gulliford, M.C. 2013: Leisure-time physical activity over the life course and cognitive functioning in late mid-adult years: a cohort-based investigation. Psychological Medicine 43(11): 2447-2458
Spörndly-Nees, S.ør.; Åsenlöf, P.; Theorell-Haglöw, J.; Svensson, M.; Igelström, H.; Lindberg, E. 2014: Leisure-time physical activity predicts complaints of snoring in women: a prospective cohort study over 10 years. Sleep Medicine 15(4): 415-421
Valtonen, M.; Laaksonen, D.E.; Laukkanen, J.; Tolmunen, T.; Rauramaa, R.; Viinamäki, H.; Kauhanen, J.; Lakka, T.; Niskanen, L. 2009: Leisure-time physical activity, cardiorespiratory fitness and feelings of hopelessness in men. Bmc Public Health 9: 204
Savela, S.; Koistinen, P.; Tilvis, R.S.; Strandberg, A.Y.; Pitkälä, K.H.; Salomaa, V.V.; Miettinen, T.A.; Strandberg, T.E. 2010: Leisure-time physical activity, cardiovascular risk factors and mortality during a 34-year follow-up in men. European Journal of Epidemiology 25(9): 619-625
Rombaldi, A.J.; Menezes, A.M.B.; Azevedo, M.Renato.; Hallal, P.C. 2010: Leisure-time physical activity: association with activity levels in other domains. Journal of Physical Activity and Health 7(4): 460-464
Zhang, M.; Chen, X.; Wang, Z.; Wang, L.; Jiang, Y. 2014: Leisure-time physical exercise and sedentary behavior among Chinese elderly, in 2010. Zhonghua Liu Xing Bing Xue Za Zhi 35(3): 242-245
Calais, F.; Fröbert, O.; Rosenblad, A.; Hedberg, P.är.O.; Wachtell, K.; Leppert, J. 2014: Leisure-time physical inactivity and risk of myocardial infarction and all-cause mortality: a case-control study. International Journal of Cardiology 177(2): 599-600
Martins, T.ís.G.; Assis, M.A.A.d.; Nahas, M.V.íc.; Gauche, H.; Moura, E.C. 2009: Leisure-time physical inactivity in adults and factors associated. Revista de Saude Publica 43(5): 814-824
Lee, D.-C.; Pate, R.R.; Lavie, C.J.; Sui, X.; Church, T.S.; Blair, S.N. 2014: Leisure-time running reduces all-cause and cardiovascular mortality risk. Journal of the American College of Cardiology 64(5): 472-481
Omariba, G.; Tong, L.; Wang, M.; Li, K.; Zhou, Y.; Xiao, J. 2018: Characterization of the dynamic change of microRNA expression in mice hypothalamus during the time of female puberty. Genes and Genomics 40(3): 295-304
Portoghese, C.; Buttiglione, M.; De Giacomo, A.; Lafortezza, M.; Lecce, P.A.; Martinelli, D.; Lozito, V.; Margari, L. 2010: Leiter-R versus developmental quotient for estimating cognitive function in preschoolers with pervasive developmental disorders. Neuropsychiatric Disease and Treatment 6: 337-342
Marshall, J. 1906: Leitfaden fur den praktisch-chemischen Unterricht der Mediziner. Science 24(608): 245
Li, G.; Zhang, Y.; Yang, B.; Xia, Y.; Zhang, Y.; Lü, S.; Kuang, H. 2010: Leiyemudanosides A-C, three new bidesmosidic triterpenoid saponins from the roots of Caulophyllum robustum. Fitoterapia 81(3): 200-204
Rümenapf, G.; Morbach, S. 2013: Lejay A, Thaveau F, Georg Y, Bajcz C, Kretz JG, Chakfé N. Autonomy following revascularisation in 80-year-old patients with critical limb ischemia. Eur J Vasc Endovasc Surg 2012;44:562-7. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 45(6): 693
Lewington, R.J.; Beveridge, P.; Renner, M.A.M. 2013: Lejeunea hodgsoniana, a newly described, long recognised Lejeunea (Jungermanniopsida, Lejeuneaceae) from lowland coastal forest habitats in New Zealand. Phytokeys 29: 1-15
Braithwaite, J. 2008: Lekking displays in contemporary organizations: ethologically oriented, evolutionary and cross-species accounts of male dominance. Journal of Health Organization and Management 22(5): 529-559
Arshad, F.; Laway, B.A.; Bhat, M.A.; Irfan Showkat, H.; Kotwal, S.; Ahmad Mir, S. 2013: Leksell Gamma Knife : An Effective Non Invasive Treatment for Rare Case of Nelson's Syndrome. International Journal of Endocrinology and Metabolism 11(3): 195-198
Sheehan, J. 2012: Leksell Gamma Knife Conference in the land down under. Journal of Neurosurgery 117 Suppl: 1
Schlesinger, D.J.; Sayer, F.T.; Yen, C.-P.; Sheehan, J.P. 2010: Leksell GammaPlan version 10.0 preview: performance of the new inverse treatment planning algorithm applied to Gamma Knife surgery for pituitary adenoma. Journal of Neurosurgery 113 Suppl: 144-148
Wowra, B.; Muacevic, A.; Tonn, J.C. 2004: Leksell gamma knife. MMW Fortschritte der Medizin 146(1-2): 56-57
Leclerc-Mercier, S.ép.; Hovnanian, A.; Fraitag, S. 2012: Lekti immunochemistry for the diagnosis of netherton syndrome. American Journal of Dermatopathology 34(8): 853
Anonymous 1987: Leland Clark's Invention of the Membrane-Covered Oxygen Electrode. International Anesthesiology Clinics 25(4): 115-129
Wang, H.; Hartwell, L. 2008: Leland H. Hartwell. Yi Chuan 30(6): 663-664
Anonymous 1899: Leland Stanford Jr. University. Science 9(235): 916
Knight, W.C. 1901: Potassium Nitrate in Wyoming. Science 13(317): 151-152
Paul, R.; Knowles, N.; Chaoui, J.; Gauci, M.-O.; Ferreira, L.; Walch, G.; Athwal, G.S. 2018: Characterization of the dysplastic Walch type C glenoid. Bone and Joint Journal 100-B(8): 1074-1079
Haddon, A.C. 1902: Leland Stanford Junior University. a Suggestion. Science 16(397): 231-232
van Steensel, M.A.M.; van der Hout, A.H. 2009: Lelis Syndrome may be a manifestation of hypohidrotic ectodermal dysplasia. American Journal of Medical Genetics. Part a 149a(7): 1612-1613
Yoshimura, A.M.; Velho, P.E.N.F.; Magalhães, R.F.; de Souza, E.M. 2008: Lelis' syndrome: treatment with acitretin. International Journal of Dermatology 47(12): 1330-1331
Bungaruang, L.; Gutmann, A.; Nidetzky, B. 2013: Leloir Glycosyltransferases and Natural Product Glycosylation: Biocatalytic Synthesis of the C-Glucoside Nothofagin, a Major Antioxidant of Redbush Herbal Tea. Advanced Synthesis and Catalysis 355(14-15): 2757-2763
Soodyall, H. 2013: Lemba origins revisited: tracing the ancestry of y chromosomes in South African and Zimbabwean Lemba. South African Medical Journal 103(12 Suppl 1: 1009-1013
Ji, Y-Qun.; Wang, J.; Kong, L-Qin.; Juggessur-Mungur, K.Sandya.; Wu, T-Hua.; Zhang, Z-He. 2013: Lemierre syndrome caused by Arcanobacterium haemolyticum. Chinese Medical Journal 126(2): 391-392
Juárez Escalona, I.; Díaz Carandell, A.; Aboul-Hons Centenero, S.; Monner Diéguez, A.; Marí Roig, A.; Arranz Obispo, C.; Piulachs Clapera, P.; Lluch Salas, Jé.Maria.; Cuscó Albors, S.; Sieira Gil, R. 2007: Lemierre Syndrome associated with dental infections. Report of one case and review of the literature. Medicina Oral Patologia Oral y Cirugia Bucal 12(5): E394-E396
Malhotra, A.; Westesson, P-Lennart. 2010: Lemierre syndrome. Pediatric Radiology 40(8): 1451
Wright, W.F.; Shiner, C.N.; Ribes, J.A. 2012: Lemierre syndrome. Southern Medical Journal 105(5): 283-288
Malis, D.D.; Busaidy, K.F.; Marchena, J.M. 2008: Lemierre syndrome and descending necrotizing mediastinitis following dental extraction. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 66(8): 1720-1725
Porquet-Bordes, V.; Guillet, E.; Cammas, B.; Runel-Belliard, C. 2011: Lemierre syndrome and influenza a (H1N1). Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 18(4): 413-415
Gilbert, J.D.; Warner, M.S.; Byard, R.W. 2009: Lemierre syndrome and unexpected death in childhood. Journal of Forensic and Legal Medicine 16(8): 478-481
Blessing, K.; Toepfner, N.; Kinzer, S.; Möllmann, C.; Geiger, J.; Serr, A.; Hufnagel, M.; Müller, C.; Krüger, M.; Ridder, G.J.; Berner, R. 2013: Lemierre syndrome associated with 12th cranial nerve palsy--a case report and review. International Journal of Pediatric Otorhinolaryngology 77(9): 1585-1588
Shah, R.K.; Wofford, M.M.; West, T.G.; Shetty, A.K. 2010: Lemierre syndrome associated with group a streptococcal infection. American Journal of Emergency Medicine 28(5): 643.E5-8
Paule, P.; Oliver, M.; Gil, J.-M.; Lightburne, E.; Miltgen, J.; Fourcade, L. 2010: Lemierre syndrome associated with vascular purpura in a patient with dilated cardiomyopathy. Presse Medicale 39(7-8): 842-845
Zhang, W-han.; Ji, Y-qun.; Zhang, Z-he. 2013: Lemierre syndrome caused by Arcanobacterium haemolyticum: a case report and review of the literature. Zhonghua Nei Ke Za Zhi 52(1): 42-45
Hot, A.; Coppere, B.; Ninet, J.; Thiebault, A. 2008: Lemierre syndrome caused by Leptotrichia buccalis in a neutropenic patient. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 12(3): 339-340
Lim, S.-C.; Lee, S.-S.; Yoon, T.-M.; Lee, J.-K. 2010: Lemierre syndrome caused by acute isolated sphenoid sinusitis and its intracranial complications. Auris Nasus Larynx 37(1): 106-109
Lundblom, K.; Jung, K.; Kalin, M. 2010: Lemierre syndrome caused by co-infection by Arcanobacterium haemolyticum and Fusobacterium necrophorum. Infection 38(5): 427-429
Saphyakhajon, P. 2007: Lemierre syndrome caused by group A streptococci. Pediatric Infectious Disease Journal 26(11): 1074; Author Reply 1075
Mewawalla, P.; Bauer, F.; Dasanu, C.A. 2011: Lemierre syndrome caused by group C streptococci and associated with red cell aplasia and immune thrombocytopenia. Southern Medical Journal 104(3): 244-246
Takenouchi, S.; Kunieda, T.; Yamada, R.; Yamakita, N. 2014: Lemierre syndrome caused by oral sex. Journal of the Formosan Medical Association 113(10): 762-763
Miller, B.; Khalifa, Y.; Feldon, S.E.; Friedman, D.I. 2012: Lemierre syndrome causing bilateral cavernous sinus thrombosis. Journal of Neuro-Ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society 32(4): 341-344
Valesky, W.; Agoritsas, K. 2013: Lemierre syndrome complicated by cerebral abscess. American Journal of Emergency Medicine 31(2): 458.E1
Lee, W.-S.; Wang, F.-D.; Shieh, Y.-H.; Teng, S.-O.; Ou, T.-Y. 2012: Lemierre syndrome complicating multiple brain abscesses caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae cured by fosfomycin and meropenem combination therapy. Journal of Microbiology Immunology and Infection 45(1): 72-74
Hile, L.M.; Gibbons, M.D.; Hile, D.C. 2012: Lemierre syndrome complicating otitis externa: case report and literature review. Journal of Emergency Medicine 42(4): E77-E80
Lu, M.D.; Vasavada, Z.; Tanner, C. 2009: Lemierre syndrome following oropharyngeal infection: a case series. Journal of the American Board of Family Medicine: Jabfm 22(1): 79-83
Albilia, J.B.; Humber, C.C.; Clokie, C.M.L.; Sándor, G.K.B. 2010: Lemierre syndrome from an odontogenic source: a review for dentists. Journal 76: A47
Rappaport, A.; Haven, F.; Peters, C.; Kessler, R. 2008: Lemierre syndrome in a 19-year-old man with acute swollen neck. JBR-BTR: Organe de la Societe Royale Belge de Radiologie 91(1): 23
Frizzola, M.A.; Hertzog, J.H. 2011: Lemierre syndrome in a 22-month-old due to Streptococcus pyogenes: a case report. Pediatric Emergency Care 27(11): 1078-1080
Aspesberro, Fçois.; Siebler, T.; Van Nieuwenhuyse, J-Paul.; Panosetti, Eène.; Berthet, Fçoise. 2008: Lemierre syndrome in a 5-month-old male infant: Case report and review of the pediatric literature. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 9(5): E35-E37
Busko, J.M.; Triner, W. 2004: Lemierre syndrome in a child with recent pharyngitis. Cjem 6(4): 285-287
Thakker, A.; Karande, S. 2010: Lemierre syndrome in the antibiotic era. Indian Pediatrics 47(3): 285
Astradsson, T.; Ekspong, L.; Norlander, T. 2013: Lemierre syndrome is a forgotten disease that primarily affects young people. Early antibiotic treatment can prevent fatal outcome. Lakartidningen 110(8): 413-415
Yamaguchi, M.; Nishizawa, H.; Yasumoto, T.; Kimura, T.; Takeuchi, Y.; Takeshita, A.; Takase, T.; Fujimoto, H.; Nakano, M.; Fukunaga, M. 2010: Lemierre syndrome with blepharoptosis. Internal Medicine 49(8): 753-757
Lin, H.-Y.; Liao, K.-H.; Jean, S.-S.; Ou, T.-Y.; Chen, F.-L.; Lee, W.-S. 2015: Lemierre syndrome with cervical spondylodiscitis and epidural abscess associated with direct injection of heroin into the jugular vein. Journal of Microbiology Immunology and Infection 48(2): 238-239
Vincent, Q.B.; Labedan, I.; Madhi, F. 2010: Lemierre syndrome with meningo-encephalitis, severe cerebral artery stenosis, and focal neurological symptoms. Journal of Pediatrics 157(2): 345-345.E2
Kim, T.; Choi, J-Young. 2013: Lemierre syndrome with thrombosis of sigmoid sinus following dental extraction: a case report. Journal of the Korean Association of Oral and Maxillofacial Surgeons 39(2): 85-89
Iwata, N.; Komiya, N.; Uchiyama-Nakamura, F.; Ohnishi, K. 2010: Lemierre syndrome: a Japanese patient returning from Thailand. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 16(3): 213-215
Gokçe Ceylan, B.; Yavuz, L.; Baydar, C.L.; Tuz, M.; Eroglu, F.; Kiris, I.; Akcam, F.Z.; Erdem, B. 2009: Lemierre syndrome: a case of a rarely isolated microorganism, Staphylococcus auerus. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 15(3): Cs58-Cs61
Seo, Y.T.; Kim, M.J.; Kim, J.H.; Ha, B.W.; Choi, H.S.; Kim, Y.T.; Ham, Y.H. 2007: Lemierre syndrome: a case of postanginal sepsis. Korean Journal of Internal Medicine 22(3): 211-214
Kisser, U.; Gurkov, R.; Flatz, W.; Berghaus, A.; Reichel, O. 2012: Lemierre syndrome: a case report. American Journal of Otolaryngology 33(1): 159-162
Passalidou, P.; Berlioz, M.; Bailly, C.; Boutté, P. 2008: Lemierre syndrome: a complication of an oropharyngeal infection. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 15(12): 1775-1778
Gashau, A. 2009: Lemierre syndrome: a needle in a haystack. BMJ Case Reports
Ridgway, J.M.; Parikh, D.A.; Wright, R.; Holden, P.; Armstrong, W.; Camilon, F.; Wong, B.J-F. 2010: Lemierre syndrome: a pediatric case series and review of literature. American Journal of Otolaryngology 31(1): 38-45
Tran, D.; Maradia, K.; Montero, J. 2010: Lemierre syndrome: a rare disease affecting previously healthy, young individuals. Southern Medical Journal 103(11): 1190
Boldt, B.M.; Nguyen, D.; Faga, M.; Caras, W. 2010: Lemierre syndrome: from pharyngitis to fulminant sepsis. BMJ Case Reports
Azzopardi, C.; Grech, R.; Mizzi, A. 2013: Lemierre syndrome: more than just a sore throat. BMJ Case Reports
Morelli, N.; Rota, E.; Sacchini, D.; Ratti, G.; Cassi, A.; Feraboli, F.; Biondi, M.; Michieletti, E.; Guidetti, D. 2013: Lemierre syndrome: more than "the forgotten disease". Neurology 81(13): 1179-1180
Zouagui, A.; Abourazzak, S.; Smaili, L.; Elarqam, L.; Chaouki, S.; Atmani, S.; Bouharrou, A.; Hida, M. 2009: Lemierre syndrome: must anticoagulation remain controversial?. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 10(2): 276-7; author reply 277
Karkos, P.D.; Karkos, C.D.; Leong, S.C.; Sivaji, N.; Papadopoulos, D.; Assimakopoulos, A.D. 2010: Lemierre syndrome: no delays in management. American Journal of Emergency Medicine 28(7): 844.E1
Gupta, N.; Kralovic, S.M.; McGraw, D. 2014: Lemierre syndrome: not so forgotten!. American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 23(2): 176-179
Abourazzak, S.; Zouagui, A.; Smaili, L.; Ouzaa, H.; Lamrani, Y.M.A.; Tizniti, S.; Elarqam, L.; Chaouki, S.; Atmani, S.; Bouharrou, A.; Hida, M. 2009: Lemierre syndrome: once seen it can never be mistaken. BMJ Case Reports
Weeks, D.F.; Katz, D.S.; Saxon, P.; Kubal, W.S. 2010: Lemierre syndrome: report of five new cases and literature review. Emergency Radiology 17(4): 323-328
Gargallo, E.; Nuevo, J.A.; Cano, J.C.; Castuera, A.I.; Andueza, J.A.; Fernández, M.ía. 2010: Lemierre syndrome: several clinical features of "a forgotten disease". Enfermedades Infecciosas y Microbiologia Clinica 28(10): 701-705
Righini, C.Adrien.; Karkas, A.; Tourniaire, R.; N'Gouan, J-Michel.; Schmerber, Sébastien.; Reyt, E.; Atallah, I. 2014: Lemierre syndrome: study of 11 cases and literature review. Head and Neck 36(7): 1044-1051
Rudski Ricondo, L.; Ramos Gómez, M.J.; Aguilar Cantador, J.; Bravo-Rodríguez, F.A. 2013: Lemierre syndrome: thrombosis of the cavernous sinus and internal carotid artery occlusion secondary to acute sphenoid sinusitis. Acta Otorrinolaringologica Espanola 64(1): 75-77
Syed, M.I.; Baring, D.; Addidle, M.; Murray, C.; Adams, C. 2007: Lemierre syndrome: two cases and a review. Laryngoscope 117(9): 1605-1610
Murray, M.; Stevens, T.; Herford, A.; Roberts, J. 2013: Lemierre syndrome: two cases requiring surgical intervention. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 71(2): 310-315
Aouad, R.; Melkane, A.; Rassi, S. 2010: Lemierre syndrome: unusual cause and presentation. Pediatric Emergency Care 26(5): 376-377
Shook, J.; Trigger, C. 2014: Lemierre's Syndrome. Western Journal of Emergency Medicine 15(2): 125-126
Aggarwal, S.Kumar.; Nath, A.; Singh, R.; Keshri, A. 2013: Lemierre's Syndrome presenting with neurological and pulmonary symptoms: Case report and review of the literature. Annals of Indian Academy of Neurology 16(2): 259-263
Gupta, S.; Merchant, S.S. 2012: Lemierre's Syndrome: Rare, but Life Threatening-A Case Report with Streptococcus intermedius. Case Reports in Medicine 2012: 624065
Chacko, E.M.; Krilov, L.R.; Patten, W.; Lee, P.J. 2010: Lemierre's and Lemierre's-like syndromes in association with infectious mononucleosis. Journal of Laryngology and Otology 124(12): 1257-1262
Bird, N.Te.; Cocker, D.; Cullis, P.; Schofield, R.; Challoner, B.; Hayes, A.; Brett, M. 2014: Lemierre's disease: a case with bilateral iliopsoas abscesses and a literature review. World Journal of Emergency Surgery: Wjes 9: 38
O'Dwyer, D.N.; Ryan, S.; O'Keefe, T.; Lyons, J.; Lavelle, L.; McKone, E. 2011: Lemierre's syndrome. Irish Journal of Medical Science 180(2): 565-567
Courtin, P.; Toro, A.; Gazagnes, M.; Berrouba, A.; Gallardo, M.; Dembele, A. 2010: Lemierre's syndrome. Annales Francaises d'Anesthesie et de Reanimation 29(11): 799-802
Eilbert, W.; Singla, N. 2013: Lemierre's syndrome. International Journal of Emergency Medicine 6(1): 40
Davidoss, N.; Ha, J.F.; Anderson, J.R.; Rodrigues, S. 2015: Lemierre's syndrome - an unusual complication of otitis externa in a young, healthy female. Journal of Laryngology and Otology 129(Suppl 1): S60-S62
Hedengran, K.Kaare.; Hertz, J. 2014: Lemierre's syndrome after evacuation of the uterus: a case report. Clinical Case Reports 2(2): 60-61
Vartzelis, G.; Theodoridou, M.; Ali, S.I.; O'Connor, R. 2008: Lemierre's syndrome and defensive antibiotic prescribing tactics: lessons to be had. Clinical Pediatrics 47(5): 510-513
Hagelskjaer Kristensen, L.; Prag, J. 2008: Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 27(9): 779-789
Dorfman, A.; Shokoohi, H.; Taheri, M.Reza. 2012: Lemierre's syndrome and rapidly deteriorating respiratory failure in the emergency department. American Journal of Emergency Medicine 30(8): 1658.E5-7
Fernández-Suárez, A.; Aguilar Benítez, Jé.Miguel.; López Vidal, A.María.; Díaz Iglesias, Jé.Miguel. 2009: Lemierre's syndrome and septicaemia caused solely by Arcanobacterium haemolyticum in a young immunocompetent patient. Journal of Medical Microbiology 58(Pt 12): 1645-1648
Reinholdt Jensen, J.; Weinreich, U.M.øl. 2012: Lemierre's syndrome as differential diagnosis of lung cancer. Ugeskrift for Laeger 174(22): 1533-1534
Meyer García-Sípido, E.; Puente Domínguez, T.; Sanz Sanz, C.L.; Fuentes Ponte, M.; Chamorro Borraz, N.; Rebollo Ferreiro, J. 2013: Lemierre's syndrome associated to right external jugular vein thrombosis. Medicina Intensiva 37(2): 120-121
Georgopoulos, S.; Korres, S.; Riga, M.; Balatsouras, D.; Kotsis, G.; Ferekidis, E. 2008: Lemierre's syndrome associated with consumption coagulopathy and acute renal failure: a case report. Journal of Laryngology and Otology 122(5): 527-530
Lwin, A.A.; Lohani, S. 2010: Lemierre's syndrome complicated by an infected branchial cyst. Journal of the Royal College of Physicians of Edinburgh 40(4): 308-310
Hlibczuk, V. 2007: Lemierre's syndrome complicating bacterial pharyngitis in a patient with undiagnosed factor XIi deficiency. Journal of Emergency Medicine 32(4): 365-369
Thompson, M.; Awonuga, A.O.; Bell, J.; Ray, C.; Awonuga, M.T.; Helfgott, A. 2007: Lemierre's syndrome complicating pregnancy. Infectious Diseases in Obstetrics and Gynecology 2007: 68084
Kuppalli, K.; Livorsi, D.; Talati, N.J.; Osborn, M. 2012: Lemierre's syndrome due to Fusobacterium necrophorum. LANCET. Infectious Diseases 12(10): 808-815
Kadhiravan, T.; Piramanayagam, P.; Banga, A.; Gupta, R.; Sharma, S.K. 2008: Lemierre's syndrome due to community-acquired meticillin-resistant Staphylococcus aureus infection and presenting with orbital cellulitis: a case report. Journal of Medical Case Reports 2: 374
Takazono, T.; Izumikawa, K.; Tsurutani, J.; Tanaka, A.; Kakugawa, T.; Fukuda, Y.; Saito, M.; Kurihara, S.; Imamura, Y.; Seki, M.; Kakeya, H.; Yamamoto, Y.; Yanagihara, K.; Kohno, S. 2009: Lemierre's syndrome followed by acute respiratory distress syndrome successfully rescued by antibiotics and hemoperfusion with polymyxin B-immobilized fiber. Japanese Journal of Infectious Diseases 62(2): 133-136
Garimorth, K.; Kountchev, J.; Bellmann, R.; Semenitz, B.; Weiss, G.ün.; Joannidis, M. 2008: Lemierre's syndrome following infectious mononucleosis. Wiener Klinische Wochenschrift 120(5-6): 181-183
Ehrenfried Berthelsen, R.; Hein, L. 2012: Lemierre's syndrome following peritonsillar abscess. Ugeskrift for Laeger 174(22): 1534-1535
Blasco, V.; Leone, M.; Xeridat, F.; Albanèse, J.; Martin, C. 2008: Lemierre's syndrome from necrotizing pneumonia treated with extracorporeal CO2 removal. Annales Francaises d'Anesthesie et de Reanimation 27(3): 244-248
LoVerme, W.; McCarten, K.M. 2013: Lemierre's syndrome in 15-year-old female. Rhode Island Medical Journal 96(10): 33-34
Paudyal, B.P. 2011: Lemierre's syndrome in a patient with severe lupus nephritis. Jnma; Journal of the Nepal Medical Association 51(183): 137-140
Healy, B.; Llewelyn, M.; Cavalle, F.; Bernard, M. 2007: Lemierre's syndrome in association with a cholesteatoma. British Journal of Hospital Medicine 68(6): 330-331
Rødgaard, J.C.; Niedvaraite, R.; Andersen, G.N. 2013: Lemierre's syndrome in systemic lupus erythematosus: a report of two cases. Scandinavian Journal of Rheumatology 42(2): 167-168
Kröll, D.; Sendi, P. 2012: Lemierre's syndrome in the liver. Infection 40(4): 477-478
Johnston, L.; Costello, J. 2012: Lemierre's syndrome masquerading as necrotizing fasciitis. British Journal of Hospital Medicine 73(11): 652-653
Lin, D.; Suwantarat, N.; Young, R.S. 2010: Lemierre's syndrome mimicking leptospirosis. Hawaii Medical Journal 69(7): 161-163
Pitsiou, G.; Kachrimanidou, M.; Papa, A.; Kioumis, I.; Paspala, A.; Boutou, A.; Vlachou, S.; Tsorlini, E.; Argyropoulou-Pataka, P. 2013: Lemierre's syndrome presenting to the ED: rapidly fatal sepsis caused by methicillin-susceptible Staphylococcus aureus Staphylococcus protein a type t044. American Journal of Emergency Medicine 31(1): 268.E5-7
Marulasiddappa, V.; Tejesh, C.A. 2013: Lemierre's syndrome presenting with septic shock. Indian Journal of Critical Care Medicine: Peer-Reviewed Official Publication of Indian Society of Critical Care Medicine 17(6): 382-384
Harris, C.M.; Johnikin, M.; Rhodes, H.; Fuller, T.; Rana, S.R.; Nabhani, H.; Hussain, D.; Kurukumbi, M.; Jayam-Trouth, A.; Gajjala, J.; Farhat, F.; Mody, V. 2009: Lemierre's syndrome resulting from streptococcal induced otitis media and mastoiditis: a case report. Journal of Medical Case Reports 3: 6658
Chiu, O.; Erbay, S.H.; Bhadelia, R.A. 2007: Lemierre's syndrome revisited: case report and imaging findings. Australasian Radiology 51 Suppl: B196-B198
Thoufeeq, M.H.; Salloum, W.; Win, S.S.; Sinha, L. 2009: Lemierre's syndrome secondary to Fusobacterium necrophorum infection, a rare cause of hepatic abscess. Acta Gastro-Enterologica Belgica 72(4): 444-446
Iwamoto, Y.; Kawakami, H.; Kishi, F.; Miyamoto, M.; Minakata, T. 2007: Lemierre's syndrome with acute renal failure. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 96(12): 2792-2793
Behpour-Oskooee, M.; Karimi, A.; Sayyahfar, S. 2014: Lemierre's syndrome with double heterozygote status in the methylenetetrahydrofolate reductase gene. World Journal of Pediatrics: Wjp 10(3): 281-283
Lee, S.; Rutar, T.; Velez, F.G.; Rosenbaum, A.L. 2009: Lemierre's syndrome with fourth nerve palsy. Journal of Aapos: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 13(1): 107-108
Aljohaney, A.; McCarthy, A. 2010: Lemierre's syndrome with paradoxical emboli. Internal Medicine 49(14): 1433-1436
Wang, D.; Price, A.K.; Leitch, K.K.; Salvadori, M.; Singh, R.N.; Kornecki, A.; McKillop, S.D.; Fraser, D.D. 2007: Lemierre's syndrome with septic shock caused by Fusobacterium necrophorum. Anaesthesia and Intensive Care 35(5): 796-801
Kushawaha, A.; Popalzai, M.; El-Charabaty, E.; Mobarakai, N. 2009: Lemierre's syndrome, reemergence of a forgotten disease: a case report. Cases Journal 2: 6397
Morariu, I.; Curran, A.; Killeen, R.P. 2014: Lemierre's syndrome, the forgotten disease. Irish Medical Journal 107(8): 242-243
Krishna, K.; Diwan, A.G.; Gupt, A. 2012: Lemierre's syndrome--the syndrome quite forgotten. Journal of the Association of Physicians of India 60: 60-63
Rosique López, L.; Rodríguez Domínguez, F.; Navarro Paule, P.; Soler Valcárcel, A. 2007: Lemierre's syndrome. An unusual variant. Acta Otorrinolaringologica Espanola 58(5): 217-218
Karkos, P.D.; Asrani, S.; Karkos, C.D.; Leong, S.C.; Theochari, E.G.; Alexopoulou, T.D.; Assimakopoulos, A.D. 2009: Lemierre's syndrome: a systematic review. Laryngoscope 119(8): 1552-1559
Srivali, N.; Ungprasert, P.; Kittanamongkolchai, W.; Ammannagari, N. 2014: Lemierre's syndrome: An often missed life-threatening infection. Indian Journal of Critical Care Medicine: Peer-Reviewed Official Publication of Indian Society of Critical Care Medicine 18(3): 170-172
Monteiro, M.J.; Thompson, S. 2008: Lemierre's syndrome: a forgotten disease. British Journal of Oral and Maxillofacial Surgery 46(4): 324
Nisar, M.K.; Kuttikat, A.V.; Ramabhadran, B.; Fishman, D. 2013: Lemierre's syndrome: a rare cause of septic polyarthritis. Rheumatology International 33(3): 817-818
Rosado, P.; Gallego, L.; Junquera, L.; de Vicente, J.C. 2009: Lemierre's syndrome: a serious complication of an odontogenic infection. Medicina Oral Patologia Oral y Cirugia Bucal 14(8): E398-E401
Paul, S.Prosad.; Beri, R.; Linney, M.John. 2012: Lemierre's syndrome: a sinister sore throat every clinician should remember. Turkish Journal of Pediatrics 54(5): 528-531
Soh, T.; Lim, M.H. 2013: Lemierre's syndrome: an unusual cause of calf abscess. Annals of the Academy of Medicine Singapore 42(1): 52-54
Bentley, T.P.; Brennan, D.F. 2009: Lemierre's syndrome: methicillin-resistant Staphylococcus aureus (MRSA) finds a new home. Journal of Emergency Medicine 37(2): 131-134
Monteiro, M.J.; Thompson, S. 2009: Lemierre's syndrome: the changing face of a life-threatening infection. British Journal of Oral and Maxillofacial Surgery 47(8): 648
Hawes, D.; Linney, M.J.; Wilkinson, R.; Paul, S.P. 2013: Lemierre's syndrome: the importance of early detection. British Journal of Nursing 22(18): 1075-1078
Bondy, P.; Grant, T. 2008: Lemierre's syndrome: what are the roles for anticoagulation and long-term antibiotic therapy?. Annals of Otology Rhinology and Laryngology 117(9): 679-683
Ledochowski, S.; Freichet, M.; Wallet, F.; Friggeri, A. 2015: Lemierre's syndrome: when a contralateral thrombosis stirs the debate. Intensive Care Medicine 41(2): 329-330
Hoehn, K.S.; Capouya, J.D.; Daum, R.S.; Glikman, D.; Gossett, J.G.; Hafzalah, M.; Johnson, D.; Marcinak, J. 2010: Lemierre-like syndrome caused by community-associated methicillin-resistant Staphylococcus aureus complicated by hemorrhagic pericarditis. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 11(3): E32-E35
Hoffman, M.A.; Birge, N.D.; Chatterjee, A.; Cavalieri, S.J.; Akhtar, J.I.; Cornish, N.E.; Truemper, E.J.; Varman, M. 2010: Lemierre-like syndrome: a series of unique cases. Clinical Pediatrics 49(9): 893-896
Beech, D.J. 1998: Lemildipine Merck and Co Inc. Idrugs: the Investigational Drugs Journal 1(3): 355-361
Rouet, J.ér.ém.; Gaujoux, S.éb.; Ronot, M.; Palazzo, M.; Cauchy, F.; Vilgrain, V.ér.; Belghiti, J.; O'Toole, D.; Sauvanet, A. 2012: Lemmel's syndrome as a rare cause of obstructive jaundice. Clinics and Research in Hepatology and Gastroenterology 36(6): 628-631
Kang, H.Sung.; Hyun, J.Jin.; Kim, S.Young.; Jung, S.Woo.; Koo, J.Seol.; Yim, H.Joon.; Lee, S.Woo. 2014: Lemmel's syndrome, an unusual cause of abdominal pain and jaundice by impacted intradiverticular enterolith: case report. Journal of Korean Medical Science 29(6): 874-878
Ramsauer, B.; König, C.; Spehn, J.; Klose, G. 2008: Lemmel's syndrome--a rare cause of posthepatic icterus. MMW Fortschritte der Medizin 150(Suppl 3): 120-122
Gilder, S.S. 1967: Lemming Fever of man. Canadian Medical Association Journal 97(10): 548
Colletti, G. 2012: Lemmo's flap for nasal dorsum reconstruction. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 70(3): 672-676
Aliferis, K.A.; Materzok, S.; Paziotou, G.N.; Chrysayi-Tokousbalides, M. 2009: Lemna minor L. as a model organism for ecotoxicological studies performing 1H NMR fingerprinting. Chemosphere 76(7): 967-973
Gilbert, H.C. 1937: Lemnaceae in Flower. Science 86(2231): 308
Yao, G.; Vidor, N.B.; Foss, A.P.; Chang, L.C. 2007: Lemnalosides A-D, decalin-type bicyclic diterpene glycosides from the marine soft coral Lemnalia sp. Journal of Natural Products 70(6): 901-905
Haidarliu, S.; Yu, C.; Rubin, N.; Ahissar, E. 2008: Lemniscal and Extralemniscal Compartments in the VPM of the Rat. Frontiers in Neuroanatomy 2: 4
Sitnikova, E.I.; Raevskiĭ, V.V. 2009: Lemniscal and paralemniscal afferent pathways in rodents' trigeminal system are integrated at the level of the somatosensory cortex. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 59(1): 98-106
Rzepa, H.S. 2008: Lemniscular hexaphyrins as examples of aromatic and antiaromatic double-twist Möbius molecules. Organic Letters 10(5): 949-952
Valgimigli, L.; Gabbanini, S.; Berlini, E.; Lucchi, E.; Beltramini, C.; Bertarelli, Y.L. 2012: Lemon (Citrus limon, Burm.f.) essential oil enhances the trans-epidermal release of lipid-(A, E) and water-(B6, C) soluble vitamins from topical emulsions in reconstructed human epidermis. International Journal of Cosmetic Science 34(4): 347-356
Fukuchi, Y.; Hiramitsu, M.; Okada, M.; Hayashi, S.; Nabeno, Y.; Osawa, T.; Naito, M. 2008: Lemon Polyphenols Suppress Diet-induced Obesity by Up-Regulation of mRNA Levels of the Enzymes Involved in beta-Oxidation in Mouse White Adipose Tissue. Journal of Clinical Biochemistry and Nutrition 43(3): 201-209
Weidner, C.; Wowro, S.J.; Freiwald, A.; Kodelja, V.; Abdel-Aziz, H.; Kelber, O.; Sauer, S. 2014: Lemon balm extract causes potent antihyperglycemic and antihyperlipidemic effects in insulin-resistant obese mice. Molecular Nutrition and Food Research 58(4): 903-907
Rasmussen, P. 2011: Lemon balm--Melissa officinalis; also known as lemon balm, bee balm, garden balm, Melissa, melissengeist. Journal of Primary Health Care 3(2): 165-166
Campos, J.; Schmeda-Hirschmann, G.; Leiva, E.; Guzmán, L.; Orrego, R.; Fernández, P.; González, M.; Radojkovic, C.; Zuñiga, F.A.; Lamperti, L.; Pastene, E.; Aguayo, C. 2014: Lemon grass (Cymbopogon citratus (D.C) Stapf) polyphenols protect human umbilical vein endothelial cell (HUVECs) from oxidative damage induced by high glucose, hydrogen peroxide and oxidised low-density lipoprotein. Food Chemistry 151: 175-181
Watanabe, C.; Hokari, R.; Komoto, S.; Kurihara, C.; Okada, Y.; Matsunaga, H.; Takebayashi, K.; Kawaguchi, A.; Nagao, S.; Tsuzuki, Y.; Yokoyama, H.; Hibi, T.; Miura, S. 2010: Lemon grass (Cymbopogon citratus) ameliorates murine spontaneous ileitis by decreasing lymphocyte recruitment to the inflamed intestine. Microcirculation 17(5): 321-332
Boukhatem, M.N.; Ferhat, M.A.; Kameli, A.; Saidi, F.; Kebir, H.T. 2014: Lemon grass (Cymbopogon citratus) essential oil as a potent anti-inflammatory and antifungal drugs. Libyan Journal of Medicine 9(1): 25431
Adibelli, Z.; Dilek, M.; Akpolat, T. 2009: Lemon juice as an alternative therapy in hypertension in Turkey. International Journal of Cardiology 135(2): E58-E59
Touhami, M.; Laroubi, A.; Elhabazi, K.; Loubna, F.; Zrara, I.; Eljahiri, Y.; Oussama, A.; Grases, F.él.; Chait, A. 2007: Lemon juice has protective activity in a rat urolithiasis model. Bmc Urology 7: 18
Najimu Nisha, S.; Aysha, O.S.; Syed Nasar Rahaman, J.; Vinoth Kumar, P.; Valli, S.; Nirmala, P.; Reena, A. 2014: Lemon peels mediated synthesis of silver nanoparticles and its antidermatophytic activity. Spectrochimica Acta. Part A Molecular and Biomolecular Spectroscopy 124: 194-198
Stoklosa, M.J. 1948: Lemon syrup; an improved vehicle. Journal of the American Pharmaceutical Association. American Pharmaceutical Association 9(9): 556
Brocato, C. 2010: Lemon-Aid: using a mnemonic devices to assess difficult airways. Jems: a Journal of Emergency Medical Services 35(3): 28-30
Martin, D.C.; Dabbs, G.R.; Roberts, L.G. 2013: Lemonade from lemons: the taphonomic effect of lawn mowers on skeletal remains. Journal of Forensic Sciences 58(5): 1273-1278
Krinn, K.L. 2011: Lemonade in the new normal. Journal of Environmental Health 73(7): 4-5
Sforcin, J.M.; Amaral, J.T.; Fernandes, A.; Sousa, J.P.B.; Bastos, J.K. 2009: Lemongrass effects on IL-1beta and IL-6 production by macrophages. Natural Product Research 23(12): 1151-1159
Warad, S.B.; Kolar, S.S.; Kalburgi, V.; Kalburgi, N.B. 2013: Lemongrass essential oil gel as a local drug delivery agent for the treatment of periodontitis. Ancient Science of Life 32(4): 205-211
Amornvit, P.; Choonharuangdej, S.; Srithavaj, T. 2014: Lemongrass-Incorporated Tissue Conditioner Against Candida albicans Culture. Journal of Clinical and Diagnostic Research: Jcdr 8(7): Zc50-Zc52
Lauer, M.S. 2012: Lemons for obesity. Annals of Internal Medicine 157(2): 139-140
Chambers, D.W. 2009: Lemons in dentistry. Journal of the California Dental Association 37(10): 693 696
Restrepo, G.; Llanos, E.J.; Silva, A.E.; Kier, L.B. 2013: Lemont B. Kier: a bibliometric exploration of his scientific production and its use. Current Computer-Aided Drug Design 9(4): 491-505
Lempert, J. 1948: Lempert decompression operation for hydrops of the endolymphatic labyrinth in ménière's disease. Archives of Otolaryngology 47(5): 551-570
Lempert, J. 1949: Lempert endaural subcortical mastoidotympanectomy for the cure of chronic persistent suppurative otitis media. Archives of Otolaryngology 49(1): 20-35
Lempert, J. 1949: Lempert fenestra nov-ovalis for the restoration of practical unaided hearing in clinical otosclerosis; its present status. Journal of Laryngology and Otology 63(2): 57-69 Disc. 89-90
Lempert, J. 1947: Lempert fenestra nov-ovalis operation for the restoration of serviceable unaided hearing in patients with clinical otosclerosis: its present evolutionary status. Archives of Otolaryngology 46(4): 478-511
Fishman, L.Z. 1946: Lempert fenestration; preliminary report of fifteen cases. Bulletin of Practical Ophthalmology 16(1): 11-18
Anonymous 1959: Lemuel Shattuck (1793-1859): Prophet of American Public Health. American Journal of Public Health and the Nation's Health 49(5): 676-677
Winkelstein, W.; Shattuck, L. 2008: Lemuel Shattuck: architect of American public health. Epidemiology 19(4): 634
Kappeler, P.M. 2014: Lemur behaviour informs the evolution of social monogamy. Trends in Ecology and Evolution 29(11): 591-593
King, S.J.; Boyer, D.M.; Tecot, S.; Strait, S.G.; Zohdy, S.; Blanco, M.B.; Wright, P.C.; Jernvall, J. 2012: Lemur habitat and dental senescence in Ranomafana National Park, Madagascar. American Journal of Physical Anthropology 148(2): 228-237
Doggrell, S.A. 2011: Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer. Expert Opinion on Therapeutic Targets 15(12): 1419-1422
Stebbing, J.; Filipović, A.; Giamas, G. 2011: Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution. Oncotarget 2(6): 428-429
Shi, H.; Li, Q.; Ji, M.; Wu, J.; Li, Z.; Zheng, X.; Xu, B.; Chen, L.; Li, X.; Lu, C.; Tan, Y.; Wu, C.; Jiang, J. 2014: Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer. International Journal of Clinical and Experimental Pathology 7(3): 1101-1107
Yoder, A.D. 2007: Lemurs. Current Biology: Cb 17(20): R866-R868
Jones, S.M.; Pearson, J.; DeWind, N.K.; Paulsen, D.; Tenekedjieva, A.-M.; Brannon, E.M. 2014: Lemurs and macaques show similar numerical sensitivity. Animal Cognition 17(3): 503-515
Hamm, R.M.; Dalgleish, L. 2011: Len Dalgleish (1950-2010). Medical decision making: an international journal of the Society for Medical Decision Making 31(2): 223-225
Mutt, E.; Mathew, O.K.; Sowdhamini, R. 2014: LenVarDB: database of length-variant protein domains. Nucleic Acids Research 42(Database Issue): D246-D250
Washburn, A. 1999: Lena Adell Benjamin: missionary gold medallist. American Baptist Quarterly 18(4): 342-354
Novotová, E.; Neuwirtová, R.; Jonásová, A.; Straub, J.; Spicka, I. 2008: Lenalidomid (Revlimid) in the treatment of multiple myeloma--first experience in the Czech Republic. Casopis Lekaru Ceskych 147(12): 623-626
Weisel, K.; Kanz, L. 2014: Lenalidomide. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 201: 347-357
Neymotin, A.; Petri, S.; Calingasan, N.Y.; Wille, E.; Schafer, P.; Stewart, C.; Hensley, K.; Beal, M.F.; Kiaei, M. 2009: Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology 220(1): 191-197
Van de Donk, N.W.C.J.; Wittebol, S.; Minnema, M.C.; Lokhorst, H.M. 2010: Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma. British Journal of Haematology 148(2): 335-337
Jimenez-Zepeda, V.H.; Reece, D.E.; Trudel, S.; Chen, C.; Tiedemann, R.; Kukreti, V. 2013: Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma. Leukemia and Lymphoma 54(3): 555-560
Jimenez-Zepeda, V.H.; Reece, D.E.; Trudel, S.; Chen, C.; Tiedemann, R.; Kukreti, V. 2015: Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia. Leukemia and Lymphoma 56(1): 232-235
Sekeres, M.A.; List, A. 2006: Lenalidomide (Revlimid, CC-5013) in myelodysplastic syndromes: Is it any good?. Current Hematologic Malignancy Reports 1(1): 16-19
McCarthy, P.L.; Owzar, K.; Hofmeister, C.C.; Hurd, D.D.; Hassoun, H.; Richardson, P.G.; Giralt, S.; Stadtmauer, E.A.; Weisdorf, D.J.; Vij, R.; Moreb, J.S.; Callander, N.Scott.; Van Besien, K.; Gentile, T.; Isola, L.; Maziarz, R.T.; Gabriel, D.A.; Bashey, A.; Landau, H.; Martin, T.; Qazilbash, M.H.; Levitan, D.; McClune, B.; Schlossman, R.; Hars, V.; Postiglione, J.; Jiang, C.; Bennett, E.; Barry, S.; Bressler, L.; Kelly, M.; Seiler, M.; Rosenbaum, C.; Hari, P.; Pasquini, M.C.; Horowitz, M.M.; Shea, T.C.; Devine, S.M.; Anderson, K.C.; Linker, C. 2012: Lenalidomide after stem-cell transplantation for multiple myeloma. New England Journal of Medicine 366(19): 1770-1781
Gao, M.; Gao, L.; Yang, G.; Tao, Y.; Tompkins, V.S.; Wu, X.; Xu, H.; Zhan, F.; Shi, J. 2014: Lenalidomide after stem-cell transplantation for multiple myeloma: a meta-analysis of randomized controlled trials. International Journal of Clinical and Experimental Pathology 7(6): 3073-3080
Shannon, E.; Sandoval, F.; Greig, N.; Stagg, P. 2012: Lenalidomide alone or lenalidomide plus dexamethasone significantly inhibit IgG and IgM in vitro... A possible explanation for their mechanism of action in treating multiple myeloma. International Immunopharmacology 12(2): 441-446
Ueda, S.; Yonemoto, S.; Oka, K.; Fujii, N.; Nakata, K.; Matsunaga, H.; Kataoka, S.; Iwama, Y.; Narahara, H.; Yasunaga, Y.; Inui, Y.; Kawata, S. 2014: Lenalidomide and Dexamethasone for a Patient of POEMS Syndrome Presenting with Massive Ascites. Case Reports in Hematology 2014: 818946
Perry, C.; Polliack, A. 2014: Lenalidomide and T-cell homeostasis: tolerating immune reconstitution after autologous stem cell transplant. Leukemia and Lymphoma 55(8): 1699-1700
González-Rodríguez, A.P.; Payer, A.R.; Acebes-Huerta, A.; Huergo-Zapico, L.; Villa-Alvarez, M.; Gonzalez-García, E.; Gonzalez, S. 2013: Lenalidomide and chronic lymphocytic leukemia. Biomed Research International 2013: 932010
Ludwig, H.; Rauch, E.; Kuehr, T.; Adam, Z.ěk.; Weißmann, A.; Kasparu, H.; Autzinger, E.-M.; Heintel, D.; Greil, R.; Poenisch, W.; Müldür, E.; Zojer, N. 2015: Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase Ii study. Haematologica 100(3): 385-391
Mahmood, S.; Venner, C.P.; Sachchithanantham, S.; Lane, T.; Rannigan, L.; Foard, D.; Pinney, J.H.; Gibbs, S.D.J.; Whelan, C.J.; Lachmann, H.J.; Gillmore, J.D.; Hawkins, P.N.; Wechalekar, A.D. 2014: Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens. British Journal of Haematology 166(6): 842-848
Dimopoulos, M.A.; Christoulas, D.; Roussou, M.; Kastritis, E.; Migkou, M.; Gavriatopoulou, M.; Matsouka, C.; Mparmparoussi, D.; Psimenou, E.; Grapsa, I.; Efstathiou, E.; Terpos, E. 2010: Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment. European Journal of Haematology 85(1): 1-5
Benboubker, L.; Dimopoulos, M.A.; Dispenzieri, A.; Catalano, J.; Belch, A.R.; Cavo, M.; Pinto, A.; Weisel, K.; Ludwig, H.; Bahlis, N.; Banos, A.; Tiab, M.; Delforge, M.; Cavenagh, J.; Geraldes, C.; Lee, J-Jung.; Chen, C.; Oriol, A.; de la Rubia, J.; Qiu, L.; White, D.J.; Binder, D.; Anderson, K.; Fermand, J-Paul.; Moreau, P.; Attal, M.; Knight, R.; Chen, G.; Van Oostendorp, J.; Jacques, C.; Ervin-Haynes, A.; Avet-Loiseau, Hé.; Hulin, C.; Facon, T.; Forsyth, C.; Presgrave, P.; Szer, J.; Durrant, S.; Campbell, P.; Mollee, P.; Coghlan, D.; Wellwood, J.; Cannell, P.; Prince,; 2014: Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. New England Journal of Medicine 371(10): 906-917
Zonder, J.A.; Crowley, J.; Hussein, M.A.; Bolejack, V.; Moore, D.F.; Whittenberger, B.F.; Abidi, M.H.; Durie, B.G.M.; Barlogie, B. 2010: Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232). Blood 116(26): 5838-5841
Falco, P.; Cavallo, F.; Larocca, A.; Liberati, A.M.; Musto, P.; Boccadoro, M.; Palumbo, A. 2008: Lenalidomide and its role in the management of multiple myeloma. Expert Review of Anticancer Therapy 8(6): 865-874
Buckstein, R.; Kerbel, R.; Cheung, M.; Shaked, Y.; Chodirker, L.; Lee, C.R.; Lenis, M.; Davidson, C.; Cussen, M.-A.; Reis, M.; Chesney, A.; Zhang, L.; Mamedov, A.; Wells, R.A. 2014: Lenalidomide and metronomic melphalan for CMML and higher risk MDS: a phase 2 clinical study with biomarkers of angiogenesis. Leukemia Research 38(7): 756-763
Mesa, R.A.; Yao, X.; Cripe, L.D.; Li, C.Y.; Litzow, M.; Paietta, E.; Rowe, J.M.; Tefferi, A.; Tallman, M.S. 2010: Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903. Blood 116(22): 4436-4438
James, D.F.; Werner, L.; Brown, J.R.; Wierda, W.G.; Barrientos, J.C.; Castro, J.E.; Greaves, A.; Johnson, A.J.; Rassenti, L.Z.; Rai, K.R.; Neuberg, D.; Kipps, T.J. 2014: Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortium. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32(19): 2067-2073
Treon, S.P.; Soumerai, J.D.; Branagan, A.R.; Hunter, Z.R.; Patterson, C.J.; Ioakimidis, L.; Chu, L.; Musto, P.; Baron, A.D.; Nunnink, J.C.; Kash, J.J.; Terjanian, T.O.; Hyman, P.M.; Nawfel, E.L.; Sharon, D.J.; Munshi, N.C.; Anderson, K.C. 2009: Lenalidomide and rituximab in Waldenstrom's macroglobulinemia. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(1): 355-360
Pratt, G. 2014: Lenalidomide and second malignancies in myeloma patients. LANCET. Oncology 15(3): 253-254
Asher, C.; Furnish, T. 2013: Lenalidomide and thalidomide in the treatment of chronic pain. Expert Opinion on Drug Safety 12(3): 367-374
Giagounidis, A.; Mufti, G.J.; Fenaux, P.; Germing, U.; List, A.; MacBeth, K.J. 2014: Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes. Annals of Hematology 93(1): 1-11
Chen, Y.; Borthakur, G. 2013: Lenalidomide as a novel treatment of acute myeloid leukemia. Expert Opinion on Investigational Drugs 22(3): 389-397
Gilbert, J.A. 2013: Lenalidomide as first-line therapy for elderly CLL patients. LANCET. Oncology 14(9): E345
Lestang, E.; Caristan, A.; Néel, A.; Graveleau, J.; Duhamel, E.; Masseau, A.; Connault, J.; Maisonneuve, Hè.; Le Gouill, S.; Blin, N.; Touzeau, C.; Moreau, P.; Hamidou, M. 2015: Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients. Leukemia and Lymphoma 56(6): 1895-1896
Coman, T.; Bachy, E.; Michallet, M.; Socié, Gérard.; Uzunov, M.; Bourhis, J.Henri.; Lapusan, S.; Brebion, A.; Vigouroux, Séphane.; Maury, Sébastien.; François, S.; Huynh, A.; Lioure, B.; Yakoub-Agha, I.; Hermine, O.; Milpied, Nël.; Mohty, M.; Rubio, M.Thérèse. 2013: Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy. Haematologica 98(5): 776-783
Tuchman, S.A.; Chao, N.J.; Gasparetto, C.G. 2012: Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. Advances in Hematology 2012: 712613
Olivieri, A.; Attolico, I.; Cimminiello, M.; Discepoli, G.; Cifarelli, R.Anna. 2009: Lenalidomide can induce graft versus leukemia effect in primary plasma cell leukemia: a case report. Leukemia Research 33(11): E191-E193
Spina, F.; Montefusco, V.; Crippa, C.; Citro, A.; Sammassimo, S.; Olivero, B.; Gentili, S.; Galli, M.; Guglielmelli, T.; Rossi, D.; Falcone, A.P.; Grasso, M.; Patriarca, F.; De Muro, M.; Corradini, P. 2011: Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant. Leukemia and Lymphoma 52(7): 1262-1270
Krönke, J.; Udeshi, N.D.; Narla, A.; Grauman, P.; Hurst, S.N.; McConkey, M.; Svinkina, T.; Heckl, D.; Comer, E.; Li, X.; Ciarlo, C.; Hartman, E.; Munshi, N.; Schenone, M.; Schreiber, S.L.; Carr, S.A.; Ebert, B.L. 2014: Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343(6168): 301-305
Nowakowski, G.S.; LaPlant, B.; Macon, W.R.; Reeder, C.B.; Foran, J.M.; Nelson, G.D.; Thompson, C.A.; Rivera, C.E.; Inwards, D.J.; Micallef, I.N.; Johnston, P.B.; Porrata, L.F.; Ansell, S.M.; Gascoyne, R.D.; Habermann, T.M.; Witzig, T.E. 2015: Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase Ii study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33(3): 251-257
Clave, E.; Douay, C.; Coman, T.; Busson, M.; Bompoint, C.; Moins-Teisserenc, H.; Glauzy, S.é; Carmagnat, M.; Gorin, N.C.; Toubert, A.; Garderet, L. 2014: Lenalidomide consolidation and maintenance therapy after autologous stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis. Leukemia and Lymphoma 55(8): 1788-1795
Siniscalchi, A.; Tendas, A.; Morino, L.; Dentamaro, T.; De Bellis, A.; Perrotti, A.; de Fabritiis, P.; Musto, P.; Caravita, T. 2012: Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 20(7): 1585-1587
Lee, M.J.; Wickner, P.; Fanning, L.; Schlossman, R.; Richardson, P.; Laubach, J.; Castells, M. 2014: Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma. British Journal of Haematology 167(1): 127-131
Dauguet, N.; Fournié, J.-J.; Poupot, R.ém.; Poupot, M. 2010: Lenalidomide down regulates the production of interferon-gamma and the expression of inhibitory cytotoxic receptors of human Natural Killer cells. Cellular Immunology 264(2): 163-170
Lapalombella, R.; Yu, B.; Triantafillou, G.; Liu, Q.; Butchar, J.P.; Lozanski, G.; Ramanunni, A.; Smith, L.L.; Blum, W.; Andritsos, L.; Wang, D.-S.; Lehman, A.; Chen, C.-S.; Johnson, A.J.; Marcucci, G.; Lee, R.J.; Lee, L.J.; Tridandapani, S.; Muthusamy, N.; Byrd, J.C. 2008: Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells. Blood 112(13): 5180-5189
Lopez-Girona, A.; Heintel, D.; Zhang, L-Hua.; Mendy, D.; Gaidarova, S.; Brady, H.; Bartlett, J.Blake.; Schafer, P.H.; Schreder, M.; Bolomsky, A.; Hilgarth, B.; Zojer, N.; Gisslinger, H.; Ludwig, H.; Daniel, T.; Jäger, U.; Chopra, R. 2011: Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response. British Journal of Haematology 154(3): 325-336
Lim, H.; Kane, L.; Schwartz, J.B.; Hesdorffer, C.S.; Deeks, S.G.; Greig, N.; Ferrucci, L.; Goetzl, E.J. 2012: Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients. Clinical and Experimental Immunology 169(2): 182-189
Wu, L.; Parton, A.; Lu, L.; Adams, M.; Schafer, P.; Bartlett, J.B. 2011: Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers. Cancer Immunology Immunotherapy: Cii 60(1): 61-73
Cox, M.C.; Mannino, G.; Lionetto, L.; Naso, V.; Simmaco, M.; Spiriti, M.A.A. 2011: Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?. American Journal of Hematology 86(11): 957
Manning, D.C.; Alexander, G.; Arezzo, J.C.; Cooper, A.; Harden, R.N.; Oaklander, A.L.; Raja, S.N.; Rauck, R.; Schwartzman, R. 2014: Lenalidomide for complex regional pain syndrome type 1: lack of efficacy in a phase Ii randomized study. Journal of Pain 15(12): 1366-1376
Bertolini, F. 2012: Lenalidomide for multiple myeloma. New England Journal of Medicine 367(6): 573; Author Reply 573-575
Safran, H.; Charpentier, K.P.; Kaubisch, A.; Mantripragada, K.; Dubel, G.; Perez, K.; Faricy-Anderson, K.; Miner, T.; Eng, Y.; Victor, J.; Plette, A.; Espat, J.; Bakalarski, P.; Wingate, P.; Berz, D.; Luppe, D.; Martel, D.; Rosati, K.; Aparo, S. 2015: Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study. American Journal of Clinical Oncology 38(1): 1-4
Chanan-Khan, A.A.; Cheson, B.D. 2008: Lenalidomide for the treatment of B-cell malignancies. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(9): 1544-1552
Lin, R.J.; Curran, J.J.; Zimmerman, T.M.; Song, J.; Niewold, T.B.; Sweiss, N.J. 2010: Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 16(2): 90-91
Van de Donk, N.W.; Görgün, G.ül.ü; Groen, R.W.; Jakubikova, J.; Mitsiades, C.S.; Hideshima, T.; Laubach, J.; Nijhof, I.S.; Raymakers, R.A.; Lokhorst, H.M.; Richardson, P.G.; Anderson, K.C. 2012: Lenalidomide for the treatment of relapsed and refractory multiple myeloma. Cancer Management and Research 4: 253-268
Gajraj, E.; Chung, H.; Boysen, M.; Barnett, D.B.; Longson, C. 2009: Lenalidomide for the treatment of relapsed multiple myeloma. LANCET. Oncology 10(7): 647-648
Shah, A.; Albrecht, J.; Bonilla-Martinez, Z.; Okawa, J.; Rose, M.; Rosenbach, M.; Werth, V.P. 2009: Lenalidomide for the treatment of resistant discoid lupus erythematosus. Archives of Dermatology 145(3): 303-306
Komrokji, R.S.; List, A.F. 2010: Lenalidomide for treatment of myelodysplastic syndromes: current status and future directions. Hematology/Oncology Clinics of North America 24(2): 377-388
Dürr, D.; Siciliano, R.D.; Hummel, Y.; O'Meara, A.; Hirschi, A.; Burkhard, R.; Honegger, H. 2010: Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?. Annals of Hematology 89(1): 105-106
Steensma, D.P.; Stone, R.M. 2011: Lenalidomide in AML: del(5q) or who?. Blood 118(3): 481-482
Wendtner, C.M. 2011: Lenalidomide in CLL: what is the optimal dose?. Clinical Advances in Hematology and Oncology: H&o 9(3): 220-224
Oliva, E.N.; Latagliata, R.; Laganà, C.; Breccia, M.; Galimberti, S.; Morabito, F.; Poloni, A.; Balleari, E.; Cortelezzi, A.; Palumbo, G.; Sanpaolo, G.; Volpe, A.; Specchia, G.; Finelli, C.; D'Errigo, M.Grazia.; Rodà, F.; Alati, C.; Alimena, G.; Nobile, F.; Aloe Spiriti, M.A. 2013: Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy. Leukemia and Lymphoma 54(11): 2458-2465
Sekeres, M.A. 2011: Lenalidomide in MDS: 4th time's a charm. Blood 118(14): 3757-3758
Anonymous 2014: Lenalidomide in combination with R-CHOP (R2-CHOP) in patients with high burden follicular lymphoma: phase 2 study. Clinical Advances in Hematology and Oncology: H&o 12(2 Suppl. 6): 12; 14-5
Stadtmauer, E.A.; Weber, D.M.; Niesvizky, R.; Belch, A.; Prince, M.H.; San Miguel, J.ús.F.; Facon, T.; Olesnyckyj, M.; Yu, Z.; Zeldis, J.B.; Knight, R.D.; Dimopoulos, M.A. 2009: Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma. European Journal of Haematology 82(6): 426-432
Hazarika, M.; Rock, E.; Williams, G.; Dagher, R.; Sridhara, R.; Booth, B.; Farrell, A.; Justice, R.; Pazdur, R. 2008: Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy. Oncologist 13(10): 1120-1127
Chanan-Khan, A.A.; Lonial, S.; Weber, D.; Borrello, I.; Foà, R.; Hellmann, A.; Dimopoulos, M.; Swern, A.S.; Knight, R. 2012: Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma. International Journal of Hematology 96(2): 254-262
Urata, C.; Yoshimura, M.; Itamura, H.; Hisatomi, T.; Kubota, Y.; Fukushima, N.; Sueoka, E.; Kimura, S. 2011: Lenalidomide in combination with dexamethasone induced rhabdomyolysis in a multiple myeloma patient treated with pravastatin. International Journal of Hematology 94(2): 216-217
Klein, U.; Neben, K.; Hielscher, T.; Heiss, C.; Ho, A.D.; Goldschmidt, H. 2011: Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment. Annals of Hematology 90(4): 429-439
Infante, J.R.; Arkenau, H-Tobias.; Bendell, J.C.; Rubin, M.S.; Waterhouse, D.; Jones, G.Tripp.; Spigel, D.R.; Lane, C.M.; Hainsworth, J.D.; Burris, H.A. 2013: Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trial. Cancer Biology and Therapy 14(4): 340-346
Moreau, P.; Jaccard, A.; Benboubker, L.; Royer, B.; Leleu, X.; Bridoux, F.; Salles, G.; Leblond, V.; Roussel, M.; Alakl, M.; Hermine, O.; Planche, L.; Harousseau, J.-L.; Fermand, J.-P. 2010: Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study. Blood 116(23): 4777-4782
Hopfinger, G.; Nösslinger, T.; Lang, A.; Linkesch, W.; Melchardt, T.; Weiss, L.; Egle, A.; Greil, R. 2014: Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial. Annals of Hematology 93(3): 459-462
Tiu, R.V.; Sekeres, M.A. 2011: Lenalidomide in del 5q MDS: responses and side effects revisited. Leukemia Research 35(11): 1440-1441
Krawczyk, K.; Jurczak, W.; Gałązka, K.; Gruchała, A.; Skotnicki, A.B. 2014: Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report. Journal of Medical Case Reports 8: 325
Jin, X.; Zhang, Y.-Z. 2012: Lenalidomide in hematological malignancies---review. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20(1): 205-209
Wiernik, P.H. 2013: Lenalidomide in lymphomas and chronic lymphocytic leukemia. Expert Opinion on PharmacoTherapy 14(4): 475-488
Bagchi, S. 2007: Lenalidomide in multiple myeloma. Lancet. Oncology 8(10): 872
Sirohi, B.; Powles, R. 2009: Lenalidomide in multiple myeloma. Expert Review of Anticancer Therapy 9(11): 1559-1570
Chen, C.; Baldassarre, F.; Kanjeekal, S.; Herst, J.; Hicks, L.; Cheung, M. 2013: Lenalidomide in multiple myeloma-a practice guideline. Current Oncology 20(2): E136-E149
Richardson, P.; Mitsiades, C.; Laubach, J.; Schlossman, R.; Ghobrial, I.; Hideshima, T.; Munshi, N.; Anderson, K. 2010: Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy. Core Evidence 4: 215-245
Zeldis, J.B.; Knight, R.D.; Jacques, C.; Tozer, A.; Bizzari, J.-P. 2010: Lenalidomide in multiple myeloma: current role and future directions. Expert Opinion on PharmacoTherapy 11(5): 829-842
Shah, S.R.; Tran, T.M. 2007: Lenalidomide in myelodysplastic syndrome and multiple myeloma. Drugs 67(13): 1869-1881
List, A.F. 2008: Lenalidomide in myelodysplastic syndromes. Clinical Advances in Hematology and Oncology: H&o 6(4): 271
Komrokji, R.S.; Lancet, J.E.; List, A.F. 2010: Lenalidomide in myelodysplastic syndromes: an erythropoiesis-stimulating agent or more?. Current Hematologic Malignancy Reports 5(1): 9-14
Sirulnik, L.A.; Stone, R.M. 2008: Lenalidomide in myelodysplastic syndromes: where do we go from here?. Current Hematologic Malignancy Reports 3(1): 5-9
Singhal, S.; Mehta, J. 2007: Lenalidomide in myeloma. Current Treatment Options in Oncology 8(2): 154-163
Badros, A.Z. 2012: Lenalidomide in myeloma--a high-maintenance friend. New England Journal of Medicine 366(19): 1836-1838
Keizman, D.; Zahurak, M.; Sinibaldi, V.; Carducci, M.; Denmeade, S.; Drake, C.; Pili, R.; Antonarakis, E.S.; Hudock, S.; Eisenberger, M. 2010: Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/Ii double-blinded, randomized study. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(21): 5269-5276
Zagouri, F.; Kastritis, E.; Gavriatopoulou, M.; Sergentanis, T.N.; Psaltopoulou, T.; Terpos, E.; Dimopoulos, M.-A. 2014: Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis. Leukemia and Lymphoma 55(9): 2018-2023
Oechsle, K.; Bokemeyer, C.; Honecker, F. 2010: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors. Journal of Cancer Research and Clinical Oncology 136(1): 165-167
Böll, B.; Borchmann, P.; Topp, M.S.; Hänel, M.; Reiners, K.S.; Engert, A.; Naumann, R. 2010: Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma. British Journal of Haematology 148(3): 480-482
Zago, M.; Oehrlein, K.; Rendl, C.; Hahn-Ast, C.; Kanz, L.; Weisel, K. 2014: Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatment. Annals of Hematology 93(12): 1993-1999
Desai, M.; Newberry, K.; Ou, Z.; Wang, M.; Zhang, L. 2014: Lenalidomide in relapsed or refractory mantle cell lymphoma: overview and perspective. Therapeutic Advances in Hematology 5(3): 91-101
Delforge, M.; Michiels, A.; Doyen, C.; Kentos, A.; Van Droogenbroeck, J.; Offner, F.; Bries, G.; Demuynck, H.; Vekemans, M.C.; Meuleman, N.; Mineur, P.O.; Ravoet, C.; Depryck, B.; Van de Velde, A.; Pierre, P.; Wu, K.L.; Schots, R. 2011: Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium. Acta Clinica Belgica 66(5): 371-375
Borrello, I. 2009: Lenalidomide in renal insufficiency--balancing the risks and benefits. British journal of haematology 144(3): 446-7; author reply 447-8
Segler, A.; Tsimberidou, A.-M. 2012: Lenalidomide in solid tumors. Cancer ChemoTherapy and Pharmacology 69(6): 1393-1406
Cortelezzi, A.; Sciumè, M.; Reda, G. 2012: Lenalidomide in the treatment of chronic lymphocytic leukemia. Advances in Hematology 2012: 393864
Liberati, A.M.; Vitolo, U.; Palumbo, A.; Cortelezzi, A. 2013: Lenalidomide in the treatment of lymphoproliferative disorders and multiple myeloma. Advances in Hematology 2013: 812605
Machálková, K.; Maisnar, V. 2009: Lenalidomide in the treatment of multiple myeloma. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 22(3): 117-120
Armoiry, X.; Aulagner, G.; Facon, T. 2008: Lenalidomide in the treatment of multiple myeloma: a review. Journal of Clinical Pharmacy and Therapeutics 33(3): 219-226
Palumbo, A.; Cavallo, F. 2013: Lenalidomide in the treatment of plasma cell dyscrasia: state of the art and perspectives. Haematologica 98(5): 660-661
Risum, M.; Dufva, I.H.øg. 2010: Lenalidomide in the treatment of transfusion dependent myelodysplastic syndromes. Ugeskrift for Laeger 172(6): 452-455
Martinez, V.ér.; Tateo, M.; Castilla, M.-A.èl.; Melica, G.; Kirstetter, M.; Boué, F.ço. 2011: Lenalidomide in treating AIDS-related Kaposi's sarcoma. Aids 25(6): 878-880
Okon, L.; Rosenbach, M.; Krathen, M.; Rose, M.; Propert, K.; Okawa, J.; Werth, V. 2014: Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial. Journal of the American Academy of Dermatology 70(3): 583-584
Mandac, I.; Kolonic, S.O. 2010: Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma. Journal of Hematology and Oncology 3: 20
Adam, Z.; Rehák, Z.; Koukalová, R.; Szturz, P.; Krejčí, M.; Pour, L.; Zahradová, L.; Moulis, M.; Kodet, R.; Nebeský, T.; Brejcha, M.; Adamová, Z.; Hájek, R.; Mayer, J. 2012: Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation. Vnitrni Lekarstvi 58(1): 62-71
Kim, K.; An, S.; Cha, H.J.; Choi, Y.M.; Choi, S.J.; An, I.-S.; Lee, H.G.; Min, Y.H.; Lee, S.-J.; Bae, S. 2013: Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells. Oncology Letters 5(2): 588-592
Acebes-Huerta, A.; Huergo-Zapico, L.; Gonzalez-Rodriguez, A.P.; Fernandez-Guizan, A.; Payer, A.R.; López-Soto, A.; Gonzalez, S. 2014: Lenalidomide induces immunomodulation in chronic lymphocytic leukemia and enhances antitumor immune responses mediated by NK and CD4 T cells. Biomed Research International 2014: 265840
Strati, P.; Keating, M.J.; Wierda, W.G.; Badoux, X.C.; Calin, S.; Reuben, J.M.; O'Brien, S.; Kornblau, S.M.; Kantarjian, H.M.; Gao, H.; Ferrajoli, A. 2013: Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia. Blood 122(5): 734-737
Dumas, P.-Y.; Pigneux, A.; Tabrizi, R.; Milpied, N. 2010: Lenalidomide induces remission and mixed quantitative chimerism fluctuations in refractory and relapsed myeloid malignancy with del (5). Leukemia Research 34(11): E302-E303
Song, K.; Herzog, B.H.; Sheng, M.; Fu, J.; McDaniel, J.M.; Chen, H.; Ruan, J.; Xia, L. 2013: Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma. Cancer Research 73(24): 7254-7264
Fecteau, J.-F.; Corral, L.G.; Ghia, E.M.; Gaidarova, S.; Futalan, D.; Bharati, I.S.; Cathers, B.; Schwaederlé, M.; Cui, B.; Lopez-Girona, A.; Messmer, D.; Kipps, T.J. 2014: Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21(WAF1/Cip1)-dependent mechanism independent of functional p53. Blood 124(10): 1637-1644
Fiorcari, S.; Martinelli, S.; Bulgarelli, J.; Audrito, V.; Zucchini, P.; Colaci, E.; Potenza, L.; Narni, F.; Luppi, M.; Deaglio, S.; Marasca, R.; Maffei, R. 2015: Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia. Haematologica 100(2): 253-262
Nakazato, T.; Mihara, A.; Ito, C.; Sanada, Y.; Aisa, Y. 2012: Lenalidomide is active for extramedullary disease in refractory multiple myeloma. Annals of Hematology 91(3): 473-474
Harada, H.; Watanabe, M.; Suzuki, K.; Yanagita, S.; Suzuki, T.; Yoshida, Y.; Kimura, A.; Tsudo, M.; Matsuda, A.; Tohyama, K.; Taniwaki, M.; Takeshita, K.; Takatoku, M.; Ozawa, K. 2009: Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality. International Journal of Hematology 90(3): 353-360
Alegre, A.án.; Aguado, B.; Giraldo, P.; Ríos, E.; Cánovas, A.; Ibáñez, Án.; Castillo, I.; Hernández, M.T.; Oriol, A.; Palomera, L.; Rodríguez, J.-N.; García, F.-L.; Calvo, J.é M.; Martínez-Chamorro, C.; de la Serna, J.; Lahuerta, J.-J. 2011: Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate use Registry in advanced patients. International Journal of Hematology 93(3): 351-360
Calvo-Villas, J.é M.; Alegre, A.án.; Calle, C.; Hernández, M.T.; García-Sánchez, R.; Ramírez, G. 2011: Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma. European Journal of Haematology 87(3): 281-284
Ito, C.; Aisa, Y.; Mihara, A.; Nakazato, T. 2013: Lenalidomide is effective for the treatment of bortezomib-resistant extramedullary disease in patients with multiple myeloma: report of 2 cases. Clinical Lymphoma Myeloma and Leukemia 13(1): 83-85
Sockel, K.; Bornhaeuser, M.; Mischak-Weissinger, E.; Trenschel, R.; Wermke, M.; Unzicker, C.; Kobbe, G.; Finke, J.ür.; Germing, U.; Mohr, B.; Greiner, J.; Beelen, D.; Thiede, C.; Ehninger, G.; Platzbecker, U. 2012: Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial. Haematologica 97(9): E34-E35
Attal, M.; Lauwers-Cances, V.; Marit, G.; Caillot, D.; Moreau, P.; Facon, T.; Stoppa, A.Marie.; Hulin, C.; Benboubker, L.; Garderet, L.; Decaux, O.; Leyvraz, S.; Vekemans, M-Christiane.; Voillat, L.; Michallet, M.; Pegourie, B.; Dumontet, C.; Roussel, M.; Leleu, X.; Mathiot, C.; Payen, C.; Avet-Loiseau, Hé.; Harousseau, J-Luc.; Rajkumar, V.; Spencer, A.; Chevret, S.; Nobili-Escriva, C.; Petillon, M.Odile.; Olivier, P.; Cristini, C.; Llau, M.Elise.; Agape, P.; Ali-Ammar, N.; Assouline, D.; Audhuy, B.; Banos, A.; Bareau, B.; Belhadj, K.; Berthou, C.; Boue, F.; Boullanger, N. 2012: Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. New England Journal of Medicine 366(19): 1782-1791
Alsina, M.; Becker, P.S.; Zhong, X.; Adams, A.; Hari, P.; Rowley, S.; Stadtmauer, E.A.; Vesole, D.H.; Logan, B.; Weisdorf, D.; Qazilbash, M.; Popplewell, L.L.; McClune, B.; Bensinger, W.; Riches, M.; Giralt, S.A.; Pasquini, M.C. 2014: Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 20(8): 1183-1189
Brower, V. 2012: Lenalidomide maintenance for multiple myeloma. LANCET. Oncology 13(6): E238
Roziaková, L.; Mistrík, M. 2013: Lenalidomide maintenance therapy in patients with multiple myeloma. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 26(3): 186-190
Davies, F.; Baz, R. 2010: Lenalidomide mode of action: linking bench and clinical findings. Blood Reviews 24(Suppl 1): S13-S19
Zabransky, D.J.; Smith, H.A.; Thoburn, C.J.; Zahurak, M.; Keizman, D.; Carducci, M.; Eisenberger, M.A.; McNeel, D.G.; Drake, C.G.; Antonarakis, E.S. 2012: Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer. Prostate 72(5): 487-498
Dennis, M.; Culligan, D.; Karamitros, D.; Vyas, P.; Johnson, P.; Russell, N.H.; Cavenagh, J.; Szubert, A.; Hartley, S.; Brown, J.; Bowen, D. 2013: Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities. Leukemia Research Reports 2(2): 70-74
Zinzani, P.L.; Pellegrini, C.; Broccoli, A.; Stefoni, V.; Gandolfi, L.; Quirini, F.; Argnani, L.; Berti, E.; Derenzini, E.; Pileri, S.; Baccarani, M. 2011: Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified. Leukemia and Lymphoma 52(8): 1585-1588
Nabhan, C.; Patel, A.; Villines, D.; Tolzien, K.; Kelby, S.K.; Lestingi, T.M. 2014: Lenalidomide monotherapy in chemotherapy-naive, castration-resistant prostate cancer patients: final results of a phase Ii study. Clinical Genitourinary Cancer 12(1): 27-32
Zinzani, P.Luigi.; Rigacci, L.; Cox, M.Cristina.; Devizzi, L.; Fabbri, A.; Zaccaria, A.; Zaja, F.; Di Rocco, A.; Rossi, G.; Storti, S.; Fattori, P.Paolo.; Argnani, L.; Tura, S.; Vitolo, U. 2015: Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice. Leukemia and Lymphoma 56(6): 1671-1676
Wiernik, P.H.; Lossos, I.S.; Tuscano, J.M.; Justice, G.; Vose, J.M.; Cole, C.E.; Lam, W.; McBride, K.; Wride, K.; Pietronigro, D.; Takeshita, K.; Ervin-Haynes, A.; Zeldis, J.B.; Habermann, T.M. 2008: Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(30): 4952-4957
Savini, P.; Lanzi, A.; Foschi, F.G.; Marano, G.; Stefanini, G.F. 2014: Lenalidomide monotherapy in relapsed primary cutaneous diffuse large B cell lymphoma-leg type. Annals of Hematology 93(2): 333-334
Defina, M.; Rondoni, M.; Gozzetti, A.; Aprile, L.; Chitarrelli, I.; Fabbri, A.; Lauria, F.; Bocchia, M. 2010: Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion. British Journal of Haematology 148(3): 483-484
Habermann, T.M.; Lossos, I.S.; Justice, G.; Vose, J.M.; Wiernik, P.H.; McBride, K.; Wride, K.; Ervin-Haynes, A.; Takeshita, K.; Pietronigro, D.; Zeldis, J.B.; Tuscano, J.M. 2009: Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma. British Journal of Haematology 145(3): 344-349
Witzig, T.E.; Wiernik, P.H.; Moore, T.; Reeder, C.; Cole, C.; Justice, G.; Kaplan, H.; Voralia, M.; Pietronigro, D.; Takeshita, K.; Ervin-Haynes, A.; Zeldis, J.B.; Vose, J.M. 2009: Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(32): 5404-5409
Xu, Y.; Sun, J.; Sheard, M.A.; Tran, H.C.; Wan, Z.; Liu, W.Y.; Asgharzadeh, S.; Sposto, R.; Wu, H.W.; Seeger, R.C. 2013: Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1. Cancer Immunology Immunotherapy: Cii 62(10): 1637-1648
Zeidan, A.M.; Gore, S.D.; McNally, D.L.; Baer, M.R.; Hendrick, F.; Mahmoud, D.; Davidoff, A.J. 2013: Lenalidomide performance in the real world: patterns of use and effectiveness in a Medicare population with myelodysplastic syndromes. Cancer 119(21): 3870-3878
Vitolo, U.; Chiappella, A.; Franceschetti, S.; Carella, A.M.; Baldi, I.; Inghirami, G.; Spina, M.; Pavone, V.; Ladetto, M.; Liberati, A.M.; Molinari, A.L.; Zinzani, P.; Salvi, F.; Fattori, P.P.; Zaccaria, A.; Dreyling, M.; Botto, B.; Castellino, A.; Congiu, A.; Gaudiano, M.; Zanni, M.; Ciccone, G.; Gaidano, G.; Rossi, G. 2014: Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. LANCET. Oncology 15(7): 730-737
Chiappella, A.; Tucci, A.; Castellino, A.; Pavone, V.; Baldi, I.; Carella, A.M.; Orsucci, L.; Zanni, M.; Salvi, F.; Liberati, A.M.; Gaidano, G.; Bottelli, C.; Rossini, B.; Perticone, S.; De Masi, P.; Ladetto, M.; Ciccone, G.; Palumbo, A.; Rossi, G.; Vitolo, U. 2013: Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase i study by the Fondazione Italiana Linfomi. Haematologica 98(11): 1732-1738
Mateos, Mía-Victoria.; Hernández, M-Teodoro.; Giraldo, P.; de la Rubia, J.; de Arriba, F.; López Corral, Lía.; Rosiñol, L.; Paiva, B.; Palomera, L.; Bargay, J.; Oriol, A.; Prosper, F.; López, J.; Olavarría, E.; Quintana, N.; García, Jé-Luis.; Bladé, J.; Lahuerta, J-José.; San Miguel, Jús-F. 2013: Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma. New England Journal of Medicine 369(5): 438-447
Wang, M.; Dimopoulos, M.A.; Chen, C.; Cibeira, M.T.; Attal, M.; Spencer, A.; Rajkumar, S.V.; Yu, Z.; Olesnyckyj, M.; Zeldis, J.B.; Knight, R.D.; Weber, D.M. 2008: Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure. Blood 112(12): 4445-4451
Iida, S.; Chou, T.; Okamoto, S.; Nagai, H.; Hatake, K.; Murakami, H.; Takagi, T.; Shimizu, K.; Lau, H.; Takeshita, K.; Takatoku, M.; Hotta, T. 2010: Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma. International Journal of Hematology 92(1): 118-126
Gay, F.; Hayman, S.R.; Lacy, M.Q.; Buadi, F.; Gertz, M.A.; Kumar, S.; Dispenzieri, A.; Mikhael, J.R.; Bergsagel, P.L.; Dingli, D.; Reeder, C.B.; Lust, J.A.; Russell, S.J.; Roy, V.; Zeldenrust, S.R.; Witzig, T.E.; Fonseca, R.; Kyle, R.A.; Greipp, P.R.; Stewart, A.K.; Rajkumar, S.V. 2010: Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients. Blood 115(7): 1343-1350
Gay, F.; Vincent Rajkumar, S.; Falco, P.; Kumar, S.; Dispenzieri, A.; Petrucci, M.Teresa.; Gertz, M.A.; Boccadoro, M.; Keith Stewart, A.; Palumbo, A. 2010: Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma. European Journal of Haematology 85(3): 200-208
El-Cheikh, J.; Crocchiolo, R.; Furst, S.; Ladaique, P.; Castagna, L.; Faucher, C.; Granata, A.; Oudin, C.; Lemarie, C.; Calmels, B.; Stoppa, A.-M.; Schiano De Colella, J.-M.; Duran, S.; Chabannon, C.; Blaise, D. 2012: Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma. Experimental Hematology 40(7): 521-527
Rajkumar, S.V.; Jacobus, S.; Callander, N.S.; Fonseca, R.; Vesole, D.H.; Williams, M.E.; Abonour, R.; Siegel, D.S.; Katz, M.; Greipp, P.R. 2010: Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. LANCET. Oncology 11(1): 29-37
Quintás-Cardama, A.; Kantarjian, H.M.; Manshouri, T.; Thomas, D.; Cortes, J.; Ravandi, F.; Garcia-Manero, G.; Ferrajoli, A.; Bueso-Ramos, C.; Verstovsek, S. 2009: Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(28): 4760-4766
Tuscano, J.M.; Dutia, M.; Chee, K.; Brunson, A.; Reed-Pease, C.; Abedi, M.; Welborn, J.; O'Donnell, R.T. 2014: Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma. British Journal of Haematology 165(3): 375-381
Szturz, P.; Adam, Z.ěk.; Rehák, Z.ěk.; Koukalová, R.; Slaisová, R.; Stehlíková, O.; Chovancová, J.; Klabusay, M.; Krejčí, M.; Pour, L.ěk.; Hájek, R.; Mayer, J.ří 2012: Lenalidomide proved effective in multisystem Langerhans cell histiocytosis. Acta Oncologica 51(3): 412-415
De Luisi, A.; Ferrucci, A.; Coluccia, A.M.L.; Ria, R.; Moschetta, M.; de Luca, E.; Pieroni, L.; Maffia, M.; Urbani, A.; Di Pietro, G.; Guarini, A.; Ranieri, G.; Ditonno, P.; Berardi, S.; Caivano, A.; Basile, A.; Cascavilla, N.; Capalbo, S.; Quarta, G.; Dammacco, F.; Ribatti, D.; Vacca, A. 2011: Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(7): 1935-1946
Sumrall, A.; Fredericks, R.; Berthold, A.; Shumaker, G. 2010: Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease. Journal of Neuro-Oncology 97(2): 275-277
Qian, Z.; Zhang, L.; Cai, Z.; Sun, L.; Wang, H.; Yi, Q.; Wang, M. 2011: Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in vitro and in vivo. Leukemia Research 35(3): 380-386
Dispenzieri, A.; Klein, C.J.; Mauermann, M.L. 2007: Lenalidomide therapy in a patient with POEMS syndrome. Blood 110(3): 1075-1076
Sethi, S.; Tageja, N.; Arabi, H.; Penumetcha, R. 2009: Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction. Southern Medical Journal 102(10): 1092-1093
Kluin-Nelemans, H.C.; Ferenc, V.; van Doormaal, J.J.; van Iperen, C.; Peters, W.G.; Akin, C.; Valent, P. 2009: Lenalidomide therapy in systemic mastocytosis. Leukemia Research 33(3): E19-E22
Bowcock, S.J.; Patrick, H.E. 2009: Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?. British Journal of Haematology 146(2): 220-222
Yang, B.; Yu, R.-l.; Chi, X.-h.; Lu, X.-c. 2013: Lenalidomide treatment for multiple myeloma: systematic review and meta-analysis of randomized controlled trials. Plos one 8(5): E64354
Pérez Persona, E.; Mesa, M.Gironella.; García Sánchez, P.José.; González Rodríguez, A.Pilar. 2011: Lenalidomide treatment for patients with multiple myeloma: diagnosis and management of most frequent adverse events. Advances in Therapy 28 Suppl. 1: 11-16
Prebet, T.; Charbonnier, A.; Gelsi-Boyer, V.ér.; Mozziconacci, M.J.; Blaise, D.; Vey, N. 2013: Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure. Leukemia and Lymphoma 54(7): 1538-1540
Idler, I.; Giannopoulos, K.; Zenz, T.; Bhattacharya, N.; Nothing, M.; Döhner, H.; Stilgenbauer, S.; Mertens, D. 2010: Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells. British Journal of Haematology 148(6): 948-950
Lapalombella, R.; Andritsos, L.; Liu, Q.; May, S.E.; Browning, R.; Pham, L.V.; Blum, K.A.; Blum, W.; Ramanunni, A.; Raymond, C.A.; Smith, L.L.; Lehman, A.; Mo, X.; Jarjoura, D.; Chen, C.-S.; Ford, R.; Rader, C.; Muthusamy, N.; Johnson, A.J.; Byrd, J.C. 2010: Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. Blood 115(13): 2619-2629
Zou, Y.; Sheng, Z.; Niu, S.; Wang, H.; Yu, J.; Xu, J. 2013: Lenalidomide versus thalidomide based regimens as first-line therapy for patients with multiple myeloma. Leukemia and Lymphoma 54(10): 2219-2225
Kim, K.; Kim, S.J.; Voelter, V.; Suh, C.; Yoon, S.-S.; Lee, J.-J.; Kwak, J.-Y.; Ryoo, H.-M.; Kim, Y.S.; Moon, J.H.; Park, S.K.; Kim, S.-H.; Mun, Y.-C.; Kim, J.S.; Eom, H.-S.; Jo, D.-Y.; Jun, H.J.; Kim, K.-H.; Lee, J.-O.; Lee, J.H.; Min, C.-K. 2014: Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients. Annals of Hematology 93(1): 113-121
Oestreicher, P. 2007: Lenalidomide, a thalidomide derivative, shows promise in various applications. Ons Connect 22(8): 22-23
Knop, S.; Gerecke, C.; Liebisch, P.; Topp, M.S.; Platzbecker, U.; Sezer, O.; Vollmuth, C.; Falk, K.; Glasmacher, A.; Maeder, U.; Einsele, H.; Bargou, R.C. 2009: Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom). Blood 113(18): 4137-4143
Ravikumar, K.; Sridhar, B. 2009: Lenalidomide, an antineoplastic drug, and its hemihydrate. Acta Crystallographica. Section C Crystal Structure Communications 65(Part 10): O502-O505
Seiffert, M. 2014: Lenalidomide, an antiproliferative CLL drug. Blood 124(10): 1545-1546
Tempescul, A.; Ianotto, J.-C.; Morel, F.; Marion, V.; De Braekeleer, M.; Berthou, C. 2009: Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma. Annals of Hematology 88(9): 921-922
Richardson, P.G.; Weller, E.; Lonial, S.; Jakubowiak, A.J.; Jagannath, S.; Raje, N.S.; Avigan, D.E.; Xie, W.; Ghobrial, I.M.; Schlossman, R.L.; Mazumder, A.; Munshi, N.C.; Vesole, D.H.; Joyce, R.; Kaufman, J.L.; Doss, D.; Warren, D.L.; Lunde, L.E.; Kaster, S.; Delaney, C.; Hideshima, T.; Mitsiades, C.S.; Knight, R.; Esseltine, D.-L.; Anderson, K.C. 2010: Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma. Blood 116(5): 679-686
Kumar, S.K.; Lacy, M.Q.; Hayman, S.R.; Stewart, K.; Buadi, F.K.; Allred, J.; Laumann, K.; Greipp, P.R.; Lust, J.A.; Gertz, M.A.; Zeldenrust, S.R.; Bergsagel, P.L.; Reeder, C.B.; Witzig, T.E.; Fonseca, R.; Russell, S.J.; Mikhael, J.R.; Dingli, D.; Rajkumar, S.V.; Dispenzieri, A. 2011: Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial. American Journal of Hematology 86(8): 640-645
Dinner, S.; Witteles, W.; Afghahi, A.; Witteles, R.; Arai, S.; Lafayette, R.; Schrier, S.L.; Liedtke, M. 2013: Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement. Haematologica 98(10): 1593-1599
Guglielmelli, T.; Merlini, R.; Giugliano, E.; Saglio, G. 2009: Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia. Journal of Oncology 2009: 867380
List, A. 2009: Lenalidomide--a transforming therapeutic agent in myelodysplastic syndromes. Clinical Lymphoma and Myeloma 9(Suppl 3): S302-S304
List, A.F. 2007: Lenalidomide--the phoenix rises. New England Journal of Medicine 357(21): 2183-2186
Herold, C.I.; Gasparetto, C.; Arepally, G.M. 2011: Lenalidomide-Associated ITP. Case Reports in Hematology 2011: 638020
Nojkov, B.; Signori, C.; Konda, A.; Fontana, R.J. 2012: Lenalidomide-associated hepatotoxicity--a case report and literature review. Anticancer Research 32(9): 4117-4119
Menon, S.; Habermann, T.; Witzig, T. 2007: Lenalidomide-associated hypothyroidism. Leukemia and Lymphoma 48(12): 2465-2467
Zagouri, F.; Roussou, M.; Kastritis, E.; Koureas, A.; Tsokou, E.; Migkou, M.; Gavriatopoulou, M.; Nikitas, N.; Gkotzamanidou, M.; Terpos, E.; Dimopoulos, M.-A. 2011: Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias. American Journal of Hematology 86(10): 882-884
Chanan-Khan, A.A.; Whitworth, A.; Bangia, N.; Porter, C.W.; Lee, K. 2008: Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(29): 4851
Senthilkumar, C.S.; Ganesh, N. 2012: Lenalidomide-based combined therapy induced alterations in serum proteins of multiple myeloma patient: a follow-up case report and overview of the literature. Experimental Oncology 34(4): 373-376
Govindaraj, C.; Madondo, M.; Kong, Y.Y.; Tan, P.; Wei, A.; Plebanski, M. 2014: Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients. American Journal of Hematology 89(8): 795-802
Michot, C.; Guillot, B.; Dereure, O. 2010: Lenalidomide-induced acute acneiform folliculitis of the head and neck: not only the anti-EGF receptor agents. Dermatology 220(1): 49-50
Lipson, E.J.; Huff, C.A.; Holanda, D.G.; McDevitt, M.A.; Fine, D.M. 2010: Lenalidomide-induced acute interstitial nephritis. Oncologist 15(9): 961-964
Jain, P. 2009: Lenalidomide-induced acute liver failure. Blood Transfusion 7(4): 335-6; Author Reply 337
Danbara, M.; Tadera, N.; Togano, T.; Katayama, T.; Aoki, T.; Miyazaki, K.; Higashihara, M. 2013: Lenalidomide-induced acute lung injury in case of multiple myeloma. International Journal of Clinical Pharmacology and Therapeutics 51(6): 513-516
Nakamura, N.; Kanemura, N.; Shibata, Y.; Matsumoto, T.; Mabuchi, R.; Nakamura, H.; Kitagawa, J.; Goto, N.; Hara, T.; Tsurumi, H.; Moriwaki, H. 2014: Lenalidomide-induced cytokine release syndrome in a patient with multiple myeloma. Leukemia and Lymphoma 55(7): 1691-1693
Pawlyn, C.; Khan, M.S.; Muls, A.; Sriskandarajah, P.; Kaiser, M.F.; Davies, F.E.; Morgan, G.J.; Andreyev, H.J.N. 2014: Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatment. Blood 124(15): 2467-2468
Saheer, S.; Thangakunam, B.; Christopher, D.J.; George, B. 2014: Lenalidomide-induced diffuse alveolar hemorrhage. Lung India: Official Organ of Indian Chest Society 31(1): 90-91
Hussein, K.; Tefferi, A. 2009: Lenalidomide-induced durable hematological and cytogenetic remission in del(5q)-associated de novo acute myeloid leukemia. Leukemia Research 33(8): E132-E133
Mehta, R.S.; Di Stasi, A.; Hosing, C.; Shah, N.; Rezvani, K.; Alousi, A.; O'Brien, S.; Wierda, W.; Keating, M.; Shpall, E.J. 2014: Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant. Clinical Lymphoma Myeloma and Leukemia 14(3): E105-E109
Kortuem, M.; Einsele, H. 2010: Lenalidomide-induced hypersensitivity pneumonitis. Onkologie 33(5): 219
Noonan, K.; Rudraraju, L.; Ferguson, A.; Emerling, A.; Pasetti, M.F.; Huff, C.A.; Borrello, I. 2012: Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(5): 1426-1434
Chen, Y.; Kiatsimkul, P.; Nugent, K.; Raj, R. 2010: Lenalidomide-induced interstitial lung disease. PharmacoTherapy 30(3): 325
Niesvizky, R.; Naib, T.; Christos, P.J.; Jayabalan, D.; Furst, J.R.; Jalbrzikowski, J.; Zafar, F.; Mark, T.; Lent, R.; Pearse, R.N.; Ely, S.; Leonard, J.P.; Mazumdar, M.; Chen-Kiang, S.; Coleman, M. 2007: Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy. British Journal of Haematology 138(5): 640-643
Curto Barredo, L.; Salar, A.; Pujol, R.M.; Garcia, M.; Gallardo, F. 2013: Lenalidomide-induced paronychia. Journal of Dermatology 40(4): 303-304
Pérez-Paredes, M.ía.G.; Rodríguez-Prieto, M.Án.; Ruiz-González, I.; Valladares-Narganes, L.M. 2013: Lenalidomide-induced photosensitivity. Photodermatology Photoimmunology and Photomedicine 29(6): 334-336
Dolai, T.K.; Dutta, S.; Mandal, P.K.; Saha, S.; Bhattacharyya, M. 2014: Lenalidomide-induced pure red cell aplasia. Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology 31(1): 99-100
Kuohung, V.; Goldberg, L.J.; Demierre, M.-F. 2011: Lenalidomide-induced purpuric eruption: a new adverse cutaneous reaction. Journal of the American Academy of Dermatology 65(3): 654-656
Hussain, S.; Browne, R.; Chen, J.; Parekh, S. 2007: Lenalidomide-induced severe hepatotoxicity. Blood 110(10): 3814
Eve, H.E.; Rule, S.A.J. 2010: Lenalidomide-induced tumour flare reaction in mantle cell lymphoma. British Journal of Haematology 151(4): 410-412
Aue, G.; Njuguna, N.; Tian, X.; Soto, S.; Hughes, T.; Vire, B.; Keyvanfar, K.; Gibellini, F.; Valdez, J.; Boss, C.; Samsel, L.; McCoy, J.P.; Wilson, W.H.; Pittaluga, S.; Wiestner, A. 2009: Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia. Haematologica 94(9): 1266-1273
Hickey, C.J.; Schwind, S.; Radomska, H.S.; Dorrance, A.M.; Santhanam, R.; Mishra, A.; Wu, Y-Zhong.; Alachkar, H.; Maharry, K.; Nicolet, D.; Mrózek, K.; Walker, A.; Eiring, A.M.; Whitman, S.P.; Becker, H.; Perrotti, D.; Wu, L-Chu.; Zhao, X.; Fehniger, T.A.; Vij, R.; Byrd, J.C.; Blum, W.; Lee, L.James.; Caligiuri, M.A.; Bloomfield, C.D.; Garzon, R.; Marcucci, G. 2013: Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia. Blood 121(1): 159-169
Musch, A. 2008: Lenalidomide. Treatment of multiple myeloma. Medizinische Monatsschrift für Pharmazeuten 31(1): 4-8; Quiz: 9-10
Anonymous 2010: Lenalidomide: Stevens-Johnson syndrome. Prescrire International 19(107): 125
Giagounidis, A.A.N.; Germing, U.; Haase, S.; Aul, C. 2007: Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes. Therapeutics and Clinical Risk Management 3(4): 553-562
Tariman, J.D. 2007: Lenalidomide: a new agent for patients with relapsed or refractory multiple myeloma. Clinical Journal of Oncology Nursing 11(4): 569-574
Palumbo, A.; Miguel, J.ús.S.; Sonneveld, P.; Moreau, P.; Drach, J.; Morgan, G.; Einsele, H. 2008: Lenalidomide: a new therapy for multiple myeloma. Cancer Treatment Reviews 34(3): 283-291
Szturz, P.; Adam, Z.ěk.; Chovancová, J.; Stehlíková, O.; Klabusay, M.; Rehák, Z.ěk.; Koukalová, R.; Krejčí, M.; Pour, L.ěk.; Zahradová, L.; Hájek, R.; Mayer, J.ří 2012: Lenalidomide: a new treatment option for Castleman disease. Leukemia and Lymphoma 53(10): 2089-2091
Galustian, C.; Dalgleish, A. 2009: Lenalidomide: a novel anticancer drug with multiple modalities. Expert Opinion on PharmacoTherapy 10(1): 125-133
Scott, L.J.; Lyseng-Williamson, K.A. 2011: Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma. Drugs 71(5): 625-649
Saloura, V.; Grivas, P.D. 2010: Lenalidomide: a synthetic compound with an evolving role in cancer management. Hematology 15(5): 318-331
Dimopoulos, M-Athanassios.; Terpos, E. 2010: Lenalidomide: an update on evidence from clinical trials. Blood Reviews 24 Suppl. 1: S21-S26
Kumar, G.; Lau, H.; Laskin, O. 2009: Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction. Cancer ChemoTherapy and Pharmacology 63(6): 1171-1175
Trethewey, R.N.; Geigenberger, P.; Riedel, K.; Hajirezaei, M.R.; Sonnewald, U.; Stitt, M.; Riesmeier, J.W.; Willmitzer, L. 1998: Combined expression of glucokinase and invertase in potato tubers leads to a dramatic reduction in starch accumulation and a stimulation of glycolysis. Plant Journal: for Cell and Molecular Biology 15(1): 109-118
Lin, T.S. 2008: Lenalidomide: what is the right dose in CLL?. Blood 111(11): 5268
Ortega Valín, L.; del Pozo Ruiz, J.J.; Rodríguez Lage, C.; Ramos Ortega, F. 2008: Lenalidomide; adverse effects and commercialisation. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 32(6): 358-360
Aizenman, A.I. 1983: Lend an Ear To Reader's Plea. Canadian Family Physician Medecin de Famille Canadien 29: 1267
Rebair, A. 2012: Lend an ear with care. Nursing Standard: 27(10): 64
Ash, C. 2010: Lend me your ears and your huddled masses: conversations with new Jersey patients. Md Advisor: a Journal for new Jersey Medical Community 3(4): 38-40
Bove, G.M. 2013: Lending a hand to migraine. Pain 154(9): 1493-1494
Lutz, W.; Böhnke, J.R.; Köck, K. 2011: Lending an ear to feedback systems: evaluation of recovery and non-response in psychotherapy in a German outpatient setting. Community Mental Health Journal 47(3): 311-317
Anonymous 1968: Lending and borrowing. Canadian Medical Association Journal 98(16): 793
Thompson, J.C. 2008: Lending in a turbulent market. Lenders return to more traditional underwriting standards as the industry heads into another period of uncertainty. Provider 34(4): 43-44
Labbé, D. 2009: Lenghtening temporalis myoplasty V.2. and lip reanimation. Annales de Chirurgie Plastique et Esthetique 54(6): 571-576
Vatutin, N.T.; Kalinkina, N.V.; Dziuba, E.V. 2011: Lengres disease. Kardiologiia 51(8): 72-75
Wang, T.; Zhu, Y.; Getahun, Z.; Du, D.; Huang, C.-Y.; Degrado, W.F.; Gai, F. 2004: Length Dependent Helix-Coil Transition Kinetics of Nine Alanine-Based Peptides. Journal of Physical Chemistry. B 108(39)
Smith, E.F. 1895: Length of Vessels in Plants. Science 1(3): 77-78
Bossé, Y.; Sobieszek, A.; Paré, P.D.; Seow, C.Y. 2008: Length adaptation of airway smooth muscle. Proceedings of the American Thoracic Society 5(1): 62-67
Almasri, A.M.; Ratz, P.H.; Speich, J.E. 2010: Length adaptation of the passive-to-active tension ratio in rabbit detrusor. Annals of Biomedical Engineering 38(8): 2594-2605
Chaurasia, A.; Tarallo, A.; Bernà, L.; Yagi, M.; Agnisola, C.; D'Onofrio, G. 2014: Length and GC content variability of introns among teleostean genomes in the light of the metabolic rate hypothesis. Plos one 9(8): E103889
Dabney, J.; Meyer, M. 2012: Length and GC-biases during sequencing library amplification: a comparison of various polymerase-buffer systems with ancient and modern DNA sequencing libraries. Biotechniques 52(2): 87-94
Chernak, L.A.; DeWall, R.J.; Lee, K.S.; Thelen, D.G. 2013: Length and activation dependent variations in muscle shear wave speed. Physiological Measurement 34(6): 713-721
McKinnon, N.K.; Bali, M.; Akabas, M.H. 2012: Length and amino acid sequence of peptides substituted for the 5-HT3A receptor M3M4 loop may affect channel expression and desensitization. Plos one 7(4): E35563
Tricoli, L.; Naeem, A.; Parasido, E.; Mikhaiel, J.P.; Choudhry, M.Umer.; Berry, D.L.; Abdelgawad, I.A.; Lee, R.J.; Feldman, A.S.; Ihemelandu, C.; Avantaggiati, M.; Kumar, D.; Byers, S.; Gallagher, R.; Wulfkuhle, J.; Petricoin, E.; Rodriguez, O.; Albanese, C. 2018: Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells. Oncotarget 9(2): 2193-2207
Lopes, G.P.; Ferreira-Silva, M.ár.M.; Ramos, A.A.; Moraes-Souza, H.; Prata, A.íz.; Correia, D. 2013: Length and caliber of the rectosigmoid colon among patients with Chagas disease and controls from areas at different altitudes. Revista da Sociedade Brasileira de Medicina Tropical 46(6): 746-751
Borget, I.; Remy, H.; Chevalier, J.; Ricard, M.; Allyn, M.; Schlumberger, M.; De Pouvourville, G. 2008: Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen. European Journal of Nuclear Medicine and Molecular Imaging 35(8): 1457-1463
Clayton, H.M.; Larson, B.; Kaiser, L.J.; Lavagnino, M. 2011: Length and elasticity of side reins affect rein tension at trot. Veterinary Journal 188(3): 291-294
Deng, X.; Zhang, Z.; Zhou, J.; Qiu, M.; Tang, G. 2010: Length and end group dependence of the electronic transport properties in carbon atomic molecular wires. Journal of Chemical Physics 132(12): 124107
Asai, Y. 2013: Length and energy gap dependences of thermoelectricity in nanostructured junctions. Journal of Physics. Condensed Matter: An Institute of Physics Journal 25(15): 155305
Howard-Swirzinski, K.; Edwards, P.C.; Saini, T.S.; Norton, N.S. 2010: Length and geometric patterns of the greater palatine canal observed in cone beam computed tomography. International Journal of Dentistry 2010
Jongjirasiri, Y. 2009: Length and landmark of A1 pulley in hand: an anatomical study. Journal of the Medical Association of Thailand 92(1): 41-46
Guy, N.; Justo, D.; Lerman, Y.; Rabinovich, A. 2012: Length and outcome of acute inpatient rehabilitation for hospital-associated deconditioning in the elderly. Harefuah 151(9): 500
Ramamoorthy, S.; Garapati, H.S.; Mishra, R.K. 2014: Length and sequence dependent accumulation of simple sequence repeats in vertebrates: potential role in genome organization and regulation. Gene 551(2): 167-175
Ledee, D.R.; Byers, T.J. 2009: Length and sequence heterogeneity in the mitochondrial internal transcribed spacer of Acanthamoeba spp. Journal of Eukaryotic Microbiology 56(3): 257-262
Maljaars, P.W.J.; Peters, H.P.F.; Kodde, A.; Geraedts, M.; Troost, F.J.; Haddeman, E.; Masclee, A.A.M. 2011: Length and site of the small intestine exposed to fat influences hunger and food intake. British Journal of Nutrition 106(10): 1609-1615
Zigić, Z.; Bogdanović, G.; Ramić, S. 2008: Length and surface density of the resorption villi's blood vessels in smokers placentas. Medicinski Arhiv 62(4): 196-199
Syutkin, V.M.; Vyazovkin, V.L.; Korolev, V.V.; Grebenkin, S.Y. 2012: Length and time scales of structural heterogeneities in deeply supercooled propylene carbonate. Physical Review Letters 109(13): 137801
Sreearunothai, P.; Asaoka, S.; Cook, A.R.; Miller, J.R. 2009: Length and time-dependent rates in diffusion-controlled reactions with conjugated polymers. Journal of Physical Chemistry. a 113(12): 2786-2795
Dʼhaens, G.; Baert, F.; Gasparaitis, A.; Hanauer, S. 1997: Length and type of recurrent ileitis after ileal resection correlate with presurgical features in Crohn's disease. Inflammatory Bowel Diseases 3(4): 249-253
Zhang, Y.; Chen, X.; Wu, Z.-j.; Zhang, P.; Zhang, X.-d.; Yang, Y. 2007: Length and volume of intravesical prostatic protrusion closely correlated with bladder outflow obstruction in BPH patients. Zhonghua Nan Ke Xue 13(11): 1020-1022
Kim, J.-H.; Kim, M.-J.; Lim, S.H.; Kim, J.; Lee, M.-J. 2013: Length and volume of morphologically normal kidneys in korean children: ultrasound measurement and estimation using body size. Korean Journal of Radiology 14(4): 677-682
Macklin, C.C. 1945: Length and width changes in the pulmonary arterial system of rabbits in passing from the stage of expiration to that of collapse as revealed by roentgenography. Diseases of the Chest 11: 590-595
Muggli, E.; Sauter-Louis, C.; Braun, U.; Nuss, K. 2011: Length asymmetry of the bovine digits. Veterinary Journal 188(3): 295-300
Jedrychowski, W.ła.; Perera, F.P.; Maugeri, U.; Mróz, E.; Flak, E.; Mrozek-Budzyn, D.; Edwards, S.; Musiał, A. 2008: Length at birth and effect of prenatal and postnatal factors on early wheezing phenotypes. Kraków epidemiologic cohort study. International Journal of Occupational Medicine and Environmental Health 21(2): 111-119
Gao, L.; Fang, Z.; Zhang, K.; Zhi, D.; Cui, X. 2011: Length bias correction for RNA-seq data in gene set analyses. Bioinformatics 27(5): 662-669
Mi, G.; Di, Y.; Emerson, S.; Cumbie, J.S.; Chang, J.H. 2012: Length bias correction in gene ontology enrichment analysis using logistic regression. Plos one 7(10): E46128
Park, H.J.; Noh, H.; Park, M.; Park, K.; Chang, J.Y.; Lee, H. 2008: Length characterization of multi-walled CNT by capillary hydrodynamic fractionation (CHDF). Journal of Nanoscience and Nanotechnology 8(10): 5220-5223
Middleton, S.; Song, T.; Nayak, S. 2010: Length constraints of multi-domain proteins in metazoans. Bioinformation 4(10): 441-444
Schmelz, J.; Schedl, A.E.; Steinlein, C.; Manners, I.; Schmalz, H. 2012: Length control and block-type architectures in worm-like micelles with polyethylene cores. Journal of the American Chemical Society 134(34): 14217-14225
Wei, X.L.; Jiang, A.N.; Gao, S.; Chen, Q. 2009: Length control and sharpening of carbon nanotube scanning probe microscope tips using carbon nanotube "nanoknife". Journal of Nanoscience and Nanotechnology 9(2): 1258-1262
Kwon, S.Y. 2008: Length control in rigid cylindrical nanoassembly by tuning molecular interactions in aqueous solutions. Langmuir: the Acs Journal of Surfaces and Colloids 24(19): 10674-10679
Miller, J.; Evans, M. 2014: Length control of an optical resonator using second-order transverse modes. Optics Letters 39(8): 2495-2498
Wagner, S.; Stenta, M.; Metzger, L.C.; Dal Peraro, M.; Cornelis, G.R. 2010: Length control of the injectisome needle requires only one molecule of Yop secretion protein P (YscP). Proceedings of the National Academy of Sciences of the United States of America 107(31): 13860-13865
Harriman, A.; Mallon, L.J.; Elliot, K.J.; Haefele, A.; Ulrich, G.; Ziessel, R. 2009: Length dependence for intramolecular energy transfer in three- and four-color donor-spacer-acceptor arrays. Journal of the American Chemical Society 131(37): 13375-13386
Tsubokawa, M.; Shibata, N.; Ohashi, M.; Seikai, S. 1986: Length dependence of LP11 mode loss in the quasi-single-mode operating region. Optics Letters 11(5): 327
Quek, S.Y.; Choi, H.J.; Louie, S.G.; Neaton, J.B. 2009: Length dependence of conductance in aromatic single-molecule junctions. Nano Letters 9(11): 3949-3953
Khoo, K.H.; Chen, Y.; Li, S.; Quek, S.Y. 2015: Length dependence of electron transport through molecular wires--a first principles perspective. Physical Chemistry Chemical Physics: Pccp 17(1): 77-96
Hanft, L.M.; McDonald, K.S. 2010: Length dependence of force generation exhibit similarities between rat cardiac myocytes and skeletal muscle fibres. Journal of Physiology 588(Part 15): 2891-2903
Cohen, L.G.; Personick, S.D. 1975: Length dependence of pulse dispersion in a long multimode optical fiber. Applied Optics 14(6): 1357-1360
Meier, M.; Seelig, J. 2008: Length dependence of the coil <--> beta-sheet transition in a membrane environment. Journal of the American Chemical Society 130(3): 1017-1024
Senapati, D.; Senapati, T.; Wate, P.S.; Kanchanapally, R.; Fan, Z.; Kumar Singh, A.; Chandra Ray, P. 2012: Length dependent NLO properties of 2D hollow gold nanoprisms formed by guided assembly. Chemical Communications 48(48): 6034-6036
Allen, M.D.; Kimpinski, K.; Doherty, T.J.; Rice, C.L. 2014: Length dependent loss of motor axons and altered motor unit properties in human diabetic polyneuropathy. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 125(4): 836-843
Mela, P.; Veltink, P.H.; Huijing, P.A. 2002: Length dependent potentiation in electrically stimulated human ankle dorsiflexor muscles. Neuromodulation: Journal of the International Neuromodulation Society 5(2): 120-130
Smekal, V.; Deml, C.; Irenberger, A.; Niederwanger, C.; Lutz, M.; Blauth, M.; Krappinger, D. 2008: Length determination in midshaft clavicle fractures: validation of measurement. Journal of Orthopaedic Trauma 22(7): 458-462
Han, S.-H.; Yang, B.-C.; Ko, M.-S.; Oh, H.-S.; Lee, S.-S. 2010: Length difference between equine ZFX and ZFY genes and its application for molecular sex determination. Journal of Assisted Reproduction and Genetics 27(12): 725-728
Hramov, A.E.; Koronovskii, A.A.; Kurovskaya, M.K.; Ovchinnikov, A.A.; Boccaletti, S. 2007: Length distribution of laminar phases for type-i intermittency in the presence of noise. Physical Review. e Statistical Nonlinear and Soft Matter Physics 76(2 Part 2): 026206
Kong, Y. 2013: Length distribution of sequencing by synthesis: fixed flow cycle model. Journal of Mathematical Biology 67(2): 389-410
Pease, L.F.; Tsai, D.-H.; Fagan, J.A.; Bauer, B.J.; Zangmeister, R.A.; Tarlov, M.J.; Zachariah, M.R. 2009: Length distribution of single-walled carbon nanotubes in aqueous suspension measured by electrospray differential mobility analysis. Small 5(24): 2894-2901
Lee, C.F. 2012: Length distribution of stiff, self-assembled polymers at thermal equilibrium. Journal of Physics. Condensed Matter: An Institute of Physics Journal 24(41): 415101
Nahum, A.; Chalker, J.T.; Serna, P.; Ortuño, M.; Somoza, A.M. 2013: Length distributions in loop soups. Physical Review Letters 111(10): 100601
Goodman, W.A.; Jain, M.K. 2011: Length does not matter: a new take on telomerase reverse transcriptase. Arteriosclerosis Thrombosis and Vascular Biology 31(2): 235-236
González-Magaña, O.; Reitsma, G.; Bari, S.; Hoekstra, R.; Schlathölter, T. 2012: Length effects in VUV photofragmentation of protonated peptides. Physical Chemistry Chemical Physics: Pccp 14(13): 4351-4354
Liu, N.; Peng, Y.; Lu, X. 2014: Length effects of a built-in flapping flat plate on the flow over a traveling wavy foil. Physical Review. e Statistical Nonlinear and Soft Matter Physics 89(6): 063019
Daems, I.; Singh, R.; Baron, G.; Denayer, J. 2007: Length exclusion in the adsorption of chain molecules on chabazite type zeolites. Chemical Communications 13: 1316-1318
Lau, Y.-T.R.; Yamaguchi, M.; Li, X.; Bando, Y.; Golberg, D.; Winnik, F.ço.M. 2014: Length fractionation of boron nitride nanotubes using creamed oil-in-water emulsions. Langmuir: the Acs Journal of Surfaces and Colloids 30(7): 1735-1740
Johnson, M.G.; Tamatamah, A.R. 2013: Length frequency distribution, mortality rate and reproductive biology of kawakawa (Euthynnus affinis-Cantor, 1849) in the coastal waters of Tanzania. Pakistan Journal of Biological Sciences: Pjbs 16(21): 1270-1278
Szpinda, M. 2008: Length growth of the various aortic segments in human foetuses. Folia Morphologica 67(4): 245-250
Zhao, H.; Shen, J.; Medico, L.; Platek, M.; Ambrosone, C.B. 2010: Length heteroplasmies in human mitochondrial DNA control regions and breast cancer risk. International Journal of Molecular Epidemiology and Genetics 1(3): 184-192
Verscheure, S.; Backeljau, T.; Desmyter, S. 2015: Length heteroplasmy of the polyC-polyT-polyC stretch in the dog mtDNA control region. International Journal of Legal Medicine 129(5): 927-935
Siadat, F.; Sykes, J.; Van der Kwast, T.H. 2013: Length matters in prostate cancer. Canadian Journal of Urology 20(4): 6854
Poyurovsky, M.V. 2012: Length matters: C-terminal tails regulate Mdm2-MdmX complexes. Cell Cycle 11(8): 1485
Hillegass, W.B. 2009: Length matters: outcomes of superficial femoral artery (SFA) endovascular interventions. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 74(7): 1096
Linne, M.A. 1993: Length measurement and stabilization of optical substrates. Applied Optics 32(13): 2312-2314
Al-Mohamedi, H.; Prinz, A.; Mieskes, G.; Oltrup, T.; Bende, T. 2014: Length measurement of the eye using a swept-source interferometer. Biomedizinische Technik. Biomedical Engineering 59(1): 53-57
Dong, M.; Zhao, L.; Yuan, K.; Zeng, F.; Sun, J.; Liu, J.; Yu, D.; von Deneen, K.M.; Liang, F.; Qin, W.; Tian, J. 2013: Length of Acupuncture Training and Structural Plastic Brain Changes in Professional Acupuncturists. Plos one 8(6): E66591
Makhoul, N.; Khamisy-Farah, R.; Farah, R. 2013: Length of Stay and Outcome of Hospitalized Chronic Obstructive Pulmonary Disease Patients, Differences between General Medical Ward and Intensive Care Unit: a Cohort Study. West Indian Medical Journal 62(8): 738-743
Seetharaman, S.; Jain, K. 2014: Length of adaptive walk on uncorrelated and correlated fitness landscapes. Physical Review. e Statistical Nonlinear and Soft Matter Physics 90(3): 032703
Badran, W.A.; Fahmy, I.; Abdel-Megid, W.M.; Elder, K.; Mansour, R.; Kent-First, M. 2009: Length of androgen receptor-CAG repeats in fertile and infertile Egyptian men. Journal of Andrology 30(4): 416-425
Figueroa, J.; Mero, D. 2013: Length of capture and reproduction of green spiny lobster panulirus gracilis (Decapoda: Palinuridae) from the coast of Manabi, Ecuador. Revista de Biologia Tropical 61(3): 1189-1199
Richardson, V.E. 2010: Length of caregiving and well-being among older widowers: implications for the dual process model of bereavement. Omega 61(4): 333-356
Gu, J.; Chen, X.-P. 2011: Length of cell cycle in neural development. Yi Chuan 33(11): 1185-1190
Hamadouche, M.; Jahnke, A.; Scemama, C.; Ishaque, B.A.; Rickert, M.; Kerboull, L.; Jakubowitz, E. 2015: Length of clinically proven cemented hip stems: state of the art or subject to improvement?. International Orthopaedics 39(3): 411-416
Aldai, N.; Dugan, M.E.R.; Kramer, J.K.G.; Martínez, A.; López-Campos, O.; Mantecón, A.R.; Osoro, K. 2011: Length of concentrate finishing affects the fatty acid composition of grass-fed and genetically lean beef: an emphasis on trans-18:1 and conjugated linoleic acid profiles. Animal: An International Journal of Animal Bioscience 5(10): 1643-1652
Jubert, C.; Wagner, E.; Bizier, S.; Vachon, M.-F.; Duval, M.; Champagne, M.A. 2008: Length of cord blood unit cryopreservation does not impact hematopoietic engraftment. Transfusion 48(9): 2028-2030
Yang, M.B.; Rao, S.; Copenhagen, D.R.; Lang, R.A. 2013: Length of day during early gestation as a predictor of risk for severe retinopathy of prematurity. Ophthalmology 120(12): 2706-2713
Gravely-Witte, S.; Jurgens, C.Y.; Tamim, H.; Grace, S.L. 2010: Length of delay in seeking medical care by patients with heart failure symptoms and the role of symptom-related factors: a narrative review. European Journal of Heart Failure 12(10): 1122-1129
Malek, J. 1949: Length of delivery and the daily rhythm of clinical onset of labor. Ceskoslovenska Gynekologie 14(5): 269-282
Valdés, S.; García, E.; Pérez, H.; Hernández, M. 2010: Length of diagnostic delay in patients with non-small-cell lung cancer. Medicc Review 12(1): 29-32
Mian, M.F.; Ahmed, A.N.; Rad, M.; Babaian, A.; Bowdish, D.; Ashkar, A.A. 2013: Length of dsRNA (poly I:C) drives distinct innate immune responses, depending on the cell type. Journal of Leukocyte Biology 94(5): 1025-1036
Brüllmann, D.D.; Röhrig, B.; Sulayman, S.L.; Schulze, R. 2011: Length of endodontic files measured in digital radiographs with and without noise-suppression filters: an ex-vivo study. Dento Maxillo Facial Radiology 40(3): 170-176
Baraboutis, I.G.; Tsagalou, E.P.; Papakonstantinou, I.; Marangos, M.N.; Gogos, C.; Skoutelis, A.T.; Bassaris, H.; Johnson, S. 2011: Length of exposure to the hospital environment is more important than antibiotic exposure in healthcare associated infections by methicillin-resistant Staphylococcus aureus: a comparative study. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 15(5): 426-435
Toth, Z. 2013: Length of family medicine residency. Canadian Family Physician Medecin de Famille Canadien 59(3): 246-247
Ortiz, H.; Marzo, M.; de Miguel, M.; Ciga, M.A.; Oteiza, F.; Armendariz, P. 2008: Length of follow-up after fistulotomy and fistulectomy associated with endorectal advancement flap repair for fistula in ano. British Journal of Surgery 95(4): 484-487
Locatelli, M.; Buzzetti, R.; Galgani, A.; Montemari, A.L.; Khazrai, M.; Petrone, A.; Visalli, N.; Meschi, F.; Minicucci, L.; Lorini, R.; Cristaldi, A.; Valorani, M.G.; Bottazzo, G.F.; Pozzilli, P. 2007: Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). Diabetic Medicine: a Journal of the British Diabetic Association 24(8): 916-919
Yamagishi, A.; Morita, T.; Kawagoe, S.; Shimizu, M.; Ozawa, T.; An, E.; Kobayakawa, M.; Tsuneto, S.; Shima, Y.; Miyashita, M. 2015: Length of home hospice care, family-perceived timing of referrals, perceived quality of care, and quality of death and dying in terminally ill cancer patients who died at home. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 23(2): 491-499
Han, B.; Remsburg, R.E.; McAuley, W.J.; Keay, T.J.; Travis, S.S. 2007: Length of hospice care among U.S. adults: 1992-2000. Inquiry: a Journal of Medical Care Organization Provision and Financing 44(1): 104-113
Kaluski, E.; Alfano, D.; Randhawa, P.; Palmaro, J.; Jones, P.; Romano, K.; Dolny-Korasick, D.; Klapholz, M. 2008: Length of hospital stay after percutaneous coronary interventions. Journal of Cardiovascular Nursing 23(4): 345-348
Löwenberg, M.; Duijvis, N.W.; Ponsioen, C.; van den Brink, G.R.; Fockens, P.; D'Haens, G.R.A.M. 2014: Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis. European Journal of Gastroenterology and Hepatology 26(11): 1240-1246
Calò, P.G.; Tatti, A.; Farris, S.; Nicolosi, A. 2007: Length of hospital stay and complications in thyroid surgery. our experience. Chirurgia Italiana 59(2): 149-153
Kara, A.; Ozsurekci, Y.; Tekcicek, M.; Karadag Oncel, E.; Cengiz, A.B.; Karahan, S.; Ceyhan, M.; Celik, M.O.; Ozkaya-Parlakay, A. 2014: Length of hospital stay and management of facial cellulitis of odontogenic origin in children. Pediatric Dentistry 36(1): 18e-22e
Aujesky, D.; Stone, R.A.; Kim, S.; Crick, E.J.; Fine, M.J. 2008: Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective. Archives of Internal Medicine 168(7): 706-712
Rafiei, M.; Ayatollahi, S.M.T.; Behboodian, J. 2007: Length of hospital stay at Arak (central Iran) maternity clinics using proposed zero-inflated negative binomial modeling. Pakistan Journal of Biological Sciences: Pjbs 10(15): 2510-2516
Bartkowski, R. 2012: Length of hospital stay due to DRG reimbursement. Therapeutische Umschau. Revue Therapeutique 69(1): 15-21
Mayor, S. 2012: Length of hospital stay for hip fracture falls by a day, audit shows. Bmj 345: E5940
Muhm, M.; Walendowski, M.; Danko, T.; Weiss, C.; Ruffing, T.; Winkler, H. 2016: Length of hospital stay for patients with proximal femoral fractures : Influencing factors. Der Unfallchirurg 119(7): 560-569
Kato, N.; Kondo, M.; Okubo, I.; Hasegawa, T. 2014: Length of hospital stay in Japan 1971-2008: hospital ownership and cost-containment policies. Health Policy 115(2-3): 180-188
Jang, H.J.; Park, J.; Shin, H.-I. 2011: Length of hospital stay in patients with spinal cord injury. Annals of Rehabilitation Medicine 35(6): 798-806
Khouw, N.; Wasim, M.; Aziz, A.; Uppal, H.; Chandran, S.; Potluri, R. 2014: Length of hospital stay is shorter in South Asian patients with myocardial infarction. International Journal of Cardiology 171(2): E54-E55
Kimani, K.N.; Potluri, R.; Natalwala, A.; Ghosh, S.; Heun, R.; Narendran, P. 2012: Length of hospital stay is shorter in black and ethnic minority patients with diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 29(6): 830-831
Ishii, Y.; Noguchi, H.; Takeda, M.; Sato, J.; Suzuki, T. 2014: Length of hospital stay with patient-dependent determination in bilateral scheduled staged total knee arthroplasty. European Journal of Orthopaedic Surgery and Traumatology: Orthopedie Traumatologie 24(6): 961-965
Alwan, N.A.; Johnstone, P.; Zolese, G. 2008: Length of hospitalisation for people with severe mental illness. Cochrane Database of Systematic Reviews 1: Cd000384
Babalola, O.; Gormez, V.; Alwan, N.A.; Johnstone, P.; Sampson, S. 2014: Length of hospitalisation for people with severe mental illness. Cochrane Database of Systematic Reviews 1: Cd000384
Hölzel, L.P.; Bermejo, I.; Kriston, L.; von Wolff, A.; Kornacher, J.; Harter, C.; Büttig, S.; Sacher, E.; Härter, M. 2014: Length of hospitalization for inpatient treatment of depression. Results of a multicentre study on the effects of a new treatment model. Der Nervenarzt 85(3): 344-349
Ristić, D.Z.; Jovanović, N.D.; Cvetković, V.; Vracević, B.D. 2011: Length of hospitalization of patients with ankle fracture. Acta Chirurgica Iugoslavica 58(1): 73-76
Gravante, G.; Montone, A.; Esposito, G. 2007: Length of hospitalization: an important parameter for burned patients. Journal of Burn Care and Research: Official Publication of the American Burn Association 28(3): 537-538
Karn, M.N. 1947: Length of human gestation with special reference to prematurity. Annals of Eugenics 14(Pt 1): 44-59
Maschio, B.H.; Gentil, B.C.; Caetano, E.L.ão.A.; Rodrigues, L.S.; Laurino, L.F.; Spim, S.R.V.; Jozala, A.F.; Dos Santos, C.A.; Grotto, D.; Gerenutti, M. 2017: Characterization of the Effects of the Shiitake Culinary-Medicinal Mushroom, Lentinus edodes (Agaricomycetes), on Severe Gestational Diabetes Mellitus in Rats. International Journal of Medicinal Mushrooms 19(11): 991-1000
Santamarina-Perez, P.; Eiroa-Orosa, F.Jose.; Freniche, Vónica.; Moreno-Mayos, A.; Alegre, Jé.; Saez, N.; Jacas, C. 2011: Length of illness does not predict cognitive dysfunction in chronic fatigue syndrome. Applied Neuropsychology 18(3): 216-222
Lee, S.; Rothbard, A.B.; Noll, E.L. 2012: Length of inpatient stay of persons with serious mental illness: effects of hospital and regional characteristics. Psychiatric Services 63(9): 889-895
Santos, I.de.Souza.; Vieira, J.Edson.; Nunes, M.do.Patrocínio.Tenório. 2009: Length of internship influences performance on medical residency exam. Revista da Associacao Medica Brasileira 55(6): 744-748
Garnier, R.; Gandon, S.; Harding, K.C.; Boulinier, T. 2014: Length of intervals between epidemics: evaluating the influence of maternal transfer of immunity. Ecology and Evolution 4(5): 568-575
Brady, P.W.; Conway, P.H.; Goudie, A. 2010: Length of intravenous antibiotic therapy and treatment failure in infants with urinary tract infections. Pediatrics 126(2): 196-203
Shkolnikov, V.M.; Scholz, R.; Jdanov, D.A.; Stegmann, M.; von Gaudecker, H.-M. 2008: Length of life and the pensions of five million retired German men. European Journal of Public Health 18(3): 264-269
Smits, J.; Monden, C. 2009: Length of life inequality around the globe. Social Science and Medicine 68(6): 1114-1123
Li, L.-R.; Fang, Y.-J.; Pan, Z.-Z.; Wu, X.-J.; Wan, D.-S.; Hardingham, J.E.; Rieger, N. 2010: Length of lymphangiogenesis in the rectal tissues distal to rectal cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 31(6): 667-671
Jobe, R. 1974: The eye in facial palsy. Western Journal of Medicine 121(6): 494
Vilela, S.; Santos, S.; Padrão, Pícia.; Caraher, M. 2014: Length of migration and eating habits of Portuguese university students living in London, United Kingdom. Ecology of Food and Nutrition 53(4): 419-435
Bekier, M.E.; Fischbach, R.; Lee, J.; Taylor, W.R. 2009: Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit. Molecular Cancer Therapeutics 8(6): 1646-1654
Mondet, F.; Oddou, J.-H.; Boyer, C.; Corsois, L.; Collomb, D. 2009: Length of needle and size of prostatic biopsies influence identification of capsular and extracapsular elements. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 19(6): 414-418
Lee, C.Min.; Jee, Y.Seob.; Lee, J-Hee.; Son, S-Yong.; Ahn, S-Hoon.; Park, D.Joong.; Kim, H-Ho. 2014: Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer. World Journal of Gastroenterology 20(30): 10518-10524
Saito, T.; Narita, N.; Yamada, T.; Ogi, K.; Kanno, M.; Manabe, Y.; Ito, T. 2011: Length of nerve gap defects correlates with incidence of nerve regeneration but not with recovery of taste function in patients with severed chorda tympani nerve. Otology and Neurotology: Official Publication of the American Otological Society American Neurotology Society and European Academy of Otology and Neurotology 32(8): 1352-1357
Schweigert, M.; Solymosi, N.; Dubecz, A.; Ofner, D.; Stein, H.J. 2013: Length of nonoperative treatment and risk of pleural empyema in the management of pancreatitis-induced pancreaticopleural fistula. American Surgeon 79(6): 614-619
Krairittichai, U.; Leehacharoenkul, S.; Dowreang, J. 2011: Length of normal kidneys in Thai adults. Journal of the Medical Association of Thailand 94(Suppl 2): S23-S28